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Background
Throughout the course of life, from conception to death, the human body in general and 
the brain in particular are shaped by (interactive) effects of genes and environment. As a 
consequence, individual differences in complex traits, including behavioural traits, reflect a 
mix of variation in genetic make-up and each individual’s unique history of exposures to risk 
and protective environments. This dual contribution of genetic and environmental variance 
is also prominently visible in psychopathological traits, like anxiety and depressive disorders, 
which are the focus of the present thesis.
Studies in genetically informative samples, many of which have used a twin design, show 
that about 40% of clinical anxiety and depression is due to heritable factors, whereas 
the remaining 60% of the risk for anxiety and depressive disorders can be attributed 
to environmental factors1,2, including those that interact with genetic factors3-7. A core 
assumption in this thesis is that these genetic and environmental risk factors primarily act 
through the brain; by changing the brain at a molecular level, they affect structure and 
functioning of brain modules that are critical to mood/emotion regulation. This assumption 
is generally accepted in psychiatry, where depression and anxiety are now regarded to be 
brain diseases. The present thesis, however, deviates from the ‘common view in the field 
with regard to another implicit assumption, namely that environmental risk factors have the 
same pathogenic effects as genetic risk factors. Instead, it is hypothesized that these two 
types of risk may have an impact on different brain structures, or that they may affect the 
same brain structures, but in entirely different, if not opposite, ways. 
Approach
To test this hypothesis, structural and functional brain imaging techniques were used in a 
unique design involving monozygotic (MZ) discordant/concordant twins, which allowed for 
separation of the effects of genetic and environmental risk factors.  In this design, brain 
imaging was first compared in MZ twin pairs that were strongly discordant for the risk of, 
for example, generalized anxiety, obsessive compulsive behaviour, or major depression. In 
these pairs, one twin scored very high on symptoms of these disorders, whereas the co-
twin scored very low. As monozygotic twins always are (nearly) 100% identical at the DNA 
sequence level8, any discordance at the phenotype level should be the result of differential 
exposure to environmental influences, such as the lack of social support (environmental 
deprivation) and life events. Therefore, in these twins, differences in brain activation 
linked to these behavioural traits also reflect environmental effects on the brain, including 
epigenetic effects, rather than effects of variation in DNA sequence. 
Next, MZ twin pairs were selected that were highly concordant for the risk of these traits. 
In one group the risk was very high in both twins, whilst in the other group it was very low. 
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MZ twins can be regarded as repeated sampling of the same genotype that is exposed to 
partly different environments. If the phenotypic resemblance in both twins is very high, 
genetic factors are a likely cause of this resemblance. This is particularly true in anxiety 
and depression, where the only alternative source of resemblance between MZ twins - 
common environmental factors including the sharing of parents - has been shown to have 
no significant impact2. Comparison of MZ twins that are very high on anxious depressive 
symptoms with twins that are very low on anxious depressive symptoms, therefore, 
constitutes a contrast of low versus high genetic risk for anxiety and depressive disorder. 
Verification of the contribution of genetic factors to the phenotypic contrast between 
concordant low and concordant high MZ pairs can be done by testing other family members 
of the twins (e.g. parents or siblings), who are expected to also score very low or very high 
respectively on anxious depressive symptoms. Differences in brain activation linked to 
these behavioural traits between twins from the high-risk families and those from the low-
risk families should mainly reflect effects of variation in DNA sequences between the two 
groups.
To date, the above type of imaging genetics is increasingly used9-18. In addition, there are 
many studies that employ a candidate gene approach to specifically look at cerebral effects 
of potential genetic risk factors. In the latter approach a genetic association is tested 
between measured variation in a candidate gene, usually obtained by previous association 
to a psychiatric outcome, and variation in brain structure and function, typically assessed by 
structural and functional magnetic resonance imaging19-39. This approach allows for mapping 
of the effects of risk genes on neurobiological parameters using neuroimaging, and has the 
advantage of measures causally closer to genes and gene expression than behaviour. It 
also provides a means to uncover the neurobiological mechanisms by which gene variants 
impact on the brain. It has been predicted that this booming field of imaging genetics will 
see further growth over the coming decade40-42. Remarkably, to date most imaging genetics 
studies have employed electroencephalography, magneto-encephalography, structural MRI, 
or functional magnetic resonance imaging (fMRI). At present, there has not been a single 
molecular imaging study using positron emission tomography in which such a monozygotic 
discordant/concordant twin design has been used in the context of anxiety and depressive 
disorders. This lack of molecular imaging studies is somewhat puzzling, but may in part 
be due to the paucity of relevant, adequately evaluated and valid radiotracers needed to 
specifically investigate the molecular basis of anxiety and depression. PET, however, is the 
most direct and sensitive method to measure receptor function in vivo. Therefore, it should 
be an ideal method to detect genetic differences in regional density and affinity of receptors 
for neurotransmitters involved in psychiatric disease. 
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Aims
The aims of this thesis are twofold. Firstly, using the discordant/concordant twin design, 
the hypothesis will be tested that genetic and environmental risk factors impact on partly 
different brain structures or, when they converge on the same brain structures, that they 
may do so in entirely different, perhaps even opposite, ways. Secondly, a new PET ligand, 
[11C]R116301, for in vivo investigation of NK1 receptors will be evaluated, as it is suspected 
that this receptor is involved in anxiety and depression. Molecular imaging studies using 
PET could be the basis of future (genetic) imaging studies focused on pathways involved in 
anxiety and depression.
Together, functional, structural and molecular approaches promise to advance understanding 
of neuropsychiatric disorders, in particular anxiety and depression. This is an important 
mission, because depression and anxiety disorders have high lifetime prevalence (16 and 
10%, respectively) and are associated with substantial morbidity and mortality. Unravelling 
the effects of genetic and environmental risk factors on brain structure and function may 
be the key to better understanding of the neurobiology of neuropsychiatric disorders. 
Ultimately, this may lead towards possibilities for early identification of individuals at risk, 
thereby creating a window for developing preventive strategies, based on individual risk 
profiles. 
Brain imaging techniques in this thesis 
Imaging techniques such as fMRI and structural MRI, magnetic resonance spectroscopy 
(MRS), PET, single photon emission computed tomography (SPECT), provide useful methods 
to obtain insight in the living brain. With these imaging methods, information can be 
obtained on neurobiological parameters such as neuronal activation in time and place, 
volumetry of brain structures, receptor density and affinity, and neurotransmitter 
concentration. This thesis focuses on structural MRI, fMRI and PET methods, each of which 
will be briefly introduced below. 
Structural MRI 
MRI is a relatively new technology, which has been in use for a little more than 30 years. It is 
a non-invasive imaging technique that is used in clinical practice to acquire high-resolution 
digital images of water-containing human tissues. It provides detailed and high contrast 
images everywhere in the body, providing clear distinction between different soft tissues, 
thereby making it especially useful for brain imaging. MRI uses a powerful magnetic field 
to align the nuclear magnetization vectors of atomic nuclei (of hydrogen atoms) in water 
in the body. Absorption and emission of radiofrequency radiation of hydrogen nuclei are 
detectable by the scanner. This signal can be manipulated by additional magnetic fields 
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(phase and frequency encoding) to build up enough information to construct an image of 
the body. 
The advance of volumetric measurements of brain structures using structural MRI 
has resulted in many studies reporting brain structure abnormalities in a number of 
neuropsychiatric disorders. The hippocampal region/formation is one of the brain structures 
that has been a focus of research and this has revealed a number of structural abnormalities 
in a variety of neurological and psychiatric disorders, such as Alzheimer’s disease43,44, mild 
cognitive impairment45, schizophrenia46, major depression47 and anxiety 48, 9 and others.
MR derived volumetric techniques have demonstrated good validity and reproducibility, 
and accuracy of the measurements has been shown by MRI volumetric measurement of 
phantoms with known volumes 50-52.  However, studies on brain structures in neuropsychiatric 
disorders show inconsistencies, both in terms of laterality (left or right), and in direction 
of volume changes (increase of decrease). Part of these discrepancies may be due to the 
different methods  used for measuring brain structure. 
Voxel based morphometry (VBM)53 is an automatic whole brain method and is increasingly 
being used as a tool to examine volume changes at a voxel level, obviating manual 
volumetry, i.e subjective interpretation of anatomic variations. However, it does not provide 
absolute volumes of brain structures. Most (pre)processing and analysis is automated in 
software packages, such as statistical parametric mapping (SPM) (www.fil.ion.ucl.ac.uk/
spm/), although many methodological questions remain, including what template to use 
for normalisation, what level and type of correction to use, and how best to display results. 
Functional MRI
Functional magnetic resonance imaging (fMRI) is an extension of traditional MRI. It is one 
of the most recent neuroimaging modalities. Since the early 1990s, fMRI has increasingly 
been used to study brain function. It uses the varying magnetic properties of the oxygen 
transporter molecule haemoglobin (the blood oxygen level dependent (BOLD) effect) to 
examine brain function in human subjects54. Activated nerve cells consume oxygen carried 
by hemoglobin in red blood cells from local capillaries. The local response to this use of 
oxygen is an increase in blood flow to regions with increased neural activity (hemodynamic 
response). The vascular system actually overcompensates for this oxygen need of neurons in 
an activated state. This leads to a locally increased ratio of oxygenated hemoglobin relative 
to deoxygenated hemoglobin. Because deoxygenated hemoglobin attenuates the MR signal, 
the vascular response leads to a signal increase that is related to neural activity. 
In most fMRI studies, subjects are scanned while performing a certain task (or ‘paradigm’). 
In such paradigms, conditions of interest alternate with reference conditions to produce 
differences in BOLD signal intensity. Task conditions have to be repeated in order to reduce 
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the effects of noise, enabling the detection of signal changes that correlate significantly 
with task stimuli. 
Advantages of fMRI are its good temporal resolution, allowing for event related analyses 
according to task performance, relatively low costs, possibility of repeated measurements, 
and flexible scan duration. Possible limitations of fMRI are its low signal to noise ratio, its 
relative measures (i.e. measuring differences in signal activation: active state compared to 
baseline), sensitivity to artefacts, and the fact that the BOLD signal is not a direct measure of 
neural activity. BOLD signal intensity changes may therefore be difficult to interpret in terms 
of underlying neurodynamics55,56. 
PET
The first commercial PET camera was built in 1978, 2 years before the advent of MRI. 
During the following decades, it was increasingly used as a research tool to measure 
physiologically relevant processes at a molecular level in the living human body and, more 
recently, in animal models of disease. PET scanning is a non-invasive quantitative imaging 
technique involving the use of positron emitting radionuclides. Scans are acquired following 
intravenous injection of a tracer labelled with a radionuclide (called a radioligand in case of 
neuroreceptor studies) that accumulates in the tissue to be studied, and decays by emission 
of a positron (anti-electron). After travelling at most a few millimetres, a positron will 
combine with an electron and the two particles will annihilate almost instantly, resulting in 
the simultaneous release of two gamma rays (photons) with an energy of 511 keV (equivalent 
to the mass of positron or electron) into opposite directions. PET imaging is based on the 
assumption that simultaneous detection of a pair of these gamma rays by two opposing 
detectors of the PET scanner, is the result of an annihilation event along a straight line in 
space connecting these two detectors (line of response). Following the registration of these 
events, counts from all lines of response (sinograms) are reconstructed to provide maps of 
radioactivity distribution. By performing repeated scans over time, kinetic information (rate 
of uptake, clearance) can be obtained. Using tracer kinetic modelling, this can be translated 
into quantitative measures of physiological parameters of interest. 
To perform a scan, a short-lived radioactive ligand or tracer is administered. To this end a 
positron emitting radionuclide is chemically incorporated into a biologically active molecule. 
Development of radiotracers has proven to be time and money consuming and can be seen 
as a limiting factor in PET applications. On the other hand, PET technology can be used to 
trace the biologic pathway of any compound in living humans and many other species, 
provided it can be radiolabelled with a PET radionuclide. 
Several radiotracers have been developed for imaging receptors, neurotransmitter 
transporters, enzymes and other molecular targets. Due to the short half lives of most 
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radionuclides, they must be produced using a cyclotron in close proximity to the PET imaging 
facility. Two commonly used PET radionuclides are [11C] and [18F] with half-lives of 20 and 110 
min, respectively. For example, [18F]MPPF is a ligand of the 5-HT1A receptor, [11C]raclopride a 
ligand of the D2/D3 receptor, and [18F]flumazenil a ligand of the benzodiazepine recognition 
site on the GABA/benzodiazepine receptor complex. Most commonly, [18F]FDG (fluoro-
deoxyglucose) is used for measuring glucose metabolism and [15O]H2O for measuring rCBF 
(regional cerebral blood flow). 
The properties of a PET tracer depend, amongst others, on its metabolism, and its selectivity 
and affinity for the target to be studied, i.e. in this thesis the NK1 receptor.  Another important 
property of a PET tracer is the level of non-specific binding. A signal due to specific binding 
might be lost if the level of non-specific binding (background) is too high. 
At the beginning of the neuroimaging era, more than 30 years ago, the very first activation 
studies were performed using [18F]FDG, followed by [15O]H2O as the method of choice for 
measuring neuronal activation. Nowadays, fMRI has gradually replaced [15O]H2O PET for 
examining the response of the brain to stimuli. Whereas [15O]H2O PET has better signal to noise 
ratio (S/R) and does not suffer from signal loss near bone-air transitions, this is outweighed 
by the higher temporal and spatial resolution of fMRI. Another advantage of fMRI is that it 
does not require administration of radioactive tracers, thereby enabling multiple repeated 
measurements within one subject and flexible duration of experiments. However, PET has 
the unique capability to detect molecular events at picomolar concentrations, compared 
with micromolar concentrations in MRS.
1.1 Outline of this thesis
Chapter 2 begins by examining emotion processing in relation to the risk for anxiety and 
depression. In the literature, functional brain imaging studies have reported deviant 
amygdala responses to emotional stimuli in subjects suffering from anxiety and depressive 
disorder, but compared to healthy controls both hyperactivity and hypoactivity have been 
reported. Using fMRI in extremely discordant (at very low or very high risk for anxiety and 
depression) MZ twins, in chapter 2 the hypothesis is tested that the basis for these discrepant 
findings lies in different effects of genetic and environmental risk factors on amygdala 
functioning .
In chapter 3, neuronal correlates of emotional processing are examined during an encoding 
and recognition paradigm using emotionally salient words in the same design and study 
sample as used in chapter 2. 
In chapter 4, the second part of this thesis, volumetric differences in brain structure are 
examined in relation to the risk for anxiety and depression. As current biological psychiatric 
models assume that genetic and environmental risk factors for anxiety and depression act 
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on the same brain structures, this assumption is tested in this chapter, by applying optimized 
voxel-based morphometry to magnetic resonance images obtained in the same MZ twin 
pairs as mentioned in chapters 2 and 3. 
In part 3 of this thesis, chapter 5 and chapter 6, the ligand [11C]R116301 is evaluated as a 
putative novel PET tracer for the quantification of NK1 receptors. In chapter 5 the presence of 
an NK1 related specific signal is evaluated using a blocking study and in chapter 6 the optimal 
model for quantifying NK1 receptors using [11C]R116301 is derived. 
In chapter 7 the main findings of this thesis are summarised and discussed and 
recommendation of future research are given.
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Abstract 
Background 
Functional brain imaging studies have shown deviant amygdala responses to emotional 
stimuli in subjects suffering from anxiety and depressive disorder, but both hyperactivity 
and hypoactivity compared to healthy controls have been reported. To account for these 
discrepant findings, we hypothesize that genetic and environmental risk factors differently 
impact on amygdala functioning. 
Methods
To test this hypothesis, we assessed amygdala responses to an emotional faces paradigm 
during functional magnetic resonance imaging in monozygotic twin pairs discordant for 
the risk of anxiety and depression (n =10 pairs) and in monozygotic twin pairs concordant 
for high (n=7 pairs) or low (n=15 pairs) risk for anxiety and depression. 
Results
Main effects (all faces vs. baseline) revealed robust bilateral amygdala activity across 
groups. In discordant twins, increased amygdala responses were found for negatively 
valenced stimuli (angry/anxious faces) in high-risk twins compared to their low-risk co-
twins. In contrast, concordant high-risk pairs revealed blunted amygdala reactivity to both 
positive and negative faces compared with concordant low-risk pairs. Post-hoc analyses 
showed that these findings were independent of 5-HTTLPR genotype. 
Conclusions
Our findings indicate amygdala hyperactivity in subjects who are at high risk for anxiety 
and depression through environmental factors and amygdala hypoactivity in those at risk 
mainly through genetic factors. We suggest that this result reflects a difference in baseline 
amygdala activation in these groups. Future imaging studies on anxiety and depression 
should aim to avoid admixture of subjects who are at genetic risk with those at risk due to 
environmental factors. 
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Introduction 
Functional imaging studies of brain correlates of anxiety and depression have converged 
on the amygdala, a structure crucial for emotional processing (Canli et al., 2005; Davidson 
et al., 2003; Drevets, 2001; Fu et al., 2004; Kumari et al., 2003; Lawrence et al., 2004; Rauch 
et al., 2000; Shin et al., 2005; Siegle et al., 2001; Stein et al., 2002; Surguladze et al., 2005; 
Thomas et al., 2001; Wright et al., 2003). A replicated association has been found between 
amygdala reactivity to emotional stimuli and a polymorphism in the serotonin transporter 
gene (Hariri et al., 2002, 2005; Pezawas et al., 2005), and other genes in the serotonergic 
pathway also seem to influence amygdala reactivity (Brown et al., 2005; Buckholtz et al., 
2007; Dannlowski et al., 2007; Iidaka et al., 2005). tioning. About 60% of the risk for anxiety 
and depressive disorders can be attributed to environmental factors (Kendler and Prescott, 
1999; Sullivan et al., 2000) and interaction of genetic and environmental factors has also 
been reported (Caspi et al., 2000; Eley et al., 2004; Grabe et al., 2005; Kaufman et al., 2006; 
Kendler et al., 1986). 
It is currently unclear whether environmental risk factors have the same pathogenic effects 
as genetic risk factors. It is quite possible that these two types of risk impact on the same 
brain structures but in entirely different perhaps even opposite ways. Indeed, deviant 
amygdala responses to emotional stimuli in subjects suffering from anxiety and depressive 
disorder have been observed, but although most studies have found hyperactivity compared 
to healthy controls (Canli et al., 2005; Fu et al., 2004; Siegle et al., 2001; Surguladze et al., 
2005), in others negative findings (Kumari et al., 2003; Lawrence et al., 2004; Davidson et 
al., 2003), or even amygdala hypoactivity has been reported (Drevets, 2001; Thomas et al., 
2001). Such discrepant findings may well arise because genetic and environmental risk 
factors differently impact amygdala functioning. 
Here we employ brain imaging of concordant and discordant monozygotic (MZ) twin pairs 
to test how genetic and environmental risks for anxiety and depression are reflected in 
the amygdala response to emotionally salient stimuli. Monozygotic twins are (nearly) 
always 100% identical at the DNA sequence level (Boomsma et al., 2002) and differences 
in phenotypic status can be expected to reflect discordance for environmental risk factors. 
Discordant MZ twins were selected to be at low or high risk for anxiety disorder and major 
depression based on their ratings on neuroticism, anxiety, and depression in longitudinal 
surveys. A compound risk score for anxiety and depression based on these ratings was 
shown to have strong predictive validity for clinical anxiety and clinical depression in this 
population (Middeldorp et al., 2004) as assessed by the Composite International Diagnostic 
Interview, a well-validated instrument to assess these disorders (Andrews and Peters, 
1998). Because MZ twins are genetically identical, discordance in the risk for anxiety and 
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depression must arise from differential exposure to unique environmental influences. Our 
design allows us to test the hypothesis that these influences affect emotional processing 
by the amygdala. 
In addition to discordant pairs, amygdala responses were assessed in two comparison 
groups of concordant monozygotic twin pairs. In the concordant high-risk group, both MZ 
twins scored high on neuroticism, anxiety, and depression in the longitudinal surveys. In 
the concordant low-risk group, both MZ twins had scored low on neuroticism, anxiety, and 
depression. The contrast between these two groups seems to mainly reflect a difference 
in genetic risk rather than in environmental risk because parents of the high-risk twins 
also scored very high on neuroticism, anxiety, and depression in the longitudinal surveys, 
whereas parents of the low-risk twins scored very low (De Geus et al., 2006). Comparison of 
the low and high scoring subjects allowed us to extend the finding of differential amygdala 
function in patients vs. controls to extreme scoring subjects in the normal population. 
Furthermore, comparing the contrast in amygdalar response between concordant high-
and low-risk pairs to the within-pair contrast in discordant pairs allowed us to test whether 
genetic and environmental risk factors have a similar effect on amygdala responses to 
emotional stimuli. 
Material and methods 
Subjects 
Selection of subjects has been described in detail by De Geus et al. (2006). Briefly, in a 
sample of 2455 same sex twin pairs registered in the Netherlands Twin Registry, a compound 
risk score for anxiety and depression was computed based on a genetic factor analysis of 
longitudinal survey data on trait anxiety, depression, neuroticism, and somatic anxiety (for 
details, see Boomsma et al., 2000). The surveys were collected in 1991, 1993, 1997, and 2000. 
An average risk score was computed for each twin across all available surveys (which could 
vary from one to four surveys). 
Discordant MZ twins pairs were considered eligible for participation if both were right-
handed, the high-risk subject had a risk score at least 0.5 standard deviation above the 
mean, and the score of high-and low-risk twins was at least 2 standard deviations apart. 
To estimate the relative risk for actual anxiety and depression disorder in twins ascertained 
by these criteria, we selected all subjects with comparable low-or high-risk scores from the 
larger sample of 1256 subjects that underwent a CIDI interview in 2000 (Middeldorp et al., 
2004). To resemble the observed mean risk scores in our discordant twins (-0.62 vs. 0.97, SD 
= 0.74), we selected subjects with a risk score of at least 1.5 standard deviation above the 
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mean (1.06) on the 1991, 1993, and 1997 surveys and subjects with a risk score of at least 
0.5 standard deviations below the mean (-0.32). In this sample, the relative risk to receive 
a lifetime depression diagnosis in the high scoring subjects was 11.8 compared with low 
scoring subjects and 40.1 for generalized anxiety disorder. 
A total of 31 discordant MZ twin pairs met our criteria, of which we invited 17 pairs because 
they lived near Amsterdam and had filled out our most recent survey. Two pairs were 
excluded because one of the members had epilepsy or was pregnant. Four pairs refused 
to participate, mainly out of time constraints. One pair turned out to be dizygotic. This left 
a final 10 MZ pairs who were extremely discordant for the risk for anxiety and depression. 
Notably, the risk scores of the high-risk twin in these final 10 pairs did not differ from the 
risk scores in the high-risk twin from the original 31 selected pairs. 
Concordant MZ twin pairs were considered eligible for participation if both were right-
handed and both their risk scores were at least 0.8 standard deviation above (high risk) 
or below (low risk) the mean risk score. An even more stringent selection of extreme risk 
scores was possible here compared to the discordant MZ twin selection, because extreme 
scoring concordant MZ pairs are much less rare than extremely discordant pairs. This 
yielded 115 concordant high-risk and 137 concordant low-risk pairs, of which we invited 48 
pairs that lived near Amsterdam and had filled out our most recent survey. Five pairs were 
excluded because one of the members had a medical illness or was pregnant. Twenty-one 
pairs refused to participate, mainly out of time constraints. This left a final 15 MZ pairs who 
were concordant for low risk and 7 MZ pairs who were concordant for high risk for anxiety 
and depression. Of the total group of 64 MZ, 28 were male and the mean age was 30 years 
(range 20–42 years). 
Procedure 
Subjects visited the outpatient MR unit and experimental procedures were explained 
in detail. Twins from the same pair always came on the same day. Twins were randomly 
assigned to an MRI scan session or a psychometric session. After about 90 min, twins 
switched between sessions. During the psychometric session, cognitive abilities and 
current psychiatric diagnostic state were assessed. All subjects were interviewed using 
the Composite International Diagnostic Interview (Peters and Andrews, 1995; Wittchen, 
1994). The Montgomery Asberg Depression Rating Scale and the Beck Depression Inventory 
were used to assess depressive symptom characteristics and severity scores (Beck et al., 
1961; Montgomery and Asberg, 1979). Furthermore, the state version of the State-Trait 
Anxiety Inventory (Spielberger et al., 1970) was administered pre-and post-scanning. Verbal 
comprehension (IQ) and working memory (forward and backward recall scores of digit scan) 
were assessed using subtests of the Wechsler Adult Intelligence Scale (Wechsler, 1997). 
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Finally, social support was measured using the Duke–UNC questionnaire (Broadhead et al., 
1988) and subjects were asked to recall the occurrence of 21 major life events. These included 
individual (e.g. maltreatment, disease, financial problems, job strain, relational problems) 
events as well as network-related events (e.g. disease or loss of close kin). Subjects were 
asked to locate these events in four temporal categories, i.e. whether they occurred the 
last six months, between 6 and 12 months, between 1 and 5 years, or more than 5 years ago. 
For each event, they indicated the impact on their lives on a 10-point visual analogue scale 
ranging from ‘no impact’ to ‘extreme impact’. 
During each MRI session, which lasted 45 min, subjects performed two tasks using 
emotionally relevant stimuli (faces and words). At first, a verbal memory task took place, 
followed by an emotional faces task. Between the encoding and recognition phase of the 
memory task, a structural MR scan was performed (De Geus et al., 2006). At the end of 
both sessions, subjects were debriefed and received sets of buccal swabs to collect mucosal 
cells for DNA extraction. DNA was used to confirm zygosity using 11 highly polymorphic 
markers and to type the l/s polymorphism in the promoter of the 5HT transporter gene. 
The 5-HTTLPR genotype was assessed in 26 MZ pairs. The ethical review board of the VU 
medical center approved the study and all participants provided written informed consent. 
Task paradigm 
We used an event-related emotional faces paradigm known to reliably activate the anterior 
medial temporal lobe including the amygdala (Wright et al., 2003). All subjects viewed 
human face stimuli: angry, fearful, happy, and neutral human faces (Ekman and Friesen, 
2006), as well as a scrambled face, which was used as a baseline condition. Each face 
stimulus condition consisted of 10 pictures, and each picture was presented three times. 
Stimuli were randomized once and then presented in the same fixed order to all subjects. 
Stimuli were displayed for 2500 ms with a variable interstimulus interval (400–600 ms), to 
increase experimental power and to decrease expectancy effects. To control for overflow 
effects, we displayed a baseline stimulus after each one or two face pictures. 
Subjects were requested to make sex judgments during presentation of face stimuli to 
control for attention differences. Baseline stimuli (scrambled faces) were imbedded with 
two arrows in the center of the screen, and subjects were asked to indicate whether the 
arrows pointed to the left or to the right. To ensure that participants were familiar with 
the procedure, the task was explained outside the scanner before fMRI was performed. No 
feedback regarding the answers was provided during the task. 
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Image acquisition 
Magnetic resonance imaging was performed on a 1.5-T Sonata MR system (Siemens, 
Erlangen, Germany) with a standard RF receiver head coil. Stimuli were generated by a 
Pentium PC and projected on a screen at the end of the scanner table, which was seen 
Table 2:  Regions showing signifi cantly increased brain activation across groups during fMRI scanning (faces vs. baseline)
Region (cortex)  MNI coordinates  Z-value  BA
 X  Y Z
DLPFC L  -48 15 27 3.59* 45
DLPFC R 51 12 27 4.57* 45
VLPFC L  -36 27 0 3.50* 46
VLPFC R  – – –  –  –
Anterior cingulate  -6 9 45 3.12* 24
Amygdala L -21 -6 -18 4.86*
Amygdala R  21 -6 -15  3.94*
Thalamus R  -6 -9 -3 3.87*
Temporo-occipital L  -39 -60 -18  6.55* 4
Temporo-occipital R 39 -57 -18 7.68* 4
Occipital  -33 -90 -12  5.51* 18/19
 36 -87 -9 5.92*
 -6 -93 9 7.08* 17
* Signifi cant FDR corrected at p<0.05.
Cluster size threshold, 5 voxels; BA, Brodmann area; DLPFC, dorsolateral prefrontal cortex; L, left; R, right; VLPFC, ventrolateral 
prefrontal cortex.
Table 3:  Comparison of the amygdala effects (faces vs. baseline) in low-risk and high-risk twins
Condordant pairs
Concordant low-risk twins > concordant high-risk twins
Contrast  Region  MNI coordinates  Z-score
All faces vs. baseline L amygdala  -18 -3 -15  2.59#
 R amygdala  27 -6 -24  3.15*
  21 0 -6  2.97*
Angry/anxious faces vs. baseline  R amygdala  27 -3 -24  3.39*
Happy faces vs. baseline  R amygdala  24 0 -24  2.91*
Discordant pairs
High risk twin > low risk co-twin
Contrast  Region  MNI coordinates  Z-score
All faces vs. baseline  L amygdala  -21 0 -21  2.67*
Angry/anxious faces L amygdala  -30 -6 -21  2.71*
vs. baseline
* Results reported signifi cant at uncorrected p < 0.005, cluster size threshold 5 voxels.
# p=0.0054.
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through a mirror mounted above the subject’s head. Two magnet-compatible four-key 
response boxes were used to record subject’s performance and reaction times (RTs). To 
reduce motion artefacts, the subject’s head was immobilized using foam pads. 
For functional MRI, an echo planar imaging sequence (TR = 3.04 s; TE = 45 ms; matrix: 64 
x 64; field of view: 192 x 192 mm; flip angle = 90°) was used, creating transversal whole-
brain acquisitions (35 slices, 3 x 3-mm in-plane resolution, 2.5-mm slice thickness, 0.5-mm 
interslice gap). In total, 214 EPI volumes per subjects were scanned. In addition, a coronal 3D 
gradient-echo T1-weighted sequence was performed (matrix: 256 x 256, inversion time: 300 
ms, TR = 15 ms, TE = 7 ms; flip angle = 8°; voxel size, 1 x 1 x 1.5 mm, 160 slices). 
Data analysis 
Differences in the questionnaire and interview based variables and in the performance data 
(reaction times) during the faces task were examined by a mixed model ANOVA (MIXED 
SPSS) with type of twin pair (Discordant, Concordant low-risk, Concordant high-risk) and 
risk score level (High, Low) as two fixed factors and family as a random factor to account for 
within-family dependence. Primary planned contrasts were the comparison of the low-risk 
vs. the high-risk co-twin within the 10 discordant pairs, and of the 7 concordant high-risk vs. 
the 15 concordant low-risk pairs. 
Imaging data were analyzed using SPM2 (Statistical Parametric Mapping; Wellcome 
Department of Cognitive Neurology, London, UK). After the first two volumes were 
discarded to allow for magnetic saturation, time series were corrected for differences in 
slice acquisition times and realigned. Next, data were warped to MNI space as defined by 
the SPM EPI template, and spatially smoothed using an 8 mm FWHM Gaussian kernel. After 
spatial preprocessing, data were analyzed using delta functions convolved with a canonical 
hemodynamic response function to model responses to each stimulus type. For each 
subject, weighted contrasts were computed for simple main effects. This was done across 
all stimulus types, i.e. viewing angry/anxious, happy, and neutral faces vs. baseline, and 
within stimulus type, e.g. angry/ anxious vs. baseline. The resulting contrasts images were 
entered into second level (random effects) analyses for between-group comparisons. These 
used a one-way ANOVA for the groups of concordant high-vs. low-risk pairs (Group) and 
paired t-tests for the high-risk twin vs. the low-risk co-twin within discordant pairs (Twin). 
SPM2’s non-sphericity option was used to account for within-pair correlated observations. 
Main effects of risk status (Group or Twin) are reported at p<0.05 FDR-corrected for multiple 
comparisons with an extent threshold of five voxels (Genovese et al., 2002). Interactive 
effects of Risk by stimulus type (angry/anxious vs. baseline, happy vs. baseline, neutral vs. 
baseline; masked with the relevant main effect) within the amygdala region are reported at 
p<0.005 uncorrected, also with an extent threshold of five voxels. 
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Figure 1:  Main effect of faces (all faces vs. baseline) across all 4 experimental groups (upper left panel: 
glass brain; upper right panel: overlaid on T1-weighted anatomical image) and for the subgroups of the concordant low-risk 
pairs (LC, middle left panel), the concordant high-risk pairs (HC, middle right panel), the discordant low-risk twins (LD, lower 
left panel), and their high-risk co-twins (HD, lower right panel).
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Figure 2:  Left panel: parameter estimates (% signal change) and 90% confidence intervals for angry/anxious/
happy/neutral faces vs. baseline (scrambled faces) inconcordant high-risk (effects 1–4) vs. concordant low-risk twins (effects 
5–8). Right panel: parameter estimates (% signal change) and 90% confidence intervals for angry/anxious/happy/neutral faces 
vs. baseline (scrambled faces) in concordant high-risk (effects 9–12) vs. concordant low-risk twins (effects 13–16).
Results 
Demographic data and depression/anxiety ratings (BDI, MADRS, STAI-state) obtained at 
the time of the scanning session are listed in Table 1. Age and male/female distribution 
was not significantly different across the groups. Only one subject in a concordant high-
risk pair received a current diagnosis of depression using these instruments. One further 
subject currently used antidepressant medication (SSRI). This was the subject with the high-
risk score from a discordant pair. Mixed ANOVA confirmed that the concordant low-risk 
pairs scored significantly lower on the MADRS, BDI, and state anxiety measures than the 
concordant high-risk pairs. Within the discordant pairs, the MADRS, BDI, and state anxiety 
measures all showed significant intra-pair differences in the expected direction. 
Reaction times during the task (sex judgments) for angry, anxious, happy, neutral faces, and 
across categories did not differ significantly between groups (mean RT±SD: angry faces, 
800±171 ms; anxious faces, 787±170 ms; happy faces, 794±172 ms; neutral faces, 769± 173 
ms; across categories, 787±166 ms; baseline, 698±132 ms). 
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Imaging data 
Effects of faces 
Across groups, viewing faces compared to baseline were associated with robust activity 
in bilateral occipital cortex, extending into fusiform gyrus and posterior parahippocampal 
gyrus, as well as in bilateral amygdala, with additional activity in predominantly left lateral 
prefrontal cortex, dorsal anterior cingulate cortex, and thalamus (Table 2). These effects 
are depicted across groups (Fig. 1, upper panel) and for individual groups (Fig. 1, middle and 
lower panels). 
Within-pair comparison of the discordant twins 
Across the neutral, happy, and angry/anxious faces, paired t-tests comparing the low-risk 
twin to the high-risk co-twin showed increased left amygdala activity in the high-risk twin 
(Table 3). Risk x stimulus type interaction analyses in discordant twins revealed increased 
left amygdala activity for angry/anxious faces in high-risk twin compared to the low-risk 
co-twin, whereas this comparison failed to reach significance for happy or neutral faces 
(Fig. 2, left panel). High-risk twins had substantially higher state anxiety levels before the 
scan compared to their low-risk co-twin (see Table 1). Rerunning the analyses using these 
state anxiety levels as a covariate rendered all amygdala effects non-significant. 
Group comparison of concordant high-risk and low-risk twin pairs 
Across the neutral, happy, and angry/anxious faces, we observed increased activity over 
baseline in bilateral amygdala for concordant low-risk pairs compared to high-risk pairs 
(using one-way ANOVA), with left amygdala approaching significance (Table 3). Risk x 
stimulus type interaction analyses showed increased amygdala activity in low-risk pairs 
compared to the high-risk pairs for angry/anxious faces and happy faces relative to baseline, 
but not for neutral faces (Fig. 2, right panel). In contrast to the findings in discordant twins, 
rerunning the analyses using state anxiety levels before the scan as a covariate left all 
group differences in amygdala reactivity significant. 
Table 4:  5-HTTLPR genotype in the three types of MZ twin pairs
 5-HTTLPR genotype
 LL LS/SL  SS  Total
Discordant twin pairs  4  12 2  18
Concordant high-risk pairs  4  4  0  8
Concordant low-risk pairs  8  14 4  26
Total pairs 16  30  6 52
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Additional post hoc analyses showed highly similar results after excluding the subject 
meeting criteria for clinical depression and the subject using antidepressants. In addition, 
in a secondary analysis, we failed to observe amygdala activity when contrasting baseline 
trials with neutral faces in either the comparison of the low-risk twin with the high-risk 
co-twin in discordant pairs or in the comparison of concordant low-risk and high-risk pairs. 
5-HTTLPR genotypes 
Previous studies have reported differential amygdala responsivity in subjects with different 
genotypes for a functional polymorphism in the gene coding for the serotonin transporter 
(LL vs. LS vs. SS; Munafò et al., 2007). Because the frequency of the LL genotype in the 
concordant high-risk pairs is high compared to that found in unselected samples, part of the 
attenuated amygdale response may have reflected effects of this particular polymorphism. 
To test whether our findings reflected effects of the 5-HTTLPR genotype, we first examined 
the 5-HTTLPR genotype distribution across groups (Table 4). Permutation tests showed that 
5-HTTLPR genotype was not related to twin depression status (low or high risk for anxiety 
and depression). Next, we examined whether the amygdala response differed as a function 
of genotype by contrasting the BOLD responses of the LL (n = 8 pairs) and SL/ SS (n = 18 pairs) 
5-HTTLPR genotypes. This was done independent of risk or concordance status, i.e. pooled 
across the four groups. No significant differences between genotype groups were found. 
Discussion 
The main aim of this study was to investigate differences in amygdala response to emotional 
faces in relation to a “pure” environmental risk for depression and anxiety and to contrast 
this with the amygdala response in relation to genetic risk. All subjects viewed positively 
and negatively valenced emotional and neutral faces during functional MR imaging. 
Analysis of imaging data revealed robust activation in visual processing areas including the 
fusiform face area as well as in bilateral amygdala, left ventrolateral prefrontal cortex, and 
bilateral dorsolateral prefrontal cortex, the latter presumably reflecting sex categorization 
(Adams and Janata, 2002). These results are in agreement with a number of previous 
studies using a similar paradigm. Specifically, although in some studies predominantly 
right-sided responses were observed, irrespective of emotion (Gur et al., 2002), in others 
bilateral amygdala responses were found across stimulus conditions (Britton et al., 2006; 
Fitzgerald et al., 2006; Yang et al., 2002), similar to the present study. 
In discordant MZ twin pairs, increased left amygdala responsiveness was found in the high-
risk twin for angry/anxious faces. As MZ twins are nearly always genetically identical, this 
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amygdala hyperactivity in the high-risk twin necessarily reflects the role of environmental 
factors. Indeed, as reported previously (De Geus et al., 2006), nine out of the ten high-risk 
twins from the discordant pairs reported major life events that occurred more than 5 years 
ago, and 5 twins reported multiple events. From the low-risk co-twins, only four reported 
such events, and only one reported multiple events. In addition, the average impact of the 
life events was generally rated to be larger by the high-risk twins. In keeping with these 
findings, amygdala hyperactivity in response to faces has been found in posttraumatic 
stress disorder (Rauch et al., 2000; Siegle et al., 2001), in which life events are by definition 
of aetiological significance, but also in social phobia and generalized anxiety disorder (Stein 
et al., 2002), in which the role of genetic factors may be only modest (Middeldorp et al., 
2004; Mackintosh et al., 2006). In contrast, normal or even lowered amygdala responses to 
emotional faces have been reported in simple phobias (Wright et al., 2003) and obsessive– 
compulsive disorder (Cannistraro et al., 2004). 
At odds with our findings in discordant twins, the concordant high-risk twin pairs had a 
blunted amygdala response to emotional faces. Assessment of parental data for all pairs 
confirmed higher values for all risk traits in the parents of the concordant high-risk twins 
compared to the parents of the concordant low-risk twins (De Geus et al., 2006). Although 
additional exposure of the high-risk twin pairs cannot be excluded, this strongly suggests 
that the concordant pairs mainly represent a contrast in genetic risk. Hence, we observed a 
clear dissociation in the amygdala responses of subjects who were at high-risk for anxiety 
and depression through environmental causes (hyperactivity) compared to those mostly at 
risk through genetic factors (hypoactivity). 
These clear differences in the effects of genetic and environmental risk factors might help 
explain the inconsistency in the outcome of previous fMRI studies using similar emotional 
paradigms in MDD patients and controls. Increased responses to negative emotional 
stimuli in depressed subjects were observed by several investigators (Canli et al., 2005; Fu 
et al., 2004; Siegle et al., 2001; Surguladze et al., 2005), although decreased responding to 
positive emotional stimuli (happy faces) has also been found, which was associated with 
anhedonia severity (Surguladze et al., 2005). Other groups, however, failed to observe 
differential amygdala activity (Davidson et al., 2003; Kumari et al., 2003; Lawrence et al., 
2004) or even reported a blunted response, in depressed children (Thomas et al., 2001) and 
familial depression (Drevets, 2001), respectively. These inconsistencies have been attributed 
to methodological issues (e.g. medication use), or differences in state anxiety (Sheline et 
al., 2001). In the present study, medication use was virtually absent in the high-risk twins 
which rules this out as an explanation here. Anxiety ratings were high in both discordant 
high-risk twins and concordant high-risk twin pairs which suggest that state anxiety 
cannot fully account for the contrast between hyporeactivity and hyperreactivity. Instead, 
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genetic and environmental risk factors, although converging on the same pathway, seem 
to exert different effects on amygdala functioning. Hence, differential exposure of patients 
to genetic or environmental risk factors, perhaps related to ascertainment methods, may 
account for part of the differential findings in the literature. 
Previous research in genetically contrasted groups has revealed larger amygdala activity 
in response to emotional faces in subjects with one or two copies of the short allele of the 
serotonin transporter promoter (HTTLPR) polymorphism (Bertolino et al., 2005; Hariri et al., 
2002, 2005). Since the short allele carriers have an increased risk for anxiety and depression 
compared to long allele homozygotes, particularly in interaction with life stress (Caspi et 
al., 2003), it might be argued that our findings could be explained by differential genotypes 
for the serotonin transporter gene in the three groups of twins (concordant low-risk, 
concordant high-risk, discordant). This was not the case, as there was no difference in the 
distribution of the HTTLPR alleles between the three groups. This is not without precedent 
since amygdala responsiveness has previously been found to be modulated by personality 
style (Bertolino et al., 2005) and harm avoidance (Hariri et al., 2005), independent of the 
5-HTTLPR genotype. Also, a direct test of 5-HTTLPR genotype effects on the amygdala 
response was nonsignificant. This may reflect the small sample size, but null findings have 
been noted before (Munafò et al., 2007). 
This leaves us to explain the attenuated amygdala responses in the concordant high-risk 
twins, a group selected to be at high genetic risk for anxiety and depression. Based on 
the proposed inverse relationship between amygdala reactivity and baseline amygdala 
activation (Canli et al., 2006), we hypothesize that this genetic risk co-occurs with an 
increase in baseline amygdala activation. This is in keeping not only with recent perfusion 
MRfindings (Canli et al., 2006) showing increased baseline amygdala perfusion in subjects 
with decreased responsiveness to emotional stimuli, but also with SPECT-and PET-resting-
state studies in familial MDD patients by Drevets and coworkers (Drevets, 2000a,b, 2001, 
2003). A consistent finding in these latter studies has been elevated baseline amygdala 
perfusion and/or glucose uptake in patients with familial MDD (Drevets, 2000 a,b, for an 
overview). The mechanism of increased amygdala baseline metabolism in familial MDD is 
insufficiently understood, but may reflect both altered afferent transmission (increased 
glutamatergic input from ventral prefrontal areas and/or decreased inhibitory control from 
dorsal medial PFC) as well as a shift from ISPS to ESPS within the amygdala due to elevated 
CRF secretion (Drevets, 2003; Phillips et al., 2003; Shekhar et al., 2003). Animal research 
has indicated that the increase in regional CBF or metabolism may be as high as 50–70% 
(Drevets, 2003). Although this is still in the physiological range, it is conceivable that a rise 
in baseline perfusion of such magnitude may compromise amygdala responsiveness during 
processing of emotional stimuli. At present, such an explanation is speculative, since studies 
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in MDD assessing both amygdala resting state perfusion and responsiveness to emotional 
stimuli have been rare (Anand et al., 2005). Moreover, it should be taken into account that 
only one of our concordant high-risk twins met criteria for major depression at the time of 
scanning, so that extension of our findings of blunted amygdala responsiveness to clinical 
studies should be done with caution. 
Various limitations of this study should be discussed. First, it is important to note that, 
although our selection of high-and low-risk twins was based on trait measures, the high-and 
low-risk twins were also strongly discriminated in state anxiety levels at the time of testing. 
This is an expected outcome. Individuals high on trait scores for neuroticism, anxiety, and 
depression are expected to respond to the study setting (unfamiliar environment, imperfect 
prediction of things to come, unknown experimenter, intimidating MRI apparatus, etc.) 
with more anxiety then individuals with low scores for these traits. It is of note that these 
state anxiety differences do not escape the basic tenet of our design: they will derive 
from differential environmental exposure in the discordant pairs and mainly derive from 
a difference in genetic make-up in the concordant pairs. Nonetheless, the effects of risk 
status defined by the longitudinal assessed trait values were obviously confounded with 
the effects of state anxiety. In an attempt to separate the effects of trait from state effects, 
we reran the analyses using state anxiety before the scan as a covariate. This was expected 
to largely undo the effects of our careful longitudinal selection for high trait values in both 
genetic and environmental contrasts. Instead, hypoactivity in the high-risk concordant twins 
remained significant, whereas hyperactivity of the high-risk discordant twin disappeared. 
This suggests that high state anxiety is responsible for amygdala hyperactivity in subjects 
at risk through environmental factors. They behave as healthy subjects deliberately made 
anxious by employing aversive conditioning paradigms. Increased amygdala responsiveness 
has consistently been observed in such paradigms (Buchel et al., 1998, 1999; Schienle et al., 
2005). In contrast, the increased baseline activation in subjects at genetic risk seems to 
completely overrule these normal effects of state anxiety. Only a design that manages to 
assess the effects of state and trait anxiety independently can fully resolve this issue. 
As a second limitation, it should be noted that blunted amygdala responses in high-
concordant subjects could be due to increased amygdala responsiveness to the baseline 
trials, as was recently demonstrated by Heinz et al. (2007). In their study, these authors 
showed that in s-allele carriers, amygdala activation was increased during passively 
viewing a fixation cross relative to neutral stimuli, explained as resulting from experiencing 
(stressful) uncertainty. However, in the present study, post-hoc analyses failed to show 
amygdala activity when contrasting baseline trials with neutral faces. We avoided the use 
of unconstrained baseline trials (Stark and Squire, 2001) by requesting subjects to report the 
direction of arrows (overlaid on scrambled faces) which apparently attenuates the effect of 
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the uncertainty generated by fixation cross type baseline stimuli. 
Finally, we acknowledge that the discordant MZ twins may not have been perfect genocopies. 
A number of rare occurrences can lead to genetic differences between MZ twins (Martin et 
al., 1997)and such MZ twin pairs may be enriched in a sample that is highly selected for 
trait discordance. If these MZ twins were not genetically identical this would question the 
role of the environment in making them discordant. In contrast to this idea and in keeping 
with true differences in environmental exposure, we found that the high-risk discordant 
twins had been exposed to adverse life events more often than their low-risk co-twin. Also, 
the most likely source of genetic differences within twin-pairs, epigenetics, seems to be 
primarily driven by differential environmental exposure itself (Fraga et al., 2005). 
In summary, we observed decreased amygdala reactivity to emotional (positive and 
negative) faces in twins at high genetic risk for anxiety and depression, whereas increased 
responsiveness to negatively valenced faces was observed in twins at high environmental 
risk. We suggest that this result reflects a difference in baseline amygdala activation in 
these two groups. Further research should aim to elucidate pathophysiological mechanisms 
of amygdala dysfunction in genetically vs. environmentally driven anxiety and depression. 
In addition, future imaging studies on anxiety and depression should avoid admixture of 
subjects who are at risk due to genetic factors with those at risk due to environmental 
factors. 
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Abstract 
Emotional processing and brain activation were examined during an encoding and 
recognition paradigm using emotionally salient words in a sample of monozygotic twin 
pairs at low or high risk for anxiety and depression. Discordant twin pairs were used to chart 
the effects of environmental risk factors and concordant twin pairs were used to chart the 
effects of genetic risk factors on performance and brain activation. 
Performance data did not support the existence of a negative response bias in subjects at 
high risk. At the neural level, however, increased left inferior frontal gyrus (LIFG) activation 
by negative words was found in high-risk subjects, most prominently during recognition. 
Increased LIFG activity was found in subjects at high risk through either genetic or 
environmental risk factors. These results suggest that fMRI activation of the LIFG in a verbal 
emotional memory task may be a useful vulnerability marker for anxiety and depression. 
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Introduction 
Psychological theories of major depression have emphasized the role of negative biases in 
information processing in the etiology and the maintenance of the disorder (Beck, 1967). 
Such biases have been reported both for the interpretation and storage of emotional 
information (Bradley et al., 1995; Leppanen, 2006; Murphy et al., 1999; Phillips et al., 2003). 
For example, in facial expression recognition tasks, depressed patients show a bias away 
from positive towards negative emotions, i.e. reduced recognition of positive expressions 
and increased perception of negative expressions (Gur et al., 1992; Bouhuys et al., 1995; 
Surguladze et al., 2004). Negative perceptual and memory biases have also been found 
in healthy volunteers following negative mood induction (Bouhuys et al., 1995; Teasdale 
and Russell, 1983). Furthermore, there is evidence that abnormal emotional processing may 
persist in the non-depressed state (Bhagwagar et al., 2004; Hayward et al., 2005; Leppanen, 
2006) and is associated with poor outcome (Beevers et al., 2007). These observations raise 
the possibility that emotional biases might pre-date the onset of clinical depression and 
thereby represent a risk factor for the subsequent development of illness in predisposed 
individuals. 
To investigate emotional bias prior to the onset of depression it is necessary to study 
people who are at risk for anxiety and depression but who are not clinically depressed. Until 
now, studies combining brain imaging and neuropsychological testing in groups at high 
risk for depression and anxiety, but not yet affected, have been scarce. Moreover, these 
studies have focused primarily on executive functioning, whereas functional imaging 
studies investigating emotion processing in a memory paradigm have been lacking. Here 
we examined emotion processing, memory performance, and brain activation during 
an encoding and recognition paradigm using emotionally salient words in a sample of 
longitudinally followed monozygotic (MZ) twin pairs selected to be at low or high risk 
for anxiety disorder and major depression based on their ratings on neuroticism, anxiety, 
and depression in longitudinal surveys. A compound risk score for anxiety and depression 
based on these ratings was shown to have strong predictive validity for clinical anxiety and 
clinical depression in this population (Middeldorp et al., 2004) as assessed by the Composite 
International Diagnostic Interview, a well-validated instrument to assess these disorders 
(Andrews and Peters, 1998). High-risk twins were included only, however, when they were 
not clinically depressed or anxious at the time of MRI recording, as assessed by a structured 
psychiatric interview. 
About 60% of the risk for anxiety and depressive disorders can be attributed to 
environmental factors (Kendler and Prescott, 1999; Sullivan et al., 2000) and interaction 
of genetic and environmental factors has also been reported (Caspi et al., 2000; Eley et al., 
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2004; Grabe et al., 2005; Kaufman et al., 2006; Kendler et al., 1986). It is currently unclear 
whether environmental risk factors have the same pathogenic effects as genetic risk 
factors. It is quite possible that these two types of risk impact on emotional processing 
but through entirely different routes. To separate the effects of genetic and environmental 
risk factors on emotional biases, we here employed the concordant and discordant twin 
pair design described earlier (de Geus et al., 2007). To detect the effects of environmental 
risk factors, performance and brain activation were compared in MZ twin pairs that were 
discordant for the risk for anxiety and depression. In these pairs, one twin scored high on 
neuroticism, anxiety, and depression in longitudinal surveys, whereas the co-twin scored 
low on these measures. Because monozygotic twins are (nearly) always 100% identical 
at the DNA sequence level (Boomsma et al., 2002), this discordance in the risk for anxiety 
and depression must arise from differential exposure to unique environmental inﬂuences. 
Differences in performance and brain activation during encoding and retrieval of emotionally 
salient words between the high-risk twin and the low-risk co-twin, therefore, must reﬂect 
environmental effects on emotional biases. To detect the effects of genetic risk factors 
on emotional biases we compared the performance and brain activation during encoding 
and recognition in twin pairs concordant for low risk with that in twin pairs concordant 
for high risk, i.e., both MZ twins of the pair scored low or high on neuroticism, anxiety, and 
depression in longitudinal surveys. The contrast between these two groups mainly reﬂects 
a difference in genetic risk rather than in environmental risk because parents of the high-
risk twins also scored very high on neuroticism, anxiety, and depression in the longitudinal 
surveys, whereas parents of the low-risk twins scored very low (de Geus et al., 2007). 
Neuroimaging studies of verbal encoding and recognition to date have found that the 
main neural correlates of semantic processing and retrieval of words are the left inferior 
frontal gyrus in healthy volunteers (LIFG, Fletcher and Henson, 2001), reﬂecting semantic 
elaboration in working memory, and the medial temporal lobe (MTL), including the 
fusiform gyrus and hippocampus (Squire and Knowlton, 2000), the latter thought to 
reﬂect intermediate memory storage. Taken the hypothesized emotional bias, we expected 
twins at high risk for anxiety and depression to show higher levels of semantic elaboration 
at encoding, reﬂected by differential activity in LIFG and/or MTL, and better memory 
performance during recognition for negative words, again paired to differential activity 
in LIFG and/or MTL. For neutral stimuli we did not expect to see an effect of the risk for 
anxiety and depression on either performance or brain activation and for positive stimuli 
we expected effects in the opposite direction. The concordant/ discordant twin design 
further enabled us to explore whether environmental and genetic risk factors for anxiety 
and depression inﬂuence performance and brain activation during verbal encoding and 
recognition in different ways. 
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Material and methods 
Subjects 
Selection of subjects has been described in detail by de Geus et al. (2007). Brieﬂy, in a sample 
of 2455 same sex twin pairs registered in the Netherlands Twin Registry, a compound risk 
score for anxiety and depression was computed based on a genetic factor analysis of 
longitudinal survey data on trait anxiety, depression, neuroticism and somatic anxiety (for 
details see Boomsma et al., 2000). The surveys were collected in 1991, 1993, 1997 and 2000. 
An average risk score was computed for each twin across all available surveys (which could 
vary from one to four surveys). 
Discordant MZ twin pairs were considered eligible for participation if both were right-
handed, the high-risk subject had a risk score at least 0.5 standard deviation above the 
mean, and the score of high-and low-risk twins were at least 2 standard deviations apart. 
To estimate the relative risk for actual anxiety and depression disorder in twins ascertained 
by these criteria, we selected all subjects with comparable low-or high-risk scores from the 
larger sample of 1256 subjects that underwent a CIDI interview in 2000 (Middeldorp et al., 
2004). To resemble the observed mean risk scores in our discordant twins (-0.62 vs. 0.97, 
S.D. = 0.74), we selected subjects with a risk score of at least 1.5 standard deviation above 
the mean (1.06) on the 1991, 1993, and 1997 surveys and subjects with a risk score of at least 
0.5 standard deviations below the mean (-0.32). In this sample the relative risk to receive a 
lifetime depression diagnosis in the high-scoring subjects was 11.8 compared to lowscoring 
subjects and 40.1 for generalized anxiety disorder. 
A total of 31 discordant MZ twin pairs met our criteria, of which we invited 17 pairs because 
they lived near Amsterdam and had ﬁlled out our most recent survey. Two pairs were 
excluded because one of the members had epilepsy or was pregnant. Four pairs refused 
to participate, mainly out of time constraints. One pair turned out to be dizygotic. This left 
a ﬁnal 10 MZ pairs who were extremely discordant for the risk for anxiety and depression. 
Notably, the risk scores of the high-risk twin in these ﬁnal 10 pairs did not differ from the 
risk scores in the high-risk twin from the original 31 selected pairs. 
Concordant MZ twin pairs were considered eligible for participation if both were right-
handed and both their risk scores were at least 0.8 standard deviation above (high risk) 
or below (low risk) the mean risk score. An even more stringent selection of extreme risk 
scores was possible here compared to the discordant MZ twin selection, because extreme 
scoring concordant MZ pairs are much less rare than extremely discordant pairs. This 
yielded 115 concordant high-risk and 137 concordant low-risk pairs, of which we invited 48 
pairs that lived near Amsterdam and had ﬁlled out our most recent survey. Five pairs were 
excluded because one of the members had a medical illness or was pregnant. Twenty-one 
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pairs refused to participate, mainly out of time constraints. This left a ﬁnal 15 MZ pairs who 
were concordant for low risk and 7 MZ pairs who were concordant for high risk for anxiety 
and depression. Of the total group of 64 MZ, 28 were male and the mean age was 30 years 
(range 20–42 years). 
Procedure 
Subjects visited the outpatient MR unit and experimental procedures were explained 
in detail. Twins from the same pair always came on the same day. Twins were randomly 
assigned to an MRI scan session or a psychometric session. After about 90 min twins 
switched between sessions. During the psychometric session, cognitive abilities and 
current psychiatric diagnostic state were assessed. All subjects were interviewed using the 
Composite International Diagnostic Interview (Peters and Andrews, 1995; Wittchen, 1994), 
a clinical interview that assessed the occurrence of a current or recent depressive episode 
(6 months). The Montgomery Asberg Depression Rating Scale and the Beck Depression 
Inventory were used to assess depressive symptom characteristics and severity scores (Beck 
et al., 1961; Montgomery and Asberg, 1979). Furthermore, the state version of the State-
Trait Anxiety Inventory (Spielberger et al., 1970) was administered pre-and post-scanning. 
Verbal comprehension (IQ) and working memory (forward and backward recall scores of 
digit scan) were assessed using subtests of the Wechsler Adult Intelligence Scale (Wechsler, 
1997). Finally, social support was measured using the Duke-UNC questionnaire (Broadhead 
et al., 1988) and subjects were asked to recall the occurrence of 21 major life events. These 
included individual (e.g. maltreatment, disease, ﬁnancial problems, job strain, relational 
problems) events as well as network-related events (e.g. disease or loss of close kin). Subjects 
were asked to locate these events in four temporal valences, i.e. whether they occurred the 
last 6 months, between 6 and 12 months, between 1 and 5 years or more than 5 years ago. 
For each event they indicated the impact on their lives on a 10-point visual analogue scale 
ranging from ‘no impact’ to ‘extreme impact’. 
During each MRI session, which lasted 45 min, subjects performed two tasks using 
emotionally relevant stimuli (faces and words). At ﬁrst, a verbal memory task took place, 
followed by an emotional faces paradigm, results of which will be reported elsewhere. 
Between the encoding and recognition phase of the memory paradigm a structural MR 
scan was performed. At the end of both sessions subjects were debriefed and received 
sets of buccal swabs to collect mucosal cells for DNA extraction. DNA was used to conﬁrm 
zygosity using 11 highly polymorphic markers. The ethical review board of the VU medical 
centre approved the study and all participants provided written informed consent. 
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Task paradigm 
Prior to scanning, all participants practiced the event-related encoding paradigm outside 
the scanner on a personal computer. In the scanner, a device with response buttons was 
positioned near the right hand of the participant. During all task blocks, participants had 
to respond in a forced choice fashion by pushing the left button with the index ﬁnger or 
the middle button with the middle ﬁnger or the right button with the ring ﬁnger. Stimuli 
were presented in a self-paced fashion, although a time limit of 5 s was maintained in case 
of nonresponses. The event-related retrieval paradigm followed 15 min after the encoding 
phase and was explained and practiced inside the scanner and presented by surprise. 
Participants were requested to judge the valence of the word during the encoding phase. 
During recognition, they were requested to indicate whether or not each word had 
appeared previously in the encoding task. On each trial, response options were indicated at 
the bottom of the screen by an arrow pointing to the left (‘«« negative’ in the encoding; ‘«« 
seen’ in the retrieval), and middle (‘»»neutral«« ’, ‘»»probably seen«« ’) and right (‘positive»»’; 
‘not seen««’). Beforehand, it was explained that pushing the left button corresponded to 
the left arrow, etc. Scores were only registered when participants responded within the 5 s 
time limit. To increase experimental power and to minimize expectancy effects, a variable 
interstimulus interval (200–600 ms, offset to onset) was used. 
Forty baseline trials were added to each phase (encoding and recognition). During a baseline 
trial, participants were presented with a cue to press either the left (‘«« left’) or the middle 
(‘«« middle»»’) or the right button (‘right»»’). All types of baseline stimuli were presented 
equally often. 
Material 
The stimuli consisted of 240 Dutch words and 80 baseline stimuli. One third of the words 
had a negative connotation, one third of the words had a neutral connotation and one 
third of the words had a positive connotation. The valence of the stimulus material was 
validated in a perceptual clariﬁcation task (Ter Laak, 1992, unpublished Master’s thesis), 
in which these words were recognized most consistently and rapidly as negative, neutral 
and positive words under conditions of minimal presentation conditions. A subset of 40 
positive, 40 neutral and 40 negative words were randomly selected and ordered for the 
affective evaluation task (encoding). All three subsets were matched for word length, 
word type (verbs, adjectives and nouns) and frequency of usage. The use of abstract words 
was avoided. For the recognition phase, another subset of 40 positive, 40 neutral and 40 
negative words were randomly selected in the same way and designated as ‘new’ words. 
Before the experiment, the trials were randomly intermixed into blocks. For the encoding 
phase, 20 blocks consisting of 2 positive, 2 negative, 2 neutral words and 2 baselines were 
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randomised. The resulting random sequence of 160 stimuli was used for all subjects to 
optimise comparison between subjects. For the recognition phase 20 blocks consisting 
of 2 positive, 2 neutral and 2 negative words from the encoding phase and 2 positive, 2 
neutral and 2 negative new words and 2 baselines were randomised. Half of the words 
were ‘new’ words and half were old words presented during the encoding phase. As for 
encoding, the same random sequence of 280 stimuli was generated once and then used 
for all subjects. To prevent primacy and recency effects in the recognition task, three buffer 
words proceeded and followed the encoding stimuli. In addition, to let the participants 
get used to the unexpected recognition task, three buffer words preceded this phase. No 
feedback regarding the answers was provided during the experiment. 
Performance measures 
Performance during the encoding phase was measured by the error rates and mean reaction 
times (RT) for words that were later correctly recognized as ‘seen’ with certainty. In the 
recognition phase, sensitivity (Pr = proportion hits -proportion false alarms) and response 
bias Br (=false alarms/(1 -Pr)) were calculated for encoded negative, neutral and positive 
items, according to two-high-threshold theory (Snodgrass and Corwin, 1988). 
Image acquisition 
Magnetic resonance imaging was performed on a 1.5-T Sonata MR system (Siemens, 
Erlangen, Germany) with a standard RF receiver head coil. Stimuli were generated by a 
Pentium PC and projected on a screen at the end of the scanner table, which was seen 
through a mirror mounted above the subject’s head. Two magnet-compatible four-key 
response boxes were used to record subject’s performance and reaction times (RTs). To 
reduce motion artefacts, the subject’s head was immobilized using foam pads. 
For functional MRI, an echo planar imaging sequence (TR 3.04 s, TE 45 ms, matrix 64 x 
64, ﬁeld of view 192 mm x 192 mm, ﬂip angle 90º) was used, creating transversal whole-
brain acquisitions (35 slices, 3 x 3-mm in-plane resolution, 2.5-mm slice thickness, 0.5-mm 
interslice gap). 
Data analysis 
Differences in the questionnaire-and interview-based variables were examined by a 
mixed model ANOVA (MIXED SPSS) with group (discordant low risk, discordant high risk, 
concordant low risk, concordant high risk) as a ﬁxed factor and family as a random factor to 
account for within-family dependence. With respect to performance, error rates and mean 
reaction times (RT) for correct responses during encoding and hits and false alarms as well 
as the two signal detection measures during recognition were tested by a similar MIXED 
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ANOVA that additionally added word valence (negative, neutral and positive) as a second 
ﬁxed factor. Primary planned contrasts in main or interaction effects involving groups were 
the comparison of the low-risk twin versus the high-risk co-twin in discordant pairs and the 
concordant low-risk twin pairs versus the concordant high-risk twins. 
Imaging data were analysed using SPM2 (Statistical Parametric Mapping; Wellcome 
Department of Cognitive Neurology, London, UK). After the ﬁrst two volumes were 
discarded to allow for magnetic saturation, time series were corrected for differences in 
slice acquisition times and realigned. Next, data were warped to MNI space as deﬁned 
by the SPM EPI template, and spatially smoothed using an 8-mm FWHM Gaussian kernel. 
After spatial preprocessing, data were analysed using delta functions convolved with 
a canonical hemodynamic response function to model responses to each stimulus type. 
For each subject, weighted contrasts were computed for 4 simple main effects: this was 
done across all word valences (correctly remembered words vs. baseline), and for each word 
valence separately (correctly remembered positive/negative/ neutral words vs. baseline). 
The resulting contrast images were entered into second-level (random effects) analyses for 
between subject comparisons. A paired t-test was used for the comparison of the low-risk 
twin versus the highrisk co-twin in discordant pairs (Twin) and a one-way ANOVA for the 
comparison of concordant low-and high-risk pairs (Group). SPM2’s nonsphericity option was 
used in the latter analysis to account for within-pair correlated observations. Main effects 
of all words across groups are reported at p<0.05 FDR-corrected for multiple comparisons 
with an extent threshold of ﬁve voxels (Genovese et al., 2002). Group interactions across 
word valence and interactive effects of Group/Twin by Word valence (negative vs. baseline, 
neutral vs. baseline, positive vs. baseline; masked with the relevant main effect) are 
reported at p<0.001 uncorrected, unless indicated otherwise, also with an extent threshold 
of ﬁve voxels. 
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Results 
Demographic data and depression/anxiety ratings (BDI, MADRS, STAI-state) obtained at the 
time of the scanning session are listed in Table 1. Age and male/female distribution were not 
signiﬁcantly different across the groups. Mixed ANOVA conﬁrmed that the concordant low-
risk pairs scored signiﬁcantly lower on the MADRS, BDI, and state anxiety measures than the 
concordant high-risk pairs. Within the discordant pairs, the MADRS, BDI, and state anxiety 
measures all showed signiﬁcant intra-pair differences in the expected direction. Only one 
subject in a concordant high-risk pair received a current diagnosis of depression using these 
instruments. Furthermore, one subject currently used antidepressant medication (SSRI). 
This was the subject with the high anxious depression score from a discordant pair. These 
two subjects were excluded from all further analyses. Data from one concordant low-risk 
pair were lost due to technical problems during scanning. 
Behavioral data 
Encoding phase (affective classiﬁcation) 
Across all four groups (concordant low risk, concordant high risk, discordant low risk, and 
discordant high risk) reaction times for words later correctly recognized with certainty were 
fastest for negative words (mean reaction time negative words: 1106 ± 251 ms vs. neutral 
words: 1332 ± 345 ms and positive words: 1235 ± 331 ms; F(2, 127.3) = 16.15, p<0.001). Error rate 
for the affective classiﬁcation of successfully recognized words was also lower for negative 
words (negative words: 9% vs. neutral words: 27% and positive words: 21%; F(2, 121.8) = 26.3, 
p<0.001). Importantly, no main group or group x valence interaction effects were found 
suggesting that affective classiﬁcation does not differ as a function of the risk for anxiety 
and depression. 
Recognition phase (retrieval) 
Performance data were missing during retrieval for four subjects and these were excluded 
from further analyses of the performance data. Hit rates, false alarm rates (FA), sensitivity 
(Pr) scores and response bias (Br) for the remaining 56 subjects are shown in Table 2. Valence 
had a signiﬁcant effect on the number of hits (F(2, 125.4) = 3.39, p = 0.039), false alarms 
(F(2, 126.0) = 25.2, p<0.001), sensitivity (F(2, 126.5) = 7.1, p =0.001), and Br (F(2, 124.6) = 22.8, 
p<0.001). More hits as well as false alarms were made on positive and negative words than 
on neutral trials, and neutral trials had a smaller response bias. These effects were due to 
the fact that neutral trials were recognized with certainty much less often than positive or 
negative words. Sensitivity, however, was signiﬁcantly lower for negative words than for 
either neutral or positive words. 
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Table 1:  Characteristics of the twins at the time of MRI scanning
 Low risk concordant Discordant twin pairs High risk concordant twins (N = 14)
 twins (N = 30) Low risk twin (N = 10)  High risk twin (N = 10)
Male/female, no. 14/16  4/6  4/6 6/8
Age, mean (year)  30.9  30.6  30.6  26.1
BDI depression, mean (S.D.)a,b 1.1 (1.5)  2.7 (2.5)  9.7 (10.6)  8.0 (6.0)
MADRS, mean (S.D.)a,b  0.43 (1.5)  2.1 (2.5)  5.0 (3.9)  5.1 (7.8)
STAI state anxiety before scan 27.7 (5.0)  31.4 (5.3) 37.0 (7.3)  36.7 (9.8)
session, mean (S.D.)a,b  
STAI state anxiety after scan 25.1 (4.7)  28.3 (5.5)  37.1 (8.1)  33.8 (8.4)
session, mean (S.D.)a,b 
Verbal IQ subscale, mean (S.D.) 13.1 (2.5)  14.5 (2.2) 14.6 (2.2)  12.9 (3.9)
Working memory IQ 
subscale, mean (S.D.)  7.6 (1.3)  8.9 (2.4)  8.3 (3.2)  8.6 (1.6)
a Signifi cant difference between low risk and high risk concordants.  b Signifi cant intra-pair difference in discordant twins.
A main effect of group was found on sensitivity only (F(3, 37.8) = 6.2, p = 0.002), which did 
not interact with valence. Post hoc comparisons revealed that, across all word valences, a 
signiﬁcant difference between the high-risk twin and the low risk twin from discordant 
pairs was found (p<0.001). A trend in a similar direction was seen when comparing the 
concordant high-risk pairs with the concordant low-risk pairs ( p = 0.079). In all instances 
the high-risk subjects performed better. Across all word valences they had higher hit rates 
and lower false alarm rates than the low-risk subjects resulting in higher sensitivity scores. 
Imaging data 
Results of random effects (RFX) analyses of the imaging data are summarized in Tables 3–5 
and are shown in 3D visualizations and cross sections in Figs. 1 and 2. 
Encoding phase 
Fig. 1 shows the average BOLD effects across all 4 groups when comparing all correctly 
encoded words against baseline stimuli (glass brain). 
Across groups, emotional classiﬁcation of words compared to baseline was associated with 
robustly increased blood oxygenation dependent (BOLD) signal in left inferior frontal gyrus 
(LIFG). Furthermore, regions showing increased activity were bilateral hippocampus (HC), 
as well as dorsal anterior cingulate cortex (ACC), and visual processing areas, including 
bilateral occipital cortex and left fusiform gyrus, situated in the ventral route (cf. Table 3). 
hoofdstuk 3.indd   59 7-3-11   10:13
Chapter 3
60
Modulation by the risk for anxiety and depression 
Across word valences, we observed increased activity in LIFG (45, 42, 6; Z = 3.34) in the 
concordant high-risk group compared to the concordant low-risk group. Conversely, 
decreased left hippocampal activity was found in concordant high-risk group compared 
to concordant low-risk group (Z = 3.15). Across word valences, we did not ﬁnd signiﬁcant 
differences between high-risk discordant twins and their low-risk co-twins. Interaction 
analyses by word valence (negative, positive and neutral; Table 4) showed increased 
activation during encoding of negative words in concordant high-risk twins in left occipital 
cortex (Z = 3.20). Conversely, decreased activation in left hippocampus was found. During 
encoding of neutral words, concordant high-risk twins showed increased activation in 
occipital cortex and left fusiform gyrus compared to concordant low-risk twins. At a slightly 
lower threshold ( p = 0.003, Z = 2.71), more LIFG activation was also found in these highrisk 
twins. Interaction analyses of encoding of positive words showed increased activation in 
concordant high-risk twins in the LIFG and right amygdala. In discordant twins, only one 
signiﬁcant group by word valence interaction was found: for negative words more right 
amygdala was found in the high-risk twin compared to the low-risk co-twin (Z = 3.22). 
Table 2:  Mean proportions (S.D. in parentheses) of hit rates, false alarm rates (FA), sensitiviy (Pr) and response bias (Br) 
across all valences and groups and separately per group and word valence
 Concordant twins  Discordant twins All groups
 Low risk  High risk  Low risk High risk
Hits
Negative 0.72 (0.12)  0.74 (0.10) 0.72 (0.23)  0.73 (0.13) 0.72 (0.14)
Neutral  0.59 (0.19)  0.73 (0.15)  0.67 (0.16) 0.74 (0.15) 0.66 (0.17)
Positive  0.67 (0.17)  0.79 (0.09)  0.73 (0.23) 0.78 (0.10) 0.73 (0.16)
All words  0.66 (0.14)  0.75 (0.09)  0.71 (0.18) 0.75 (0.09) 0.71 (0.14)
FA
Negative  0.23 (0.16)  0.20 (0.13)  0.22 (0.18) 0.16 (0.12)  0.21 (0.15)
Neutral  0.09 (0.07)  0.07 (0.06) 0.12 (0.16)  0.06 (0.04) 0.09 (0.09)
Positive  0.18  (0.14)  0.18 (0.11)  0.18 (0.22) 0.11  (0.07)  0.17 (0.15)
All words 0.17 (0.11)  0.15 (0.09) 0.17 (0.18) 0.11  (0.07) 0.15 (0.12)
Pr
Negative  0.49 (0.17)  0.54 (0.16) 0.50 (0.17) 0.57 (0.14)  0.51 (0.16)
Neutral  0.50 (0.18) 0.66 (0.14)  0.55 (0.21)  0.68 (0.18) 0.58 (0.19)
Positive  0.49 (0.19)  0.62 (0.15) 0.56 (0.23) 0.67 (0.15)  0.56 (0.19)
All words 0.49 (0.17) 0.61 (0.13) 0.54 (0.18) 0.64 (0.14) 0.55 (0.16)
Br
Negative  0.43 (0.21) 0.41 (0.18) 0.45 (0.32)  0.36 (0.20)  0.42 (0.22)
Neutral  0.20 (0.15)  0.23 (0.23) 0.22 (0.22)  0.18 (0.11)  0.21 (0.18)
Positive  0.35 (0.22)  0.45 (0.22)  0.39 (0.31)  0.31 (0.12)  0.37 (0.23)
All words  0.33 (0.16)  0.36 (0.17)  0.35 (0.27)  0.28 (0.10) 0.33 (0.18)
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Table 3:  Encoding: BOLD main effects for all correctly encoded words vs. baseline
across groups at p < 0.05, FDR corrected for multiple comparisons
Region  x y  z  Z value
Prefrontal
Lateral inferior
L   - 48  27  3  6.82
L   - 51  30   - 6  5.94
L   - 42  33   - 3  4.86
Medial
L  - 18  54  30  3.31
Anterior cingulate
L   - 6  21  45  4.13
Medial temporal lobe
R  21   - 12   - 21  5.04
L   - 21   - 24   - 6  4.11
L   - 18  - 15   - 21  3.66
L   - 27   - 12   - 21 3.46
Occipital
R  15   - 99  12  6.21
L   - 15   - 90  9  6.02
R  6   - 96 6  5.81
Table 4:  Encoding: BOLD group interactions for word valences at p < 0.001 uncorrected
 Negative vs. baseline  Positive vs. baseline  Neutral vs. baseline
 L/R x  y  z  Z value  L/R  x  y  z  Z value  L/R  x  y z  Z value
LC > HC
Medial temporal  L - 21 - 24   - 18  3.09
HC > LC
Prefrontal
Lateral inferior L   - 45  42  6 3.78
 L   - 42  36  - 3  3.24
Medial temporal L - 15  - 42   - 3  3.61
Occipital  L   - 15   - 60  3  3.20* L   - 27  - 96  18  3.55  R  9   - 93  9  3.72
 L   - 33   - 72   - 9  3.62
 R  15   - 63   - 9  3.33
 R  39   - 90  0  3.21
HD > LD
Amygdala  R  27   - 3   - 18  3.22*
HC = high concordant; LC = low concordant; HD = high discordant; LD = low discordant.
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Recognition phase 
Fig. 2 depicts activation for all groups of the cortical network in response to correct 
recognition and correct rejection of encoded words across valences. Main regions for this 
comparison are listed in Table 5. Activity was left lateralized, like in the encoding task, 
although right hemisphere activation was more apparent in the recognition phase. We 
found the activation of the LIFG, dorsal ACC, and bilateral occipital cortex, areas that were 
also active during encoding. In addition, we found bilateral insular cortex activation. 
Modulation by the risk for anxiety and depression
Across word valences, concordant high-risk twins showed increased LIFG compared to 
concordant low-risk twins (Z = 3.41), whereas in discordant twins we failed to observe 
signiﬁcant effects of risk status. Interaction analyses with valence showed that compared 
to concordant low-risk twins, concordant high-risk twins showed increased activation in 
the LIFG only during negative words (Table 6). In addition, during retrieval of negative words 
increased LIFG and RIFG activation was found in discordant high-risk twins compared to 
their discordant co-twin albeit LIFG at a lower statistical level (Table 6). 
Table 5:  Retrieval: BOLD main effects for all correctly recognized/rejected words vs.
baseline across groups at p < 0.05, FDR corrected for multiple comparisons
Region  x  y  z  Z value
Prefrontal
Lateral inferior
L   - 45  27  21  4.05
L   - 57  30  24  3.41
Anterior cingulate
R  6  27  42  3.32
Insula
L   - 30  21   - 3  4.59
R  30  24   - 3  5.14
Occipital
L   - 39   - 78   - 12  5.91
L   - 24   - 93  12  5.63
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Figure 1:  Encoding. BOLD main 
effects across all 4 groups and 
across all words. Top: glass brain; 
middle and lower panel: 3D 
visualization.
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Figure 2:  Retrieval. BOLD main effect for all words across groups. Top: glass brain and lower panel: 
3D visualization.
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Table 6:  Retrieval: BOLD group interactions for word valences at p < 0.001 uncorrected
 Negative vs. baseline  Positive vs. baseline  Neutral vs. baseline
 L/R x  y  z  Z value  L/R  x  y  z  Z value  L/R  x  y z  Z value
HC > LC
Prefrontal
Lateral inferior  L   - 42  42  0  3.05*
Insula            L   - 36  33  0  3.90
HD > LD
Prefrontal
Lateral inferior L   - 54  33  6  2.65#
 R  48  36  18  3.83
Hippocampus            L   - 36  - 21   - 21  3.37
HC = high concordant; LC = low concordant; HD = high discordant; LD = low discordant.
# p = 0.004.
Discussion 
The goal of the present study was to investigate possible emotional biases in subjects who 
were at risk for anxiety and depression through either genetic or environmental factors, but 
not yet clinically affected. To this end, we employed an incidental encoding task followed 
by an explicit retrieval task for emotional versus neutral verbal information in monozygotic 
twins, that were either strongly concordant or very discordant for scores on neuroticism, 
anxiety, and depression in longitudinal surveys. We expected that the high-risk twins would 
be characterized by differential encoding and retrieval of emotional words, particularly 
negative words, both on a behavioral and a neural level. 
In contrast to our expectation, behavioral data acquired during the encoding phase did not 
show differences between high-risk and low-risk twins. During recognition, we did observe 
improved memory performance in high-risk subjects compared to low-risk subjects, but 
this was true across all types of words, and not speciﬁc for negative words. Therefore, 
our behavioral data do not support the hypothesis that a negative response bias may be 
present in subjects at risk for depression/ anxiety. This was true for subjects at risk through 
environmental factors (discordant pairs) as well through genetic factors (concordant pairs). 
Our ﬁndings are at odds with previous studies showing increased recall of recently learned 
negatively valence words (Rinck and Becker, 2005) and decreased recognition of happy 
facial expressions (Gotlib et al., 2004; Surguladze et al., 2004) in depressed patients. These 
negative biases were not simply due to depressive state at the time of scanning, as they 
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tended to persist in patients recovered from clinical depression (Leppanen, 2006). Also, 
a recent study (Joormann et al., 2007) showed a clear negative bias in a dot probe task 
in young people at risk for depression through having a depressed mother, but not yet 
depressed. This latter study, however, employed a negative mood induction paradigm. 
Negative perceptual and memory biases following negative mood induction have also been 
found in healthy volunteers without a family history (Bouhuys et al., 1995). 
Results of other studies do converge with ours. A recent study in non-depressed people at 
familiar risk for depression failed to reveal evidence for a negative emotional bias in either 
a facial expression or an emotion categorization task (Mannie et al., 2007). With regard to 
memory performance, Pine et al. (2004) did not ﬁnd altered recall of emotional expressions 
in unaffected offspring of depressed parents. Furthermore, in a recent study in elderly non-
depressed ﬁrst-degree relatives of patients with major depression compared to controls, no 
evidence was found for a negative bias in facial expression recognition accuracy or word 
recall (Le Masurier et al., 2007). In this study, the depressed relative group responded faster 
during recognition of facial expressions of fear, but not for anger, disgust and sad faces. 
In addition, relatives responded slower when they had to recognize positive personality 
characteristics in a verbal categorization task, but there were no differences for negative 
words between groups (Le Masurier et al., 2007). 
Taking together ﬁndings from the above studies with the present ﬁndings, we are led to 
conclude that subjects at risk for depression, either through genetic or environmental 
determinants, do not exhibit a negative emotional bias at the behavioral level, unless 
emotional material is presented immediately after negative mood induction. Only in 
a setting of lowered mood vulnerable individuals might respond with larger negative 
emotional biases. This would potentially place them at greater risk of experiencing more 
severe or prolonged dysphoric reactions in response to negative stimuli (Mannie et al., 
2007). The above conclusion, however, is based only on the behavioral results and needs to 
be interpreted against the background of parallel responses at the neural level. 
For BOLD activation we also hypothesized differential results for low-and high-risk 
subjects, which we expected to be most prominent during negative emotional words. 
Overall, imaging results were in line with previous studies using this paradigm. During 
encoding, emotional classiﬁcation of words compared to baseline was associated with a 
robustly increased BOLD signal in the dorsal ACC and the LIFG, the latter reﬂecting semantic 
elaboration of words. Furthermore, regions showing increased activity were the bilateral 
occipital cortex, bilateral hippocampal region, and the left posterior medial temporal 
cortex, probably reﬂecting the visual analysis of written word forms (orthographic 
processing). During explicit retrieval in the recognition phase we observed similar brain 
regions as in the encoding phase, although activity tended to be more bilateral compared 
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to the relative left lateralization during encoding, and MTL activity was absent. These areas 
correspond closely to those reported in other fMRI studies of previously in fMRI studies 
using a similar paradigm (Daselaar lexical decision tasks indicating the involvement of 
neural et al., 2004; de Ruiter et al., 2007), other investigators have circuits responsible for 
semantic processing (Jobard et al., failed to detect signiﬁcant MTL activity. Therefore, it 
has been 2003) and verbal declarative memory (Buckner and Koutstaal, suggested that the 
hippocampus is mainly involved in 1998). Although hippocampal activity has been reported 
associative memory rather than single-item memory (as in our task), and that hippocampal 
activity observed during singleitem memory tasks is due to e.g. novelty effects (Squire et 
al., 2004, for an overview). The issue is still undecided, as a recent study demonstrated that 
hippocampal damage may impair both associative and single-item memory (Gold et al., 
2006), and that familiarity-based recognition for complex visual stimuli is supported by 
the hippocampus, as demonstrated by single-cell recordings (Rutishauser et al., 2006). Our 
data generally support the hypothesis that the hippocampus is involved during successful 
encoding of single items (words). 
Our main interest was the modulation of activity in these areas by genetic and 
environmental risk for anxiety and depression. In contrast to analyses at the behavioral level 
we found clear evidence that brain activation during encoding and retrieval of emotional 
stimuli is indeed inﬂuenced by these risk factors. During encoding, we found increased 
activity in the LIFG in concordant high-risk twins compared to the concordant low-risk 
twins across all word valences. High-and low-risk individuals from discordant twin pairs 
did not show this difference. During recognition we again found increased activity in the 
LIFG in high-risk twins, this time in both discordant and concordant pairs. A parsimonious 
explanation for the increased LIFG activation in high-risk subjects is that it reﬂects their 
better performance during the recognition task. Previous studies in healthy volunteers 
have indicated that greater activation is found in left inferior frontal and fusiform regions 
for remembered than forgotten words (Baker et al., 2001). Importantly, however, the effect 
of risk on LIFG activation, but not on performance, was most evident in negatively valenced 
words. Therefore, our ﬁndings could indicate that high-risk subjects engage in increased 
elaboration of negative words compared to the low-risk subjects. Further evidence for 
differential effects of negative words on the low-and high-risk subjects was found in the 
amygdala response during encoding. In keeping with studies showing larger reactivity to 
negative emotional faces (Canli et al., 2005; Fu et al., 2004; Siegle et al., 2001; Surguladze et 
al., 2005) discordant high-risk twins showed larger right amygdala activation to negative 
words than their low-risk co-twin.
In conclusion, in the present fMRI study we failed to ﬁnd evidence at the behavioral level for 
a negative response bias in subjects at high risk for anxiety and depression. At the neural 
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level, increased LIFG activation by negative words was found in high-risk subjects, most 
prominently during retrieval. These fMRI results applied to subjects at high risk through 
either genetic or environmental risk factors. They suggest that fMRI activation of the LIFG 
in a verbal emotional memory task may be a useful vulnerability marker for anxiety and 
depression. 
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Abstract 
Background
Current biological psychiatric models assume that genetic and environmental risk factors 
for anxiety and depression act on the same brain structures.
Methods 
To test this assumption, we assessed brain anatomy by using optimized voxel-based 
morphometry on magnetic resonance images obtained in monozygotic twin pairs who 
were discordant for the risk of anxiety and depression (n = 10 pairs) and in monozygotic
twin pairs who were concordant for high (n = 7 pairs) or low (n = 15 pairs) risk for anxiety 
and depression.
Results
We observed volume reductions in the temporal lobe, most notably in the left posterior 
hippocampal region in subjects at high risk for anxiety and depression, but exclusively in 
the intrapair comparison of discordant monozygotic twins. Because monozygotic twins are
genetically identical, any discordance in their risk for anxiety and depression and 
hippocampal volume must arise from differential exposure to environmental influences. 
A group comparison between pairs concordant for low or high risk, which is more likely 
to reflect differences in genetic vulnerability, did not show reduced temporal-lobe and 
posterior hippocampal volumes in the pairs at high risk for anxiety and depression.
Conclusions
This pattern of results suggests that damage to temporal-lobe structures may be specific to 
an environmentally driven etiology of anxiety and depression.
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Introduction 
Anxiety and depressive disorders are known to be caused in part by genetic factors, with 
heritability estimates fluctuating between 20% and 40% (Hettema et al. 2001; Kendler et al. 
2001; Sullivan et al. 2000). To identify the neurobiological pathways that harbor the genetic 
susceptibility to these disorders, deviant brain structure or function measured by magnetic 
resonance imaging (MRI) has been proposed as an intermediate phenotype (Hariri et al. 
2002, 2005; Hariri and Weinberger 2003). These attempts to use brain imaging to unravel 
the genetic etiology of anxiety and depression have not been matched by similar attempts 
to unravel the impact of environmental risk factors on the brain. This may be in part because 
of the heterogeneous nature of environmental risk for psychopathology and the difficulty 
of standardized measurement of the environment (compared with genotyping). Yet about 
60%–80% of the risk for these disorders must be attributed to environmental causes. Some 
of these may operate independent and additive to genetic predisposition, whereas others 
may directly interact with genetic predisposition (Caspi et al. 2003; Eley et al. 2004; Grabe 
et al. 2005; Kaufman et al. 2004; Kendler et al. 2005).
Beyond estimating heritability, the study of twins can be used to establish causal effects of 
environmental factors on individual trait variation (Hyde et al. 1995; Castellanos et al. 2003). 
Because monozygotic (MZ) twins are genetically identical, any discordance in their risk for 
anxiety and depression must arise from differential exposure to environmental influences. 
Here, we use voxel-based morphometry (VBM; Ashburner et al. 1997; Ashburner and Friston 
1999, 2000, 2001) on MRI images of MZ twin pairs that are strongly discordant for the risk 
for anxiety and depression. This technique compares direct size variations of anatomic 
structures on a voxel-to-voxel basis. Its application is exceptionally powerful in MZ twins 
because the error introduced by spatial normalization is minimized in intrapair comparisons 
by the large resemblance in overall MZ brain volumes, which are highly correlated (r >0.85; 
Baare et al. 2001; Posthuma et al. 2002; Toga and Thompson 2005). The expectation is that 
the MZ intrapair comparison will highlight brain regions linked to anxiety and depression 
that are particularly susceptible to environmental factors. On the basis of a large volume of 
studies, these regions are expected to include medial temporal-lobe structures, in particular 
the amygdala and hippocampal region (Campbell et al. 2004; Geuze et al. 2005; Videbech 
and Ravnkilde 2004). 
Current biological psychiatric models implicitly assume that the environmental risk factors 
for anxiety and depression act along the same neurobiological pathways as the genetic 
risk factors. In view of the heterogeneous nature of these disorders, we cannot exclude the 
possibility that some parts of the brain are more affected by genetic risk factors, and others 
more by environmental ones. To address this question directly, we also included concordant 
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MZ twin pairs in the study in which both members were either at very high or very low risk 
for anxiety and depression. These two groups of concordant MZ twins are likely to reflect 
a contrast in genetic vulnerability for anxiety and depression, which was confirmed by a 
comparison of the anxiety, depression, and neuroticism levels in the parents of these two 
twin groups. If genetic and environmental risk factors affect the brain in a similar way, 
the volume differences found in intrapair contrasts in the discordant twin pairs should be 
repeated in the group comparison of concordant high- versus concordant low-risk twin 
pairs.
Methods and materials
Participants
In a sample of 3324 twin pairs registered in The Netherlands Twin Registry and aged 
between 18 and 50 years, an average risk score for anxious depression was computed on the 
basis of longitudinal survey data on anxiety, depression, neuroticism, and somatic anxiety 
collected in 1991, 1993, 1997, and 2000 (for details, see Boomsma et al. 2000). This risk score 
was shown to have strong predictive validity for clinical anxiety and clinical depression, as 
assessed by the Composite Diagnostic Interview (Middeldorp et al. 2006). 
Discordant MZ twin pairs were considered eligible for participation if both were right-
handed, they had risk scores at least 0.5 SD above or below the mean, and their scores were 
at least 2 SDs apart. This yielded 31 pairs, of whom we invited 17 pairs because they lived near 
Amsterdam and had filled out our most recent survey. Two pairs were excluded because 
one of the members had epilepsy or was pregnant. Four pairs refused to participate, mainly 
because of time constraints. This left a final 11 MZ pairs who were extremely discordant on 
the risk for anxiety and depression.
Concordant MZ twin pairs were recruited in a comparable way. Monozygotic twin pairs 
were considered eligible for participation if both were right-handed and both their scores 
were at least 0.8 SD above (concordant high) or below (concordant low) the mean risk 
score for anxiety and depression. This yielded 115 high-concordant and 137 low-concordant 
pairs, of whom we invited the 48 pairs who lived near Amsterdam and had filled out our 
most recent survey. Five pairs were excluded because one of the members had a medical 
illness or was pregnant. Twenty-one pairs refrained from participating, mainly out of time 
constraints. This left a final 15 MZ pairs who were concordant for a low risk for anxiety and 
depression and 7 MZ pairs who were concordant for a high risk for anxiety and depression. 
During the selection procedure, twins were classified as MZ by using survey items on 
physical similarities and frequency of confusion by family members. During the actual MRI 
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study, zygosity was established by typing all subjects on 11 DNA microsatellite markers. 
One discordant pair was dizygotic (DZ) rather than MZ. Because the monozygosity is crucial 
in the pairwise comparisons, this pair was excluded, leaving 10 MZ discordant pairs. Two 
concordant-low twin pairs also were DZ. Although the group comparison of concordant-
high and -low pairs does not depend on zygosity, we repeated that analysis with and 
without these pairs. 
Of the final remaining group of 31 MZ twin pairs, the mean age was 29.5 years (range, 20–
42 y; 14 male, 17 female). The ethical review board of the Vrije Universiteit Medical Center 
approved the study, and all participants provided written informed consent.
Survey data on lifestyle and demographics
Around the time of participation in the study, all subjects filled out a detailed survey on 
lifestyle and demographics, from which we extracted the degree of urbanization of the 
subjects’ current domicile, educational attainment, mean neighborhood income, and 
presence and stability of a partner relationship. From the survey, we further extracted 
religious practices, exercise participation, alcohol use, smoking behavior, and current 
somatic health (asthma, rheumatoid arthritis, or allergy; urinogenital or kidney disease; 
skeletomuscular problems; migraine or Parkinson’s disease; hypertension, diabetes, or 
cardiovascular disease; neoplasms) and the use of medication. Finally, subjects were 
requested to obtain their birth weights from a reliable source like maternal report, birth 
cards or tiles, or hospital records. 
Parental data
Parents of the twins received the same surveys as the twins in 1991, 1993, 1997, and 2000. A 
score for anxiety and depression for 18 fathers and 21 mothers of the participating twin pairs 
was obtained in the same way as for the twins, although the Beck Depression Inventory 
(BDI), rather than the depression subscale of the Young Adult Self-Report scale, was used 
to assess depression (for details, see Boomsma et al. 2000). Furthermore, from the parental 
surveys, information on birth order, adverse prenatal behaviors, duration of pregnancy, 
obstetric complications, incubation time (if any), duration of breast feeding, and early head 
trauma were obtained for 24 of the twin pairs. These mothers also reported on whether the 
twins had been separated for a prolonged period of time in their youth.
Procedure
Subjects came to the MRI scan unit, where the experimental procedures were first explained 
in detail. Twins were randomly assigned to an MRI-scan session or to a psychometric 
session, each of which lasted about 90 min. After completion of the first session, the twins 
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switched sessions. In the psychometric session, cognitive abilities and current affective 
state were assessed. Each subject was interviewed by using the Composite International 
Diagnostic Interview (Peters and Andrews 1995; Wittchen 1994) to establish current 
psychiatric diagnosis over the last year. In addition, the Montgomery-Asberg Depression 
Rating Scale (MADRS) and the BDI were used to assess depressive symptom characteristics 
and severity scores (Beck et al. 1961; Montgomery and Asberg 1979). Furthermore, the State-
Trait Anxiety Inventory (Spielberger 1970) was administered before and after MR scanning. 
Estimates of intelligence quotient (IQ) were obtained by using the verbal comprehension 
scale from the Groningen Intelligence Test (GIT; Luteijn and van der Ploeg 1983) and two 
workingmemory scales (forward and backward digit span) from the Wechsler Adult 
Intelligence Scale (Wechsler 1997). Finally, social support was measured by using the Duke–
UNC questionnaire (Broadhead et al. 1988), and subjects were asked to indicate whether 
they had gone through 21 major life events. These were listed on paper and included 
individual events (e.g., maltreatment, disease, financial problems, job strain, relational 
problems) as well as network-related events (e.g., disease or loss of close kin). Subjects were 
asked to indicate these events in four temporal categories, that is, whether they occurred 
during the last 6 months, between 6 and 12 months ago, between 1 to 5 years ago, or more 
than 5 years ago. For each event, they indicated the impact on their lives on a 10-point visual 
analog scale ranging from no impact to extreme impact. 
The MRI session consisted of a structural part of 7 min enclosed in 35 min of functional 
MRI. The MR imaging of the brain was performed on a 1.5-T Sonata MR system (Siemens, 
Erlangen, Germany) with a standard circularly polarized head coil. For anatomic scanning, 
we used a coronal 3-D gradientecho T1-weighted sequence (magnetization prepared rapid 
gradient echo [MPRAGE]; sinversion time: 300 ms, time to repetition (TR) = 15 msec; echo 
time (TE) = 7 ms; flip angle = 8°; 160 slices, 1 x 1 x 1.5 mm voxel size). Gray-level resolution 
was 16 bit. 
At the end of both sessions, subjects were debriefed and received sets of buccal swabs to 
collect mucosal cells for DNA extraction.
Volumetric analysis
Before volumetric analyses, the integrity of the acquired MR images was visually checked, 
and the origin of each MRI volume was aligned on the anterior-commissure landmark. 
Differences in brain anatomy were assessed on a voxel-by-voxel basis by using the optimized 
VBM method proposed by Good et al (2001), an extension of the originally introduced 
standard VBM technique (Ashburner and Friston 2000, 2001; Wright et al. 1995). The 
automated procedures of VBM were implemented by using the MATLAB (The MathWorks, 
Inc, Natick, Massachusetts) VBM tools that were developed by Christian Gaser from the 
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University of Jena, Germany, based on original scripts by John Ashburner and SPM2 analysis 
software (Department of Imaging Neuroscience, Wellcome, London, United Kingdom).
In a first step, standard VBM is used to create study-specific T1 MRI templates for the whole 
brain and customized gray-matter (GM), white-matter (WM), and cerebrospinal fluid (CSF) 
priors. To this end, each raw T1 MRI image was spatially normalized to a standard T1 template 
that is available in SPM2 (Ashburner et al. 1997; Ashburner and Friston 1999). Subsequently, 
the three brain compartments were extracted after image segmentation by using voxel-
by-voxel probability mapping with respect to standard GM, WM, and CSF priors as available 
in SPM2. Each volume was spatially low-pass filtered by using an 8-mm full width at half-
maximum (FWHM) isotropic Gaussian kernel. Finally, individual study-specific T1 templates 
and GM, WM, and CSF priors were created for the discordants and concordants by averaging 
the computed volumes separately across the twins in the respective groups. 
In a following step, the raw MRI images were segmented. Compared with standard VBM, 
the optimized protocol by Good et al (2001) includes a number of additional processing 
steps aimed at reducing the probability of voxel-classification errors. In this study, we 
were interested primarily in regional changes of GM. First, the GM partition in native, not 
normalized, space was extracted from the raw T1 images by using the newly obtained 
customized whole-brain T1 templates and GM priors. Subsequently, the spatial normalization 
parameters for the GM compartment with respect to the GM template were estimated. 
The obtained deformation matrix–parameter set then was applied to the raw whole-brain 
MR images. Subsequently, the whole-brain T1 image was resegmented by using parametric 
mapping with respect to the customized priors, and the normalized GM was extracted. The 
resolution of the extracted GM images was 1 mm3. During segmentation, the images were 
corrected for intensity nonuniformities that were introduced by the MR scanner. 
To preserve volumetric information in the normalized images, a modulation step was 
added by multiplying each voxel-intensity value by the determinant of the Jacobian matrix 
defining the spatial transformation from the original MR images to each individual GM 
template. In this way, intensity values of voxels belonging to brain structures expanded 
during the warp are reduced, whereas voxel intensities from brain structures that are 
contracted are increased. As a result, voxel-intensity values code for differences in 
regional brain size that are present in the raw MR images. Before statistical analyses, the 
modulated images were smoothed by using a 12-mm FWHM isotropic Gaussian kernel to 
ensure that the image data correspond better with the Gaussian statistics underlying the 
statistical parametric-mapping technique to detect morphologic differences (Worsley et 
al. 1996). Spatial smoothing also renders the data more normally distributed and reduces 
the influence of inaccuracies in spatial normalization of individual brains on the following 
morphometric comparisons.
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Statistical analysis
Differences in the survey- and interview-based variables were tested by a mixed-model 
analysis of variance (ANOVA; general linear model [GLM] menu item in SPSS; SPSS, Chicago, 
Illinois) with type of twin pair (discordant, concordant low, concordant high) and risk-score 
level (high, low) as two fixed factors and with family as a random factor to account for 
within-family dependence. Primary planned contrasts were the comparison of the low-risk 
versus the high-risk twin within the discordant pairs, and of the concordant high-risk versus 
the concordant low-risk pairs. An alpha of 0.05 was chosen for these tests.
Differences in the overall GM volumes between the three groups (discordant, concordant 
low, concordant high) were tested by using a similar mixed-model ANOVA. Differences in 
regional brain volumes as a function of the risk for anxiety and depression were assessed by 
means of voxel-byvoxel parametric mapping by using a paired t test (discordant pairs) or a 
one-way ANOVA test (concordant groups) in SPM2. Statistical tests were performed on the 
modulated GM compartments with, in each test, global GM volume included as a covariate 
to focus on regional volume changes that were disproportionate with respect to overall GM 
size. In each comparison, two-tailed difference contrasts were applied testing for possible 
regional volume increases or decreases of brain structures in one group compared with the 
other. In a primary analysis, volumetric changes were considered significant at a p value of 
0.05, corrected for multiple testing. Because we had a relatively small number of twins, in 
a secondary analysis, this criterion was relaxed to an uncorrected p<0.001, with a minimum 
cluster size of 50 contiguous voxels meeting this p value.
Results
Table 1 displays the mean anxious-depression, (somatic) anxiety, and neuroticism scores 
for the entire twin sample (column 1) and for the MZ twins who were selected to be at 
low or high risk for anxiety and depression. Mean scores are given across all of the four 
possibly available surveys. Significant differences were found between the low- and high-
risk twins of the discordant pairs on all four variables. Likewise, the low-risk concordant 
twins significantly differed in the expected direction on all variables from the high-risk 
concordant twins. 
To confirm our expectation that our selection for low-risk versus high-risk concordant 
twin pairs mainly reflects a genetic contrast, we analyzed parental data for all pairs where 
this information was available. Table 2 displays the mean scores on depression, (somatic) 
anxiety, and neuroticism of the twin’s parents. Analysis of variance with parents as the 
repeated factor and with twin type (discordant, concordant low, and concordant high) as the 
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between factor confirmed higher values for all risk traits in the parents of the concordant 
high-risk twin group than in the parents of the concordant low-risk twins. Parents from 
discordant pairs did not differ from the parents of the concordant low-risk twins but had 
significantly lower scores on the BDI and the somatic-anxiety scale than did the parents 
of high-risk twins. This suggests that the high-risk discordant twin was the so-called odd 
person out in these families. 
Subject characteristics at the time of MRI scanning are shown in Table 3. Age and male–
female distribution were not significantly different across the groups. Only one subject in 
a concordant high-risk pair obtained a current diagnosis of depression. One further subject 
currently used antidepressant medication (selective serotonin-reuptake inhibitor). This was 
the subject with the high anxious-depression score from a discordant pair. Mixed ANOVA 
confirmed that the concordant low-risk pairs scored significantly lower on the MADRS, BDI, 
and state-anxiety measures than did the concordant high-risk pairs. Within the discordant 
pairs, the MADRS, BDI, and state-anxiety measures all showed significant intrapair 
differences in the expected direction. 
The verbal IQ subscale and the working-memory IQ subscales did not show any significant 
differences between low- and high-risk twins, either between the concordant groups or 
within discordant pairs.
Total GM volume
Before analysis of regional size differences, we set out to investigate whether there was 
any difference in global nonnormalized GM volume between the members of a pair in the 
discordant twins as well as between concordant low- and high-risk pairs. Figure 1 compares 
total GM volumes (in milliliters) of each twin pair in the study. Each plotted symbol represents 
one pair. The position on the horizontal axis represents the brain volume of one twin, and 
the position on the vertical axis, the volume of the other twin. For both the concordants 
(open and filled circles) and the discordants (asterisks), the data are scattered around the 
dashed diagonal, representing identity, indicating that the overall brain sizes of the twins 
in every pair are highly similar. The latter observation was confirmed by means of paired t 
tests, performed separately for each group, which revealed no significant differences for 
total brain volumes within each pair. Furthermore, mixed ANOVA yielded no significant 
group differences in GM volume of the concordant high-risk twins (mean ± SD: 683 ± 54 
mL), the concordant low-risk twins (671 ± 54 mL), or the discordant twins (682 ± 43 mL).
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Regional morphometry 
Discordant twin pairs
Volumetric analyses yielded evidence of significant intrapair differences only after the 
statistical criteria were relaxed to befit a region-of-interest analysis rather than a whole-
brain comparison. Compared with their low-risk co-twin, the high-risk twins showed a 
decrease of GM volume in multiple areas of the left temporal lobe, including a region at 
the occipital–temporal border (cluster 1: maximum t = 10.42 at x = -42, y = -65, z = -15 in 
Montreal Neurological Institute [MNI] space), a midtemporal area (cluster 2: maximum t = 
6.28 at x = -56, y = -34, z = -18), and two regions in the temporal pole (cluster 3: maximum 
t = 8.04 at x = -62, y = -2, z = -5; cluster 4: maximum t =  6.19 at x = -55, y = 5, z = -11). These 
areas are depicted in Figure 2. In addition to these regions, a fifth area of reduced volume 
was found in the medial temporal lobe that included the left parahippocampal formation 
extending into parahippocampal gyrus (voxel level: maximum t = 8.08 at x = -24, y = -34, 
z = -6). Figure 3A shows this voxel cluster in the hippocampus projected on a sagittal slice 
of the GM template of the 20 twins from the discordant pairs. The relative contribution of 
each twin pair to the regional difference in modulated GM can be appreciated from the 
plot in Figure 3B. For the most significant voxel, differences in intensity relative to the mean 
for all 10 twin pairs are shown consecutively, with data for the high- and low-risk twin of 
each pair at horizontal tick marks “H” and “L”, respectively. In 9 of 10 twin pairs, the plot 
indicates a very close correspondence of the data to the fitted, sawtooth-shaped paired 
t test model shown in thick gray. Figure 3C shows the posterior hippocampal voxelcluster 
centered on sagittal, coronal, and axial slices of the average MRI across the 20 discordant 
twins. To facilitate interpretation of the anatomic location, the observed region is shown in 
Table 1:  Risk for anxiety and depression in the full Netherlands Twin Registry sample and in the selected Concordant and Discordant twin pairs
 Discordant Twin pairs
 All Twins  Low Risk  Low  High Risk High Risk
 (no selection) Concordant Twins Risk Twin Twin Concordant Twins
 6298 < N < 6648  N =30  N =10  N =14
Anxious Depression  4.9 (4.1)  1.4 (1.2)  2.6 (1.0)  10.4 (4.5)  11.4 (5.0)  a,b
Anxiety  33.4 (7.9)  25.4 (3.1)  27.9 (3.5)  46.0 (8.7)  44.8 (8.5)  a,b
Somatic Anxiety  18.3 (5.0)  13.4 (1.6)  16.7 (2.9)  24.9 (6.1)  26.6 (7.7)  a,b
Neuroticism  51.8 (22.3)  26.8 (11.5)  30.4 (12.4)  68.8 (18.5)  84.9 (15.9)  a,b,c
aSignifi cant difference between Low risk and High risk concordant pairs.
bSignifi cant intrapair difference between the Low risk and High risk twin from discordant pairs.
cSignifi cant difference between High risk concordant pairs and the High risk subject from discordant pairs.
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Table 2:  Risk for anxiety and depression in the parents of the selected concordant and discordant pairs
 Low Risk High Risk
 Concordant Discordant Concordant
 Twins Twins Twins
Mother/Father  8/6  7/7  6/5
Age  52  55  56
Depression mean of 2 surveys  2.0 (3.7)  2.4 (2.8)  5.5 (6.0)  a,b
Anxiety mean of 4 surveys  27.9 (6.3)  36.9 (7.5)  42.3 (14.8) a,b
Somatic Anxiety mean of 4 surveys  14.7 (2.8)  15.8 (3.1)  20.0 (5.2)  a,b
Neuroticism mean of 4 surveys  33.5 (18.9)  48.8 (21.3)  67.5 (27.1)  a
aSignifi cant difference between parents of Low risk and High risk concordant pairs.
bSignifi cant difference between parents of discordant and High risk concordant pairs.
Table 3:  Characteristics of the twins at the time of MRI scanning
 Discordant Twin pairs
  Low Risk  Low  High High Risk
  Concordant Twins Risk Twin Risk Twin Concordant Twins
  N =30 N =10  N =10  N =14
Male/Female  14/16 4/6  4/6  6/8  -
Age  30.9  30.6 30.6  26.1  -
BDI depression 1.1     (1.5)  2.7    (2.5)  9.7      (10.6)  8.0   (6.0)  a,c
MADRAS  0.43 (1.5)  2.1    (2.5)  5.0   (3.9)  5.1    (7.8)  a,c
STAI State Anxiety before Scan session  27.7   (5.0)  31.4 (5.3)  37.0 (7.3)  36.7   (9.8)  a,c
STAI State Anxiety after Scan session  25.1   (4.7)  28.3 (5.5) 37.1   (8.1)  33.8   (8.4)  a,b,c
Verbal IQ subscale 13.1   (2.5)  14.5  (2.2)  14.6  (2.2)  12.9   (3.9)  -
Working Memory IQ subscale 7.6   (1.3) 8.9   (2.4)  8.3     (3.2)  8.6    (1.6)  -
aSignifi cant difference between Low risk and High risk concordants.
bSignifi cant differerence between High risk subjects from concordant and discordant pairs.
cSignifi cant intrapair difference in discordant twins.
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close-up view, with voxel p value threshold raised to p<0.01 (10-fold of the original). Coronal 
and axial views of Figure 3C also illustrate anatomic locations of two of the four additional 
voxel clusters observed in the left temporal lobe (clusters 2 and 3). The orthogonal-slice 
views also indicate a voxel cluster on the medial side of the hippocampus (labeled by an 
asterisk), close to the aforementioned posterior hippocampal region. The maximum of this 
voxel cluster closely borders the CSF compartment. Because VBM results at intersections 
between GM or WM and CSF can be spurious, interpreting this cluster as additional evidence 
of hippocampal volume loss must be performed with caution. 
The observed volume reductions in the high-risk twins clearly were unilateral. Post hoc 
testing at more liberal p values did not reveal similar volume reductions in the right 
temporal lobe, including the right posterior hippocampal region, even when the probability 
threshold for individual voxels was lowered to p<0.05. 
Figure 1:  Global gray-matter volumes (in mL) of individual twin pairs. Every symbol corresponds to one pair, with 
brain size of one twin on the horizontal and brain size of the other twin on the vertical axis. The dashed vertical 
line represents the identity line (gray-matter volume of twin 1 = gray-matter volume of twin 2). Different symbols 
denote the individuals from concordant high-risk pairs (open circles), concordant low-risk pairs (closed circles), and 
discordant pairs (asterisks). In the groups of concordant pairs, the twins were randomly assigned as twin 1 and twin 
2. In the discordants, the low-risk twin was assigned as twin 1, and the high-risk twin was assigned as twin 2.
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A single area was found when testing for the reverse contrast, that is, that local GM volume 
was increased in the high-risk, compared with the low-risk, twins. In the left posterior 
cingulated, a larger volume was found in the high-risk twins (maximum t = 9.98 at x = -7, 
y = -54, z = 32).
Concordant low- versus concordant high-risk groups
When comparing the modulated GM extractions of the concordant high-risk group with 
the compartments of the concordant low-risk group, we found no significant regional 
volumetric changes in the ANOVA test results. Local GM differences were absent, either 
when testing for volume decreases in the highcompared with the low-risk group or 
when testing the opposite contrast, comprising a search for relative volume increases in 
the concordants for high risk. Even after applying more liberal p value thresholds of the 
statistical parametric maps, we still did not find any indication of GM-volume differences, 
most notably also not in the left hippocampal region that had been most significant in the 
comparison of discordant twins. Repetition of the analyses excluding the two pairs who 
turned out to be DZ still yielded no differences between subjects at low or high genetic risk 
for anxiety and depression. 
Because intrapair t testing is more sensitive than between-pair ANOVA comparisons, we 
repeated the concordant low- versus concordant high-risk comparison in a within-subject 
design. Each high-risk concordant twin pair was matched with a low-risk concordant pair on 
the basis of the similarity between the pairs in total GM volumes. This matching recreates 
some of the advantages of the t tests by keeping the variance in the required warping to 
standard MNI space at a minimum. However, this two (twins within a concordant pair) by 
two (high risk, low risk) repeated-measures ANOVA did not yield evidence for smaller GM 
volumes in the concordant high-risk twins, even at liberal p value thresholds.
Environmental risk factors
To explain the discordance in the risk for anxiety and depression in genetically identical 
subjects, we tested the discordant pairs (n = 10) on a number of potential environmental 
risk factors, which are listed in full in Table 4. In view of the small sample size, the data 
presented in this table should be considered explorative only. On inspection of the table, 
two remarkable differences in the low- and high-risk members of the discordant pairs stand 
out. Significantly lower social support was experienced in the high-risk group, and these 
twins reported more chronic stress from major life events. Specifically, 9 of the 10 high-
risk twins reported major life events that occurred more than 5 years ago, and 5 subjects 
reported multiple events. Intriguingly, the only high-risk twin not reporting these early life
events came from the pair with the poorest fit in the VBM analyses (pair 3 in Figure 3B). 
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For the low-risk twins, only four subjects reported such events, and only one subject 
reported multiple events. In addition, the average impact of the life events generally was 
rated to be larger by the high-risk twins. 
Additional environmental influences may arise from adverse events or complications during 
the pregnancies for the discordant twins that may have affected the high-risk discordant 
twin more than the low-risk discordant twin. To investigate this possibility, we compared 
prenatal and perinatal events of the discordant twins with those of the concordant high- and 
low-risk twins. There were no differences in parental age, socioeconomic status, or smoking 
behavior during pregnancy, but mothers of discordant twins used more medication and 
consumed alcohol more often. There were no differences in the frequency of incubation, 
methods of delivery, or birth weight of the concordant and discordant twins. Pregnancy 
duration was on average 3 weeks longer in the discordant twin pairs than in the concordant 
twins.
Figure 2:  Parametric t map of regional gray-matter size reductions in the high-risk, relative to the low-risk, 
discordant twins. T values are mapped by the color bar and projected on the average MR sections of the 20 
discordant twins. Four of the five temporal regions that met our criterion of significant volume reduction in the 
high-risk compared with the low-risk twin (p < 0.001; min, 50 voxels) are shown. 
A fifth region is shown separately in Figure 3.
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in the high-risk twin compared within the low-risk twin (p <0.001; min, 50 voxels). (B) Relative responses of the 
discordant twin pairs at the most significant voxel (t = 8.08 at x = -24, y = -34, z = -6 in MNI space). Differences in 
intensity relative to the mean for all 10 twin pairs are shown as filled circles, connected by a dashed line. From left to 
right, data for the high-risk and low-risk twin of each pair repetitively at horizontal ticks H and L, respectively. 
The fitted paired t test model is shown in thick gray. (C) Parametric t map of regional gray-matter size reductions in 
sagittal, coronal, and axial views of the area boxed in A at lower significance (p <0.01; min, 50 voxels). The 
cross-haired cursor is at the most significant voxel of the cluster in the parahippocampal region. Coronal and axial 
views show two additional voxel clusters, 2 and 3, observed in the left temporal lobe (cluster 2: maximum t = 6.28 
at x = -56, y = -34, z = -18; cluster 3: maximum t =8.36 at x = -62, y = -2, z = -5). *A cluster bordering CSF on the medial 
side of the parahippocampus (maximum t = 8.04 at x = -9, y = -32, z = -6).
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Discussion
We used VBM on MRI images of MZ twin pairs strongly discordant for the risk for anxiety 
and depression to establish intrapair differences in regional brain volumes. This risk was 
computed on the basis of longitudinal survey data on anxiety, depression, neuroticism, 
and somatic anxiety collected in 1991, 1993, 1997 and 2000 (for details, see Boomsma et al. 
2000), which were shown to have strong predictive validity for clinical anxiety and clinical 
depression, as assessed by the Composite Diagnostic Interview (Middeldorp et al. 2006). 
Because MZ twins are considered genetically identical, any discordance in their risk for 
anxiety and depression must arise from differential exposure to environmental influences. 
Hence, we anticipated that the intrapair comparison would highlight brain regions involved 
in anxiety and depression that are particularly susceptible to environmental factors. Our 
results place these regions mainly in the left temporal lobe. Most notable were the lower 
GM volumes in the left posterior hippocampus of the high-risk twins. This region contains 
the main afferent and efferent connections of the hippocampus to the rest of the temporal 
lobe (Lavenex and Amaral 2000) and may well constitute the primary deficit.
Table 4:  Environmental Risk Factors in the Low and High Risk Twin from Discordant Pairs
 Low Risk Twin  High Risk Twin
 N 10  N 10
First born  4  6
Birth weight (grams)  2416 (sd 457)  2413 (sd 285)
# of medical conditions  1.1  1.3
Educational attainment (primary only/ vocational/ high school/ college & university)  0/1/4/5  0/0/6/4
Mean income (Euro/year)  33530,00  32950,00
Urbanization (urban/rural)  3/7  2/8
Religion (church going/belief/no)  1/4/5  2/2/6
Stable partner relation (with/without)  4/6  3/7
Current smoker (yes/no)  2/8  3/6
Alcohol use (> 3 glass/wk) 5  5
Exercise participation (> 4 METhour/wk)  5  7
Social Support 32.1 (3.7)a  29.0 (2.9)a
Major life events
- last 6 months (events/mean impact)  4/4.3  4/3.2
- 6 to 12 months ago (events/mean impact)  3/2.0  2/3.4
- 1 to 5 years ago (events/mean impact)  6/1.5a  6/4.1a
- more then 5 years ago (events/mean impact)  4a/3.5  9a/4.2
aSignifi cant intrapair difference in discordant twins (t-tests or χ2, p< 0.05).
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It should be noted that the number of discordant twin pairs in this study was only modest. 
A number of smaller regional differences elsewhere in the brain may have gone undetected. 
To reduce the risk of false negatives, we used a lenient correction for multiple testing 
in the whole brain comparisons. This, of course, increased the risk of false positives, but 
our confidence in the temporal-lobe findings is strengthened by comparison to previous 
studies. Results from our VBM approach converge rather well with those obtained by 
neuroimaging by using anatomic GM segmentation of medial temporal-lobe structures. 
Reduced hippocampal volume often has been reported in major depression (Campbell et al. 
2004; Geuze et al. 2005; Videbech and Ravnkilde 2004), even in fully remitted unmedicated 
patients (Neumeister et al. 2005), and smaller hippocampal volumes were predictive 
of a poor response to antidepressant medication (Hsieh et al. 2002; Vakili et al. 2000). 
Reduced hippocampal volumes also have been found in severe trauma-exposed subjects 
with unremitting posttraumatic stress disorder (Bremner et al. 1995; Freeman et al. 1998; 
Gilbertson et al. 2002; Gurvits et al. 1996; Vythilingam et al. 2002). 
The glucocorticoid cascade hypothesis (McEwen and Magarinos 1997, 2001; McEwen 1999, 
2001; Sapolsky et al. 1986, Sapolsky 2000) provides a powerful neurobiological framework 
to link differences in environmental risk exposure in discordant MZ twin pairs to differences 
in their hippocampal volumes. According to this hypothesis, severe life stress may cause a 
prolonged excess of glucocorticoids that damages the hippocampus. Animal studies as well 
as observations in patients with Cushing syndrome are in support of toxic effects of high 
levels of glucocorticoids on the hippocampus (Duman et al. 1999; Starkman et al. 1992, 1999; 
Uno et al. 1994; Watanabe et al. 1992). Because the hippocampal region is a major site of 
inhibitory control over cortisol release (Herman and Cullinan 1997), this damage may create 
a vicious circle (or cascade) of increased cortisol levels that further reduce the volume of 
exactly those hippocampal cells that are needed in negative feedback control over cortisol 
(McEwen 1999, 2001; McEwen and Magarinos 1997, 2001). Once depressive disorder sets 
in, the stress inherent in the repeated episodes may itself add to this process, which could 
explain why the duration of untreated depression is correlated with hippocampal size (Bell-
McGinty et al. 2002; MacQueen et al. 2003; Sheline et al. 2003). 
We probed our discordant pairs on a number of potential environmental risk factors, 
including demographic and lifestyle variables and recent major life events and social 
support structure. Although limited by a potential retrospective bias as a result of their 
higher negative affect at the time of recall, the high-risk twins reported exposure to more, 
and more severe, life stressors early in their lives. In keeping with the glucocorticoid-
cascade hypothesis, these stressors may well account for part of the environmental 
effects on temporal GM volume, especially the hippocampal region. However, despite 
the attractiveness of the glucocorticoidcascade hypothesis, an alternative environmental 
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factor that could explain the discordance in posterior hippocampal volume and risk for 
anxiety and depression in our genetically identical twins is epigenetic reprogramming. 
Epigenetic reprogramming can create large phenotypic divergence in genetically identical 
subjects by selectively repressing the expression of some genes. Fraga et al (2005) profiled 
the epigenetic patterns related to global and locus-specific DNA methylation and histone 
H3 and H4 acetylation in 80 twins across a large age range. Young twins were epigenetically 
indistinguishable but older twins exhibited remarkable differences in their gene-expression 
profile which they attributed to the impact of environmental and lifestyle factors. 
Epigenetic drift, therefore, is a potential source of the discordance in both left-temporal 
volumes and the risk for anxiety and depression. An important question that needs to be
addressed in the future is whether life stress and hypothalamicpituitary- adrenocortical 
(HPA)–axis activation can somehow directly impact on epigenetic programming. 
In striking contrast to the VBM results in discordant twins, no reduction in GM volume in 
the hippocampal region was found in the group comparison of concordant low- versus 
concordant high-risk twins. With our selection of twins concordant for extreme low or high 
risk, we attempted to select groups that differ strongly in genetic susceptibility. The higher 
average scores of family members of the high-risk twins compared with family members of 
the low-risk twins give credence to the idea that these groups indeed represent a genetic 
contrast. Our results, therefore, suggest that genetic influences on hippocampal volume 
(or related genes in the HPA axis) may not account for a large part of the heritability of 
anxiety and depression found in family and twin studies. This does not rule out that 
such genes have an indirect effect on the risk for anxiety and depression through gene–
environment interaction. Genetic influences on hippocampal volume have been found in 
several studies (Lyons et al. 2001; Sullivan et al. 2001), and they may well play a causal role 
in psychopathology by sensitizing the individual to stressful experiences (Gilbertson et al. 
2002; Gurvits et al. 1996). 
Basic research has pointed to many systems outside the HPA axis and the hippocampal 
formation that can harbor susceptibility genes to anxiety and depression (Nestler et 
al. 2002). Most prominent has been the suggestion of genetic defects in serotonergic 
neurotransmission in both animal (Ansorge et al. 2004; Gross et al. 2002) and human 
(Lesch and Gutknecht 2005; Levinson 2006; Sen et al. 2004) research. It is important 
to note that genetic variation in serotonergic neurotransmission appears to directly 
interact with environmental risk factors, as testified to by the replicated interaction 
between early life stress and genetic variation in serotonin neurotransmission (Caspi et al. 
2003; Eley et al. 2004; Grabe et al. 2005; Kaufman et al. 2004; Kendler et al. 2005). This 
gene– environment interaction could well reflect the effects of stress-induced HPA-axis 
activation on serotonergic neurotransmission and vice versa. Various neurobiological 
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models for reciprocal influences of the HPA axis on the serotonergic system have been 
proposed, all of which strikingly converge on the hippocampal formation as the major locus 
of the interaction (Czeh et al. 2001; Jacobs et al. 2000; Lopez et al. 1998; Roozendaal 2003; 
Vermetten et al. 2003). 
In summary, we conclude that the genetic and environmental etiology of mood disorder 
may differ and that damage to the posterior hippocampal region may be specific to the 
environmentally driven etiology of anxiety and depression. We reach this conclusion in a 
design that deliberately selected subjects at so-called pure genetic and pure environmental 
risk for anxiety and depression. This is unlikely to represent the majority of subjects at risk 
in the population at large. In most subjects, risk will arise through a combination of genetic 
and environmental factors. This may explain the heterogeneity of previous studies that 
have used structural MRI in depression. Although metaanalyses consistently point to a 
smaller hippocampal volume when all studies are considered jointly, various null findings 
have been reported in well-designed studies (MacQueen et al. 2003; Posener 2003; Vakili 
2000). These null findings have been attributed to low disease burden (Campbell et al. 
2004) because patients in these studies were relatively young. Our discordant MZ twins, 
however, also were young and, with a single exception, not clinically depressed at the time 
of MRI scanning. Despite this, a significant reduction in hippocampal volume was found. 
Thus, we alternatively suggest that studies with null findings may have included relatively 
fewer subjects with environmental risk factors and more subjects at genetic risk. In support 
of this idea, a smaller left hippocampal volume in adult women with major depressive 
disorder was observed exclusively in those who had a history of severe and prolonged 
physical or sexual abuse in childhood (Vythilingam et al. 2002). 
In future MRI studies on anxiety and depression, investigators should aim to avoid 
admixture of subjects who are at risk as a result of genetic factors with those who are at 
risk as a result of environmental factors.
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Abstract 
Purpose 
NK1 receptors have been implicated in various neuropsychiatric and other disorders. R116301 
is a selective NK1 receptor antagonist. In this pilot study, [11C]R116301 was evaluated as a 
potential positron emission tomography (PET) ligand for the NK1 receptor. 
Procedures 
Two dynamic PET studies were performed in three normal volunteers before and after a 
blocking dose of aprepitant. Data were analyzed using striatum to cerebellum standardized 
uptake value (SUV) ratios. 
Results 
Baseline SUV ratios at 60–90 min after injection ranged from 1.22 to 1.70. Following 
aprepitant administration, this specific signal was completely blocked. Aprepitant 
administration did not significantly affect uptake in cerebellum, confirming the absence of 
NK1 receptors in cerebellum. 
Conclusion 
These preliminary results indicate that [11C]R116301 has potential as a radioligand for in vivo 
assessment of NK1 receptors in the human brain. 
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Introduction 
Tachykinins are a class of neuropeptides that are involved in a variety of biological functions 
in the central and peripheral nervous systems1–3. Tachykinin receptors have been divided 
into three subtypes according to their preferred ligands: neurokinin 1 (NK1), NK2, and NK3. 
NK1 receptors, for which substance P has the highest affinity, have been of particular 
interest because of their potential implication in various neuro-psychiatric and other 
disorders. Autoradiography studies of the brain of various species have demonstrated 
the presence of NK1 receptors in several cerebral structures with the highest density in 
striatum4 and negligible density in cerebellum5. NK1 antagonists could potentially be 
used for treating a variety of disorders6–8. Originally, selective nonpeptide antagonists of 
the NK1 receptor were studied as potential analgesic compounds9. Several studies have 
provided evidence that NK1 receptor antagonists might be effective in the treatment of 
anxiety disorders and depression10–13, although a recent clinical study in depression could 
not confirm these findings14. The highly selective NK1 antagonist aprepitant14, 5-[[(2R,3S]-2-
[(1R)-1-[3,5-bis(trifluoromethyl)phenyl]ethoxy]-3-(4-fluorphenyl)-4-morpholinyl]methyl]-1,2-
dihydro3H-1,2,4-triazol-3-one, however, is effective in the treatment of nausea and emesis 
after chemotherapy and is already in routine clinical use as an anti-emetic agent15, 16. To assess 
novel drugs targeting the NK1 receptor, development of a positron emission tomography 
(PET) tracer for this target is warranted, as this would provide a unique in vivo means of 
measuring receptor occupancy. In addition, in vivo imaging studies might provide new 
possibilities for studying the role of the NK1 receptor in neuro-psychiatric disorders. 
Although several NK1 agonists and antagonists have been labeled successfully for in vitro 
use, to date, most attempts to develop tracers for in vivo imaging studies have not been 
successful17–19. For example, although the radioiodinated selective NK1 antagonist L-703606 
was useful for labeling NK1 receptors in vitro20, it failed to provide a specific signal in vivo 
in rat and monkey21. For the high affinity antagonist [11C]GR205171, promising results were 
obtained in monkeys22, providing images that reflected specific binding to NK1 receptors. Its 
use was limited, however, by the fact that it did not reach equilibrium within 90 min, which 
is close to the maximum scanning time possible with a carbon-11 labeled ligand. Recently, 
[2-[18F]f luoromethoxy-5-(5-trifluoromethyltetrazol-1-yl)benzyl]([2S,3S]-2-phenylpiperidin-
3-yl)-amine ([18F]SPARQ) was developed as a fluorine-18 labeled alternative. SPARQ is 
structurally related to GR205171 and is a selective high affinity antagonist of the NK1 
receptor4, 21, 23. Unfortunately, in areas with high receptor densities, [18F]SPARQ only reached 
equilibrium after 6 h, limiting its use for clinical or intervention studies5. In addition, plasma 
kinetics of [18F]SPARQ were fast, and 90 min after injection, the amount of parent compound 
in blood was too low to be measured reliably5. As such, at present there is no “ideal” tracer 
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for human NK1 receptors and, therefore, alternative compounds need to be investigated. 
N1-(2,6-Dimethylphenyl)-2-(4-{(2R,4S)-2-benzyl-1-[3,5i(trifluoromethyl) benzoyl] hexahydro-
4-pyridinyl}piperazino)acetamide (R116301) is an orally active, potent, and selective 
nonpeptide NK1 receptor antagonist with a Ki of 0.45 nM against human NK1 receptors24. 
The affinity for human NK2 and NK3 receptors is 1600-and 230-fold lower, respectively. 
At high concentrations, R116301 interacts with rat Na+ and Ca2+ ion channel binding sites 
(Ki> 2 μM), but it does not interact with other receptors, ion channels, or transporter sites 
at a concentration of 10 μM. R116301 suppresses various aspects of substance P induced 
behavior in vivo and behaves as a full antagonist in vitro25. Recently, R116301 was labeled 
with carbon-1124. The present study is the first application of [11C]R11 6301 in humans. The aim 
of the study was to evaluate presence of selective [11C]R116301 binding to the NK1 receptor 
in vivo. 
Materials and methods 
Subjects 
Three healthy subjects, two men aged 46 and 42 and one woman aged 25, were included. 
Subjects were studied within 21 days after eligibility screening, which consisted of medical 
history including Structured Clinical Interview for DSM-IV Axis I disorders26, history of 
alcohol and drug abuse, physical examination, vital signs and electrocardiogram, laboratory 
(blood and urine) assessments, and extensive drugs (of abuse) screening. The female 
subject was practicing an effective method of birth control, and pregnancy tests were 
performed at screening and on the day of the study. Volunteers were medication-free for at 
least 14 days prior to PET scanning. In addition, subjects underwent a structural magnetic 
resonance imaging (MRI) scan within 14 days prior to the actual PET study to exclude any 
clinically significant abnormalities and for coregistration with the PET images. The study 
was approved by the Medical Ethics Committee of the VU University Medical Centre. 
Subjects gave written informed consent prior to entering the study. 
Scanning protocol 
Each PET session consisted of two [11C]R116301 scans on the same day, separated by 5 h.
[11C]R116301 was synthesized as described previously24. The first scan was under baseline 
conditions, while the second was performed 3.5 h after a single oral dose of 125 mg of the 
NK1 antagonist aprepitant (EMEND®). Pretreatment with 125 mg aprepitant is expected to 
nearly block specific uptake of [11C]R116301, as it has been reported that this dose leads to an 
occupancy of NK1 receptors of more than 90%4. 
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PET scans were acquired using an ECAT EXACT HR+ PET scanner (Siemens/CTI, Knoxville, TN, 
USA)27. All subjects received an indwelling radial artery cannula for arterial sampling. After 
a 10 min 2D transmission scan, used to correct the subsequent emission scan for tissue 
attenuation, a 3D dynamic  [11C]R116301 scan was performed. This scan consisted of 23 frames 
with progressive increase in frame duration (1 x 15, 3 x 5, 3 x 10, 2 x 30, 3 x 60, 2 x 150, 2 x 
300, and 7 x 600 s), resulting in a total scan duration of 90 min. The mean (±SD) [11C]R116301 
tracer dose, administered using an injector (Multilevel CT Injector; Medrad, Pittsburgh, PA, 
USA), was 427±44 MBq, with a specific activity of 31± 7 GBq/μmol. 
During the [11C]R116301 scan, arterial blood was monitored continuously using an on-line 
detection system (Veenstra Insruments, Joure, Netherlands)28. In addition, at set times 
manual blood samples were collected for measurement of metabolite fractions. 
Magnetic resonance imaging was performed using a 1.5-T Sonata system (Siemens, Erlangen, 
Germany) with a standard receiver head coil. For each subject, a coronal 3D gradient-echo 
T1-weighted sequence (matrix 256 x 160; inversion time, 300 ms; TR=15 ms; TE=7 ms; flip 
angle=80º; voxel size 1 x 1 x 1.5 mm; 160 sections) was acquired. 
Image analysis 
[11C]R116301 scans were reconstructed using a FORE + 2D filtered back projection 
algorithm29 and a Hanning filter with a cut-off at 0.5 times the Nyquist frequency, including 
usual corrections for decay, dead time, attenuation, scatter, and randoms. A zoom factor of 
2 and an image matrix size of 256 x 256 were used, resulting in a final image resolution of ~7 
mm full width at half maximum and a voxel size of 1.2 x 1.2 x 2.4 mm3. 
Baseline and post-aprepitant dynamic PET scans were coregistered to each other and 
subsequently to individual MRI scans using the software package MIRIT30, 31. Using 
anatomical criteria and the threedimensional software program DISPLAY (http://www.
bic.mni.mcgill.ca/ software/Display), regions of interest (ROIs) were defined manually on 
the individual MRI scan for the following structures: caudate, putamen, medial temporal 
lobe (MTL), thalamus, cingulate, frontal cortex, parietal cortex, insular cortex, occipital 
cortex, and cerebellum. MRI scans were segmented into grey and white matter and, except 
for cerebellum, only grey matter voxels within a ROI were used for further analysis32. As 
segmentation in the cerebellum is less accurate, all voxels within the cerebellum ROI were 
used. Finally, tissue time–activity curves were generated by projecting these ROIs onto all 
dynamic frames. 
Assessment of specific signal 
During the study, significant sticking of  [11C]R116301 to the wall of the polytetrafluorethylene 
tubing was suspected, as flushing the line did not result in a reduction of detector counts. 
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This was confirmed in a retrospective experiment, where significant residual activity was 
measured after rinsing a tube that had been filled with [11C]R116301 containing blood. Due 
to this sticking, arterial input curves were unreliable, making compartmental analysis 
impossible. Therefore, for this first analysis, standardized uptake values (SUV) were used. 
SUV represents the mean (over a time interval) tissue concentration, normalized for injected 
dose and either subject weight, lean body mass, or body surface area33. SUV were obtained 
for all ROIs of both baseline and post-aprepitant [11C]R116301 scans. As it is known that 
the level of NK1 receptors is negligible in cerebellum5, the target to cerebellum SUV ratio 
(SUVr) was used for estimating the size of the specific signal, and this ratio was also used as 
outcome parameter for assessing the effects of aprepitant. Emphasis was on striatum, as 
this structure has the greatest density of NK1 receptors. 
Results 
Plasma clearance of [11C]R116301 was rapid with no differences between pre-and post-
aprepitant scans (data not shown). Due to this rapid plasma clearance, metabolites could 
not be measured after 60 min. Metabolite fractions (determined using the manual samples) 
at 40 min post injection ranged from 20% to 45% (average 35%). 
As expected, highest uptake was observed in striatum, with intermediate uptake in cortical 
areas, and lowest uptake in white matter and cerebellum. In Fig. 1a, pre-and postaprepitant 
SUV images (60–90 min post injection) are shown for one of the subjects (subject 1), 
illustrating substantial reduction of [11C]R116301 uptake after aprepitant administration. In 
contrast to striatum, aprepitant administration did not significantly affect [11C]R116301 SUV 
in cerebellum, confirming absence of NK1 receptors in cerebellum (Fig. 1b). 
Striatum to cerebellum SUVr steadily increased over time but tended to level off after about 
60 min post injection (Fig. 1c). Therefore, for assessment of the size of the specific signal, the 
interval 60–90 min post injection was used. 
Baseline striatum to cerebellum SUVr were 1.56, 1.70, and 1.22 and reduced to 0.97, 0.96, and 
1.01 post-aprepitant, respectively. Pre-and post-aprepitant SUVr for all ROIs are shown in 
Table 1, together with their ratio. Note that, in subject number 3, the latter ratio is smaller 
than 1 for parietal cortex and thalamus, which is probably within measurement error, at 
least for parietal cortex, although a small movement artifact for thalamus cannot be 
excluded. More importantly, pre-to post-aprepitant ratios of SUVr ranged from 1.21 to 1.77 
for striatum (Table 1).
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Table 1. Pre- and post-aprepitant SUVr (60–90 min post injection), together with their ratio
 Subject 1  Subject 2  Subject 3
 Pre  Post  Pre/post  Pre  Post  Pre/post  Pre  Post Pre/post
Striatum  1.56 0.97 1.61 1.70 0.96 1.77 1.22 1.01 1.21
Caudate  1.33 0.85 1.57 1.55 0.86 1.80 1.04 0.92 1.13
Putamen  1.95 1.19 1.64 1.95 1.16 1.69 1.61 1.19 1.35
Thalamus  1.14 0.98 1.16 1.30 1.12 1.16 0.83  102  0.81
Frontal Ctx  1.22 1.00 1.22 1.24 1.02 1.22 0.97 0.97  1.00
Cingulate  1.27  1.07 1.19 1.22  1.02 1.20 1.12 1.11 1.00
MTL  1.02 0.91 1.12 1.16 0.97  1.20 1.08 1.02 1.06
Insula  1.25 1.07 1.17  1.18 1.05 1.13 1.11 1.07  1.04
Parietal Ctx  1.24 1.00 1.24 1.24 0.99 1.24 0.93 0.99 0.95
Occipital Ctx  1.29 1.06 1.22 1.29 1.01 1.27 1.14  1.08 1.05
Ctx cortex, MTL medial temporal lobe
Figure 1:  a [11C]R116301 SUV images (60–90 min 
post injection) for subject number 1, before (left) 
and 3.5 h after (right) oral administration of 125 mg 
aprepitant. b Pre- and post-aprepitant SUV curves 
for striatum and cerebellum of subject 1. 
c Pre-aprepitant striatum to cerebellum SUVr. Note 
that SUV is normalized to body surface area and 
that results are expressed as milliSUV (mSUV).
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Discussion 
This is the first study using the highly selective novel PET ligand [11C]R116301 in human 
subjects. The distribution of this tracer corresponds to the known distribution of NK1 
receptors, with high retention in striatum (caudate and putamen) and much lower retention 
in cortical areas5. Blocking studies with the NK1 antagonist aprepitant caused a substantial 
reduction of the specific signal of [11C]R116301 to background levels, confirming selectivity 
of binding to the NK1 receptor. On the other hand, the rather low target to cerebellum SUVr 
suggests a relatively high degree of nonspecific binding in humans. 
The signal in the cerebellum could not be blocked by aprepitant, confirming that the density 
of NK1 receptors in human cerebellum is negligible5. Consequently, cerebellum can be used 
as reference region, i.e., as an estimate of free and nonspecific binding. Therefore, for the 
blocking studies, the ratio of target to cerebellum SUVr relative to baseline was used as 
outcome measure. The size of the specific signal was assessed at the interval 60–90 min 
post injection, as SUVr seemed to become fairly constant within this time span. 
It should be noted that striatum to cerebellum SUVr for the baseline scan of subject 3 was 
lower than that of the other two subjects, indicating lower specific binding (Fig. 1c). Subject 
3 was, however, screened in the same manner as the other two subjects, and all parameters 
were within normal range. Although a moderate age effect (7% decrease per decade, 
significant in other regions than striatum) on NK1 receptor density has been reported34, both 
age and gender could not explain this lower binding, as subject 3 was a man of 42 years. 
With the present sample size, it is not possible to assess whether the observed intersubject 
variability was due to biology (e.g., polymorphism with modulating effects on affinity of 
the receptor) or methodology (i.e., effect of using a simple SUVr for quantification). Further 
studies are needed to address these issues, in particular assessing the validity of using SUVr 
as outcome measure. In addition, a tracer kinetic model for more quantitative analyses of 
[11C]R116301 data needs to be developed. 
At present, [18F]SPARQ is a PET tracer that provides a much higher specific signal than
[11C]R116301. Therefore, at least in theory, it should provide a more accurate assessment 
of NK1 receptor status or occupancy. Nevertheless, for clinical applications, [18F]SPARQ is 
far from ideal because of its slow kinetics, requiring very long study durations, thereby 
increasing the risk of movement artifacts. At the cost of a reduced signal, [11C]R116301 has 
the advantage that studies can be performed within a reasonable time (90 min). 
When ranking the affinity of various NK1 ligands based on pKi values versus [3H]SP (substance 
P), the following order (from high to low) is obtained: GR205171 > aprepitant > R116301 > 
substance P35. It is likely that the affinity of SPARQ5 is higher or equal than that of GR205171. 
It is clear that the affinity of R116301 is lower than that of SPARQ, which is in agreement with 
the higher specific signal observed with [18F]SPARQ. On the other hand, the lower affinity 
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of R116301 implies that [11C]R116301 could be more sensitive to differences in endogenous 
substance P concentrations. This would be very interesting in intervention studies, where 
release of the endogenous ligand could be manipulated by a pharmacological challenge or, 
for example, a fear stimulus. Clearly, further studies are needed to establish whether this 
is feasible. 
The NK1 receptor has shown to be an enigmatic target for neuroscience drug discovery 
and development. To date, antagonists for the NK1 receptor have shown efficacy in the 
prevention of chemotherapy-induced nausea and vomiting. Although both NK1 receptors 
and substance P are widely distributed in the brain and may be involved in many 
neuropsychiatric disorders, many clinical trials on anxiety and depression have found no 
therapeutic effects of antagonist drugs. Nevertheless, Casopitant® (GlaxoSmith Kline), 
an NK1 antagonist, is still under clinical investigation for a variety of disorders, including 
phase II studies in anxiety and depression. Availability of a PET tracer could facilitate 
further clinical exploration of NK1 receptor involvement in a variety of neuropsychiatric 
disorders and serve as a tool for the development of drugs that target the NK1 receptor. The 
present study demonstrates that [11C]R116301 could be a potential candidate tracer for those 
investigations. 
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Abstract
Purpose
NK1 receptors are potential targets for therapeutic agents, as they have been implicated 
in depression, anxiety and pain perception. Recently, it was shown that, in human brain, 
a specific NK1 receptor related signal was obtained with the novel radioligand [11C]R116301 
using positron emission tomography (PET). The purpose of the present study was to 
evaluate various methods for quantifying specific [11C]R116301 binding. 
Methods
Two dynamic 90 minutes [11C]R116301 scans, separated by 5 hours, were performed in 
11 healthy volunteers. In three subjects, the second scan was performed after an oral 
blocking dose of 125 mg aprepitant, whilst in the other 8 no intervention was performed 
(test-retest). Whole striatum was used as tissue of interest, as it has the highest density 
of NK1 receptors. Cerebellum was used as reference tissue. 
Results
No useful results were obtained with plasma input models due to extensive sticking of 
the tracer to the tubing of the blood sampling device. Measured plasma curves were not 
reliable even after implementing a validated sticking correction. Reference tissue models 
were stable with the simplified reference tissue model (SRTM) performing best. Average 
(± SD) SRTM derived mean binding potential BPND of all (first) baseline scans was 0.64 ± 
0.31 (n = 11), which reduced to –0.01 ± 0.03 (n = 3) following aprepitant administration. Test-
retest results showed low variability (14.0 ± 10.7%) and excellent reliability, as indicated by 
the intraclass correlation coefficient (ICC = 0.93). The ratio of standardized uptake values 
of striatum and cerebellum minus 1 (SUVr-1), an approximation of BPND, showed very low 
variability (6.2 ± 3.1%) with excellent reliability (ICC = 0.98), and correlated well with SRTM 
derived BPND (R2 = 0.96). 
Conclusions
In the absence of a reliable plasma input function, SRTM is the model of choice for 
quantifying [11C]R116301 binding. Semi-quantitative tissue ratios hold promise for routine 
clinical applications.
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Introduction 
Substance P (SP) is one of the most abundant neuropeptides in the central nervous 
system. It has been implicated in a variety of neuro-psychiatric processes, including 
stress-regulation as well as affective and anxiety-related behaviour1. SP and its preferred 
G-protein-coupled neurokinin 1 (NK1) receptor have been found in brain areas known to 
be involved in the regulation of stress and anxiety responses with the highest density in 
striatum2 and negligible density in cerebellum3. In these regions, SP frequently coexists 
in the same neuron with other neurokinins and with ‘classical’ neurotransmitters such as 
dopamine, acetylcholine, serotonin, noradrenalin, GABA and glutamate1.
Over the last decades, NK1 receptors gained interest as a pharmacological target and 
antagonists for this receptor were thought to be useful for the treatment of depression, 
anxiety and inflammatory pain4-6. In addition, preclinical evidence suggested a role of SP-
NK1 in nociception, neurogenesis and emetogenesis7-9. The NK1 antagonist, aprepitant 
(EMEND®) is on the market for treatment of radio- and chemo-therapy induced emesis. 
Several NK1 antagonists went into advanced clinical trials for treatment of depression (e.g. 
L759274, phase III; vesipitant, phase II), or anxiety (R673, phase II), but these studies failed. 
Recently, compounds like casopitant and AV608 are in phase II clinical trials for various 
indications such as myalgia, insomnia, irritable bowel syndrome and urinary incontinence. 
PET could be a useful tool to visualise and quantify specific receptor binding in order to 
gain more insight in neurotransmitter-receptor function and it could aid in assessing the 
optimal dose range of new drugs for central NK1 receptor occupancy.
N1-(2,6-Dimethylphenyl)-2-(4-{(2R,4S)-2-benzyl-1-[3,5i(trifluoromethyl) benzoyl] hexahydro-
4-pyridinyl}piperazino)acetamide (R116301) is an orally active, potent and selective non-
peptide NK1 receptor antagonist with a Ki value of 0.45 nM for human NK1 receptors10. 
Recently, it was labelled with carbon-1110 and in a pilot study in healthy human subjects an 
NK1 related specific signal could be observed11. 
The purpose of the present study was to evaluate various tracer kinetic models for 
quantification of [11C]R116301 binding to the NK1 receptor using both blocking and test-
retest data. 
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Methods 
Subjects
In total 11 healthy subjects were included in this study. Three healthy subjects, two males 
aged 46 and 42 and one female aged 25, have previously been included in a pilot study to 
assess whether a specific signal could be detected in vivo by comparing [11C]R116301 scans 
before and after aprepitant predosing11 . In the present study these data were used for 
modelling purposes. Test-retest data were obtained in 8 healthy males aged 19 to 27 years. 
All subjects were studied after eligibility screening, which consisted of medical history 
including Structured Clinical Interview for DSM-IV Axis I disorders (SCID-I)12 and history of 
alcohol and drug abuse, physical examination, vital signs and ECG, laboratory (blood and 
urine) assessments, and extensive toxicology screening. Subjects were medication free 
for at least 14 days prior to the PET study. All subjects underwent a structural MRI scan 
within 14 days prior to the actual PET study. None of the MRI scans showed any clinical 
significant abnormalities, as reported by a neuroradiologist. The study was approved by 
the Medical Ethics Review Committee of the VU University Medical Centre. All subjects 
gave written informed consent prior to entering the study.
Synthesis of [11C]R116301 
GMP compliant production of [11C]R116301 was performed in a government licensed GMP 
hotlab facility. [11C]R116301 was synthesized according to a previously published method 
with minor modifications10 . In short, at a temperature of -65°C, 3,5-bis(trifluoromethyl)
bromobenzene was treated with n-butyllithium and [11C]CO2 was passed through this 
solution. The reaction mixture was quenched with 1M HCl in diethyl ether to yield 
[11C]3,5-bis(trifluoromethyl)benzoic acid quantitatively. This product was subsequently 
transformed to [11C] 3,5-bis(trifluoromethyl)benzoyl chloride (1) by treatment with 2M oxalyl 
chloride in dichloromethane. After removal of excess of oxalyl chloride by evaporation 
with a stream of Helium at 68°C, the mixture was cooled to -20 °C and a solution of the 
precursor R187662, N1-(2,6-dimethylphenyl)-2-{4-[(2R,4S)-2-benzylhexahydro-4-pyridinyl]
piperazino}acetamide (2), in dimethylformamide (DMF) and triethylamine (TEA) was 
added. The product [11C]R116301 was purified with semipreparative HPLC and isolated 
by solid phase extraction. As a result, [11C]R116301 was obtained in an average decay-
corrected radiochemical yield of 24 ± 6 % (from [11C]CO2) in a total synthesis time of 35 
minutes with a chemical and radiochemical purity exceeding 98% and a specific activity 
of 28.8 ± 8.6 GBq/µmol at time of injection. The product was formulated in a sterile and 
pyrogen free mixture of ethanol (1.3 mL), 7.09 mM NaH2PO4 in 0.9% NaCl (1.5 mL) and 0.9% 
NaCl (12 mL). 
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Five percent human serum albumin (HSA) was added to the formulation to prevent 
adhesion to the injection system. 
Scanning protocol 
Each PET session consisted of two [11C]R116301 scans on the same day, separated by 5 hours. 
In the blocking study, the first scan was under baseline conditions, whilst the second was 
performed 3.5 hours after a single oral dose of 125 mg of the NK1 antagonist aprepitant 
(EMEND®). Pre-treatment with 125 mg aprepitant is expected to nearly block specific 
uptake of [11C]R116301, as it has been reported that this dose leads to an occupancy of NK1 
receptors of more than 90%2. For the test- retest study exactly the same protocol was 
used, but without intervention.
PET scans were acquired using an ECAT EXACT HR+ scanner (Siemens/CTI, Knoxville, TN, 
USA), which has been described previously13. All subjects received an indwelling radial 
artery cannula for arterial sampling. After a 10 minutes 2D transmission scan, which was 
used to correct the subsequent emission scan for attenuation, a 3D dynamic emission 
scan was performed following an intravenous bolus injection of [11C]R116301. This scan 
consisted of 23 frames with progressive increase in frame length (1x15, 3x5, 3x10, 2x30, 
3x60, 2x150, 2x300 and 7x600 s) and a total duration of 90 minutes. Arterial blood was 
monitored continuously using an online detection system (Veenstra Instruments, Joure, 
Netherlands)14 with a withdrawal rate of 5 mL/min during the first 10 minutes and 2.5 mL/
min thereafter. PTFE tubing was used to minimise potential sticking of activity to the tube 
wall. In addition, at set times (5, 10, 20, 40, 60, 75 and 90 minutes post-injection), discrete 
manual samples were taken. After each sample, the line was flushed with heparinised 
saline. 
Magnetic resonance imaging was performed on a 1.5-T Sonata MR system (Siemens, 
Erlangen, Germany) with a standard receiver head coil. Anatomic imaging included a 
coronal 3D gradient-echo T1-weighted sequence (matrix 256 x 160, inversion time: 300 
ms, TR = 15 ms; TE = 7 ms; flip angle = 80º; voxel size 1 x 1 x 1.5 mm, 160 sections).
Image analysis
[11C]R116301 scans were reconstructed using a FORE+2D filtered back projection algorithm15 
and a Hanning filter with a cut-off at 0.5 times the Nyquist frequency, resulting in a final 
image resolution of ~7 mm full width at half maximum. A zoom factor of 2 and an image 
matrix size of 256x256, were used, resulting in a voxel size of 1.2 x 1.2 x 2.4 mm3. (All data 
were normalised and corrected for attenuation, dead time, decay, scatter and randoms.) 
The first and second dynamic PET scans were co-registered to each other, and subsequently 
to the individual MRI scan using the software package MIRIT16, 17 . 
hoofdstuk 6.indd   123 7-3-11   10:26
Chapter   6
124
Using anatomical criteria and the three-dimensional software program DISPLAY (http://
www.bic.mni.mcgill.ca/software/Display), striatum, consisting of caudate and putamen, 
and cerebellum were defined manually. Both assessment of blocking effect of aprepitant 
and test-retest variability was based on striatum, as this structure has the highest density 
of NK1 receptors. As it is known that the level of NK1 receptors in cerebellum is negligible 
3,11,18,19, this structure was used as reference region. MRI scans were segmented into grey 
and white matter and, except for cerebellum, only grey matter voxels within an ROI were 
used for further analysis20. Tissue time-activity curves (TACs) were generated by projecting 
these ROIs onto all dynamic frames of both scans. 
Kinetic analysis
Striatal TACs were analysed using several analytical methods: plasma input models, 
reference tissue models and analyses based on standardized uptake values (SUV). 
Plasma input models
For plasma input models21, an accurate metabolite corrected input function is required. 
Previously, it was shown that plasma input curves were not reliable due to stickiness 
of [11C]R116301 to the walls of the sampler tubing11. Therefore, in the present analysis, a 
correction for sticking activity, previously validated for [11C]deprenyl, was incorporated22. 
This correction assumes that sticking can be described by a single exponential function. 
In addition, in the present analysis, also a double exponential approach was implemented 
to correct for sticking. 
Reference Tissue Models
Using cerebellum as indirect input function, both full (FRTM; 4 parameters)23 and 
simplified (SRTM; 3 parameters)24 reference tissue models were evaluated, yielding non-
displaceable binding potential BPND25 of striatum. In order to stabilize fits, the following 
boundaries were used: k2>0.025, 0.0000001<R1<2, and BP>-0.499. Although binding 
cannot be negative, the lower limit of BPND was set to a negative value to avoid noise 
induced positive bias in case of negligible binding (as expected in the blocking study). 
Akaike26 and Schwarz27 criteria were used to assess which model best described the data.
Single scan method
Standardized uptake values (SUV) for striatum and cerebellum, together with their ratio 
(SUVr) were calculated for the interval 60-90 minutes after injection. SUVr–1 was used as 
an index of binding potential. 
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Test-retest reproducibility and blocking analysis
Test-retest reproducibility of BPND and SUVr–1 was assessed in terms of variability and 
reliability28. The within subject variability was defined as the absolute value of the 
difference between test and retest values, expressed as the percentage of the mean of 
test and retest values: 
Variability (%) = 100 x |test - retest| / ((test + retest)/2)
Here test and retest refer to the estimated values of the specific parameter of interest for 
scans 1 and 2, respectively. VAR < 10% was considered as very low, between 10% and 15% as 
low, between 15 and 20% as moderate, and > 20% as high. As a measure of reliability the 
intraclass correlation coefficient (ICC) was used. This is defined by:
ICC = (MSBS – MSWS) / (MSBS + MSWS)
where MSBS is the mean sum of squares between subjects, and MSWS is the mean sum 
of squares within subjects. This coefficient is an estimate of the reliability of the two sets 
of measurements and ranges from –1 (no reliability) to + 1 (perfect reliability, i.e., identical 
test and retest measurements). Values close to 1 indicate that most variance is due to 
between subject rather than within subject variation (good reliability), whereas values 
below zero imply greater within subject than between subject variation (poor reliability). 
ICC over 0.90 was considered as excellent, ICC between 0.70 and 0.90 as good and ICC 
under 0.70 as poor 29. 
In addition, occupancy after blocking, as assessed using BPND and SUVr–1, was calculated 
according to the following equation: 
Occupancy (%) = 100 x (1 - scan2/scan1)
where scan1 and scan2 represent observed outcome measures of baseline and ‘blocked’ 
PET studies, respectively.
Finally, SUVr–1 was compared with BPND derived from SRTM to assess the 
feasibility of using SUVr–1. 
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Results 
Average administered tracer dose across all 22 scans was 390 ± 47 MBq with an average 
specific activity of 28.8 ± 8.6 GBq/mmol. Average total administered R116301 (cold and 
hot) was 14.7 ± 4.5 nmol (N=22). There were no statistically significant differences in any 
of these parameters between test and retest scans, nor between baseline and blocking 
scans. 
Plasma input models
Significant sticking of [11C]R116301 to the wall of the PTFE tubing was observed, as counts 
detected by the online sampler remained high when flushing the line after taking a 
manual blood sample. This was confirmed in a separate experiment, where significant 
residual activity was measured after rinsing a tube filled with blood that contained 
[11C]R116301. 
Figure 1:  Normalized pre- and post-aprepitant time activity curves for striatum and cerebellum. 
Lines represent SRTM fits to the striatum data using cerebellum as reference tissue input function.
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In an attempt to generate reliable plasma curves, a single exponential sticking correction 
algorithm, previously validated for [11C]deprenyl22 , was incorporated to characterise binding 
of [11C]R116301 to the tubing wall. Unfortunately, the shape of the tail of a “corrected” curve 
did not correspond with that of the corresponding samples. Clearly, a single exponential 
was not sufficient to characterise sticking and, therefore, a double exponential was 
attempted. In most cases, however, sticking fits did not converge, indicating that too 
many parameters were involved for reliable estimation. Consequently, despite attempts 
to correct for sticking activity, plasma curves remained unreliable, prohibiting the use of 
plasma input models. 
Table 1:  Occupancy (%) of NK1 receptors in striatum following predosing with 125 mg 
aprepitant
Subject No BPND SUVr-1 
1 101.9 105.4
2 105.0 105.7
3 87.0 95.5
BPND based on SRTM; SUVr: ratio of striatum over cerebellum SUV, 60-90 minutes p.i.
Table 2:  SRTM derived BPND for striatum and SUVr-1 for both scans. Averages (±SD) 
for all baseline scans (scan 1; N=11) are given in the last row
Subject No BPND
Scan 1
BPND
Scan 2
SUVr-1
Scan 1
SUVr-1
Scan 2
1 0.73 -0.01 0.56 -0.03
2 0.86 -0.04 0.70 -0.04
3 0.15 0.02 0.22 0.01
4 0.44 0.57 0.45 0.46
5 0.99 0.84 0.83 0.75
6 0.05 -0.03 0.16 0.13
7 0.81 0.79 0.65 0.62
8 0.82 0.62 0.66 0.59
9 0.51 0.60 0.52 0.56
10 0.88 0.88 0.71 0.63
11 0.75 0.69 0.64 0.68
Average 0.64±0.31 0.55±0.21
SUVr: ratio of striatum over cerebellum SUV, 60-90 minutes p.i.
Scan 2: for subjects 1-3 after predosing with aprepitant, for subjects 4-11 retest scan.
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Reference tissue models
Representative baseline and post-aprepitant [11C]R116301 TACs for striatum, together with 
best fits according to SRTM, with corresponding cerebellar TACs are shown in figure 1. 
After aprepitant administration, striatal TACs were similar to cerebellar TACs, indicating 
complete occupancy of the NK1 receptor. 
According to both Akaike and Schwarz criteria, SRTM was preferred in 21 out of the total of 
22 cases. Only in one post-aprepitant scan (subject 1) was a better fit obtained with FRTM. 
In addition, in case of FRTM, in 18 out of 22 cases standard errors of fitted BPND were >100% 
and in another 2 they were >25% (data not shown). Therefore, only BPND results obtained 
with SRTM were used for further analysis. 
Post-aprepitant BPND values were close to zero, indicating complete occupancy 
independent of (variation in) baseline values (Table 1). Mean baseline BPND (± SD) over all 
subjects (all baseline, test and retest values; n=19) was 0.63 ± 0.29. Mean baseline BPND 
over all subjects (without retest values; n=11) was 0.64 ± 0.31 (Table 2). For one of the 
subjects (subject number 6) both test and retest BPND values were close to zero. Although 
there was a reasonable large range in BPND values between subjects, only in this subject 
specific binding appeared to be negligible. As calculations for (relative) test-retest 
variability are based on absolute differences, and for very low binding levels even minor 
absolute differences can result in large relative differences, this analysis was applied over 
all subjects except subject number 6. This resulted in low mean variability (14.0%) (Table 
3). Test-retest reliability was excellent (ICC = 0.93).
Table 3:  Test-retest variability (%) of BPND in striatum and SUVr-1 for all subjects. 
Averages (±SD) across all subjects are given in the last row
Subject No BPND SUVr-1 
4 26.9 4.4
5 16.6 10.1
7 2.7 4.7
8 27.0 9.5
9 16.0 7.4
10 0.5 1.4
11 8.3 6.1
Average 14.0±10.7 6.2±3.1
BPND based on SRTM; SUVr: ratio of striatum over cerebellum SUV, 60-90 minutes p.i.
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Single scan method
Mean SUVr–1 of baseline scans was 0.55 ± 0.21 (Table 2). As shown in Table 1, aprepitant 
administration completely blocked the signal, indicating that SUVr–1 indeed reflects 
specific binding. Test-retest variability (Table 3) was very low (6.2%) and reliability was 
also excellent (ICC = 0.98). 
BPND vs SUVr-1
To assess the accuracy of SUVr–1, results from both blocking and test-retest studies were 
compared with those of SRTM derived BPND. The correlation between both parameters is 
shown in figure 2. Both outcome measures were highly correlated (R2 = 0.96), but there 
was a slight (systematic) underestimation of SUVr–1 as compared with BPND. A Bland-
Altman plot of BPND obtained with SRTM and SUVr-1 is given in figure 3 showing that SUVr–1 
underestimates specific binding at higher BPND consistent with the slope = ~0.8 in figure 2.
Figure 2:  Correlation of 
SUVr-1 (60-90 min p.i.) 
with SRTM derived BPND.
Figure 3:  Bland-Altman 
of SUVr-1 (60-90 min) 
and SRTM derived BPND, 
showing the differences 
versus the averages. The 
difference was calculated 
using SUVr-1 minus 
BPND(STRM)
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Discussion
The purpose of the present study was to evaluate various different methods for 
quantification of binding of the novel PET ligand [11C]R11630110 to NK1 receptors in humans. 
Recently, in the first human application of [11C]R116301, a specific NK1 related signal was 
demonstrated using predosing with aprepitant and simple striatum (highest density of 
NK1 receptors) to cerebellum (devoid of NK1 receptors) ratios11. To evaluate whether this 
tracer can be used to quantitatively assess NK1 receptor status, tracer kinetic models were 
applied to the predosing data mentioned above. In addition, precision of these models 
was assessed using a test-retest study, providing an estimate of within-subject variability 
(%) for each method. The intraclass correlation coefficient (ICC) was used as a measure of 
reliability28, as this statistical parameter compares within- to between-subject variability 
in repeated measurements. 
After identifying that sticking of the tracer was a problem for generating reliable plasma 
curves, two potential correction algorithms were investigated. The first correction, 
previously validated for [11C]deprenyl, assumes that sticking can be described by a single 
exponential function23. It was clear, however, that this simple correction was not able 
to provide a satisfactory correction for sticking of [11C]R116301 to the walls of the online 
tubing, as no consistent match between online curve and manual samples could be 
obtained. Apparently, a single exponential did not fully characterise sticking kinetics 
and, therefore, a second attempt was made using a double exponential function. This 
approach, however, also was not successful, as most fits did not converge, indicating that 
too many parameters were involved. Consequently, it was not possible to use plasma 
input models. 
As the cerebellum is known to be devoid of NK1 receptors3, it was possible to investigate 
reference tissue models using cerebellum as reference tissue. In the present study, SRTM 
was preferred over FRTM in all but one of the baseline scans according to both Akaike and 
Schwarz criteria. In addition, standard errors of parameter estimates were much higher 
for FRTM than for SRTM. Therefore, SRTM was chosen as the (reference tissue) model of 
choice. Baseline scans showed a mean BPND of 0.63 ± 0.29 (n=19). As expected, specific 
binding reduced to almost zero after pre-dosing with 125 mg aprepitant in the blocking 
study (n=3), indicating almost complete blocking. 
Test-retest results for SRTM derived BPND showed good reproducibility and excellent 
reliability. It should be noted, however, that there was little specific signal in subject 3 
and none in subject 6. The absence of a specific signal in this latter subject was consistent 
in both test and retest scans, indicating that this is unlikely due to a measurement error. 
Both subjects were, however, screened and scanned in the same manner as all other 
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subjects and all clinical parameters were within normal range. 
The moderate age effect (7% decrease per decade, significant in other regions than 
striatum) of binding to NK1 receptors that has been reported30 could potentially have 
played some role in the lower signal of subject number 3, as this was a male of 41. This 
would, however, be no explanation for subject number 6, as this was a male of 27 years 
old. Theoretically, it could also be due to differences in genetic make-up, for example a 
polymorphism in the binding region of the human NK1 receptor gene, potentially resulting 
in lower affinity for [11C]R116301. A recent study, however, reported that the variant (Y192H) 
displayed similar properties as the wild type receptor31. Therefore, at present there is no 
evidence for an affinity related change in binding of [11C]R116301 to the receptor based 
on receptor polymorphisms. Therefore, it still remains unclear as to why specific binding 
measured in subject number 6 was so low. 
Finally, for potential application in routine clinical studies, SUVr–1, an index of binding 
potential, was investigated. Note, that this ratio would equal BPND in case of true 
equilibrium. Test-retest results for SUVr–1 were excellent, showing very low test-retest 
variability (6.2%) and excellent reliability (ICC: 0.98). In addition, the signal reduced to zero 
after predosing with aprepitant. 
To assess the validity of a simplified SUVr–1 approach, results were compared with BPND 
obtained using SRTM. Using both blocking and test-retest data, a good correlation (R2 = 
0.96) was obtained. It should be noted, however, that SUVr–1 was consistently lower than 
BPND (slope = 0.8 in Figure 2), indicating absence of equilibrium. Nevertheless, the high 
correlation shown in figure 2 indicates that SUVr–1 might provide a reasonable estimate/
index of BPND in case of clinical studies, although both figures 2 and 3 demonstrate that 
SUVr-1 underestimates BPnd for regions showing higher binding.
In conclusion, in the absence of a reliable plasma input function, SRTM is the method 
of choice for quantifying [11C]R116301 binding is SRTM, as reliability (ICC) was excellent 
and test-retest variability low. The semi-quantitative tissue ratio method (SUVr–1) holds 
promise in a clinical setting, showing high correlation with SRTM, but further studies are 
needed to assess its validity in patient populations.
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The research described in this thesis examined brain correlates of anxiety and depression 
using various neuroimaging techniques. Sections A and B report on functional and structural 
neuroimaging studies in MZ twins at high and low risk for anxiety and depression. In section 
C, a novel PET ligand for NK1 receptors, which are involved in anxiety and depression, was 
evaluated in vivo. This approach could be the basis of future imaging genetics studies 
focusing on functional, structural and molecular (receptor ligand) changes, to disentangle 
the contributions of genetic and environmental risk factors for anxiety and depression.  
Summary sections A and B: the MZ discordant/concordant twin study
In sections A and B, the hypothesis was tested that genetic and environmental risk factors 
for anxiety and depression impact on partly different brain structures or, alternatively, 
even if they converge on the same brain structures, they do so in entirely different, perhaps 
opposite, ways. 
To this end, dual modal imaging was used in MZ twin pairs strongly concordant or discordant 
for the risk for anxiety and depression to establish intrapair differences in regional brain 
structure and function. This risk was computed on the basis of longitudinal survey data on 
anxiety, depression, neuroticism, and somatic anxiety collected in 1991, 1993, 1997, and 2000 
57, which were shown to have strong predictive value for clinical anxiety and depression, as 
assessed by the Composite International Diagnostic Interview58. 
Because MZ twins are considered genetically identical, any discordance in their risk for 
anxiety and depression must arise from differential exposure to environmental influences. 
Hence, the intrapair comparison of discordant twins highlighted neural activation and brain 
regions that are particularly susceptible to environmental factors. In MZ twin pairs that are 
selected to be highly concordant, the risk was either very high in both members of the pair 
(even though they have been exposed to partly different environments) or very low in both 
members. Comparing these two groups creates a genetic contrast, which was confirmed 
by verifying that the parents of these twins indeed had high versus low risk scores as well. 
Hence, the low / high group comparison of concordant twins highlighted neuronal activation 
and brain regions that are particularly susceptible to genetic factors.
Section A: Functional Neuroimaging
Previous functional brain imaging studies in subjects suffering from anxiety and depressive 
disorder have shown deviant amygdala responses to emotional stimuli, but compared to 
healthy controls both hyperactivity and hypoactivity have been reported. In chapter 2, the 
hypothesis was tested that these discrepant findings are based on different effects of genetic 
and environmental risk factors on amygdala functioning. To test this hypothesis, amygdala 
responses to an emotional faces paradigm were assessed during fMRI in monozygotic twin 
hoofdstuk 7-8, etc.indd   139 9-3-11   11:05
Chapter 7
140
pairs discordant for the risk of anxiety and depression (n=10 pairs) and in monozygotic twin 
pairs concordant for high (n=7 pairs) or low (n=15 pairs) risk for anxiety and depression. Main 
effects (all faces vs. baseline) revealed robust bilateral amygdala activity across groups. In 
discordant twins, increased amygdala responses were found for negatively valenced stimuli 
(angry/anxious faces) in high-risk twins compared to their low-risk co-twins. In contrast, 
concordant high-risk pairs revealed blunted amygdala reactivity to both positive and 
negative faces compared with concordant low-risk pairs. Post-hoc analyses showed that 
these findings were independent of serotonin transporter (5-HTTLPR) genotype. 
These findings indicate that amygdala hyperactivity was found in subjects who are 
at high risk for anxiety and depression through environmental factors, but amygdala 
hypoactivity in those at risk mainly through genetic factors. The hyperactivity of the 
environmentally at risk twins disappeared after correcting for state anxiety, which indicates 
that hyperresponsiveness to emotional stimuli went together with increased anxiety. State 
anxiety was similarly increased in the twins at genetic risk, although here amygdala reactivity 
to the emotional stimuli was lower compared to neutral stimuli and this hypoactivity did not 
disappear when state anxiety was taken into account. This pattern of results appears to 
reflect higher baseline amygdala activation in subjects at high genetic risk for anxiety and 
depression, which acts to reduce further activation in response to general increases in state 
anxiety and specific emotion-inducing stimuli (e.g. angry faces). 
In chapter 3, emotional processing and brain activation were examined during an encoding 
and recognition paradigm using emotionally salient words in a sample of monozygotic twin 
pairs at low and high risk for anxiety and depression, using the same study sample as in 
chapter 2. Psychological theories of major depression have emphasized the role of negative 
biases in information processing in the etiology and the maintenance of the disorder. Such 
biases have been reported both for interpretation and storage of emotional information59-62. 
These observations raise the possibility that emotional biases might pre-date the onset 
of clinical depression and thereby represent a risk factor for subsequent development of 
illness in predisposed individuals. To investigate emotional bias prior to onset of depression 
it is necessary to study people who are at risk for anxiety and depression, but who are not 
clinically depressed. To date, studies combining brain imaging and neuropsychological 
testing in groups at high risk for depression and anxiety, but not yet affected, have been 
scarce and have focused primarily on executive functioning. 
In the present study, performance data did not support the existence of a negative response 
bias in high risk subjects. At the neural level, however, increased left inferior frontal gyrus 
activation by negative words was found in high risk subjects through either genetic or 
environmental risk factors, most prominently during recognition. In other words, genetic and 
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environmental pathways seemed to converge, both pointing towards increased activation 
in the left inferior frontal gyrus in response to negatively valenced words in both high risk 
groups. This may indicate that increased activation of left inferior frontal gyrus in a verbal 
emotional memory task is a useful vulnerability marker for anxiety and depression. 
Section B: Structural Neuroimaging
In chapter 4, the same study sample as in chapters 2 and 3 was used. Volume reductions 
in the temporal lobe were observed in high risk twins, most notably in the left posterior 
hippocampal region, but exclusively in twins at high risk through environmental factors. 
A group comparison between pairs concordant for low or high risk, which is more likely 
to reflect differences in genetic vulnerability, did not show reduced temporal lobe and 
posterior hippocampal volumes in the pairs at high risk for anxiety and depression. This 
pattern of results suggests that damage to temporal lobe structures may be specific to 
an environmentally driven aetiology of anxiety and depression. The following potential 
explanations were considered for this pattern of findings. The high risk discordant twins 
reported exposure to more, and more severe, life stressors early in their lives. In line with 
the glucocorticoid cascade hypothesis, these stressors may well account for part of the 
environmental effects on temporal grey matter volume, especially the hippocampal region, 
having a high density of glucocorticoid receptors. An alternative explanation is epigenetic 
reprogramming. Epigenetic reprogramming can create large phenotypic divergence in 
genetically identical subjects by selectively repressing the expression of some genes. In 
particular in older twins, remarkable differences in their gene-expression profile have been 
found63. 
Epigenetic drift, therefore, is a potential source for discordance in amygdala activation, left 
temporal volumes and the risk for anxiety and depression. Finally, it might be possible that 
both explanations converge, and that life stress and hypothalamic-pituitary-adrenocortical 
(HPA)-axis activation somehow have a direct impact on epigenetic reprogramming. Future 
(longitudinal) studies should address this important question. 
Discussion sections A and B
Several lines of evidence suggest the presence of specific neural circuits within the limbic 
cortical system that mediate stress responsiveness, mood and emotion regulation64-66. 
A recent comprehensive meta-analysis revealed brain volume reductions in depressed 
patients in many regions related to emotional processing and stress regulation, such as the 
frontal lobe and hippocampus, and amygdala67. In the studies described in this thesis both 
volumetric and functional abnormalities were found in those regions. 
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The hippocampus is well known to be a target for glucocorticoids, which potentially contribute 
to atrophy in this brain structure68-79. Furthermore, amygdala and prefrontal cortex are also 
involved in HPA-axis regulation. This is important to note, as depression has been associated 
with disrupted HPA-axis activity and increased cortisol levels80,81, also mentioned in section 
B. Several mechanisms have been proposed to explain how prolonged stress can result in 
limbic and prefrontal (volumetric) abnormalities, such as decreased dendritic branching82,83, 
loss of neurons, or decreased expression of brain derived neurotrophic factor68,82,84. Evidence 
for stress induced brain abnormalities in depression is also provided by studies examining 
genetic variations in the glucocorticoid receptor gene. Especially functional polymorphisms 
of the NR3C1 (nuclear receptor subfamily 3, group C, member 1) gene are associated with 
increased susceptibility to depression68,85,86. Interestingly, a recent study reported an 
association of four illness-related polymorphisms of the NR3C1 gene with overall smaller 
hippocampal volumes in patients with depression87. This suggests that risk alleles of the 
NR3C1 gene influence hippocampal volume, and it would not be surprising when future 
research will reveal more risk alleles associated with volume changes or differences in 
activation, potentially confounding study results with un unknown effect size.
A genetic variant that repeatedly has been implicated in amygdala function is the 5-HTTLPR 
promoter polymorphism. The short allele (S) of the promoter polymorphism is associated 
with reduced expression of the gene and lower availability of the transporter88,89, and 
individuals carrying the s-allele tend to have increased anxiety related temperamental traits, 
which in turn are related to increased risk of developing depression68,90.  The few studies that 
examined the association between 5-HTTLPR polymorphism and brain volumes in depressed 
patients showed mixed results with respect to amygdala and hippocampus93-96, but fMRI 
studies systematically have shown that this polymorphism affects amygdala activity in 
response to emotional stimuli38,89,91. This latter finding was not replicated in the study 
described in this thesis, but sample size may have been a major issue. 
Frontal regions (anterior cingulate, orbitofrontal and prefrontal cortex) are known to exert 
emotion regulation by inhibiting the activity of limbic regions such as the hippocampus and 
the amygdala97,98. Prominent volume reductions in those frontal regions in major depression 
were demonstrated68 in many studies. Although these findings were not replicated, evidence 
for different functional activation in the left inferior frontal gyrus during emotional word 
processing was shown.   
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Limitations of the MRI twin study design
When studying the effects of anxiety and depression on MRI traits, four important effects 
need to be disentangled: the effects of an ongoing depressive episode, the effects of anti-
depressant medication, the effects of vulnerability traits and the effects of increased anxiety 
at the time of scanning. The main intent was to detect effects of trait vulnerability caused 
either by detrimental environmental or genetic risk factors, which meant that the other 
three (confounding) effects needed to be contained as much as possible. It was possible 
to limit the effects of current depression and antidepressant medication. Apart from one 
exception in a concordant high-risk pair, no twin was diagnosed with current MDD at the 
time of scanning, and only one subject used antidepressants (results did not noticeably 
differ after excluding these subjects). However, there clearly were higher levels of state 
anxiety and depressive symptoms scores at the time of scanning in the (trait) high risk twins. 
Increased left inferior frontal gyrus activity during emotional words may therefore reflect 
state anxiety at the time of scanning rather than genetic or environmental effects on this 
brain region. Although this first limitation is recognised, it is very hard to envision a design 
that successfully separates state and trait anxiety. 
 A second limitation is the absence of baseline activation measurements. A prerequisite 
of finding a significant BOLD signal is that task related activation in a region of interest is 
significantly different from the reference baseline activation in that region, as fMRI is based 
on relative measurements. However, it is likely that the response to stimuli is simply based 
on ceiling effects, as the response is dependent on the baseline activation99. Therefore, 
interpreting genetic and environmental effects on regional fMRI contrasts should ideally be 
done in relation to parallel genetic and environmental effects on baseline activation of those 
regions. 
Conclusions sections A and B
In conclusion, the main finding of these studies was that genetic and environmental 
risk factors for anxiety and depression may impact on partly different brain structures 
(amygdala, hippocampus), but that they could also converge on the same brain structures 
(frontal lobe). Therefore, future brain imaging studies on anxiety and depression should aim 
to avoid an admixture of subjects who are at genetic risk with those at risk for environmental 
reasons. This can, in principle, be done by selecting patients with known exposure to strong 
environmental risk factors (e.g. childhood trauma) or with known genetic risk markers. Based 
on the current understanding of the role of genetics in psychiatric disorders, however, the 
discordant/concordant MZ twin design remains the most powerful method of separating 
genetic and environmental risk factors. If fMRI is used as the imaging modality, however, 
an active attempt should be made to measure baseline activation levels, for example by 
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using15OH2O PET for absolute measurements of cerebral perfusion or arterial spin labelling 
techniques.
Summary section C: Molecular Neuroimaging
NK1 receptors have been implicated in various neuropsychiatric and other disorders, and 
NK1 receptors are potentially important targets for drug development, as they have been 
implicated in depression, anxiety and pain perception. R116301 is a selective high affinity NK1 
receptor antagonist. In chapter 5, a pilot study was performed, evaluating [11C]R116301 as a 
potential PET ligand for the NK1 receptor. More specifically, the presence of a specific signal 
was investigated using two dynamic 90 minutes [11C]R116301 scans, separated by 5 hours, in 
3 normal volunteers, before and after an oral dose of 125 mg aprepitant. Data were analysed 
using striatum to cerebellum standardised uptake value (SUV) ratios. Baseline SUV ratios at 
60-90 minutes after injection ranged from 1.22 to 1.70. Following aprepitant administration 
this specific signal was completely blocked. Aprepitant administration did not significantly 
affect cerebellar uptake, confirming the absence of NK1 receptors in cerebellum. These 
preliminary results indicated that [11C]R116301 has potential as a radioligand for in vivo 
assessment of NK1 receptors in the human brain. 
As a specific signal was found in chapter 5, chapter 6 describes the evaluation of various 
quantitative outcome measures of [11C]R116301 binding in healthy subjects using both 
blocking and test-retest data with the aim to find the optimal model for quantification. Two 
dynamic 90 minutes [11C]R116301 scans, separated by 5 hours, were performed in 11 healthy 
volunteers. Data from the blocking study, using the same 3 paired PET studies as in chapter 
5, were now used for further evaluation, whilst in the other 8 no intervention was performed 
(i.e. test-retest). Whole striatum, as defined on a co-registered MRI scan, was used as tissue 
of interest, as it has the highest density of NK1 receptors. Cerebellum was used as reference 
tissue. Unfortunately, measured plasma curves were not reliable due to severe stickiness 
of the tracer. Even after implementing a validated sticking correction, no useful results 
were obtained when plasma input models were used. In contrast, reference tissue models 
appeared to be more stable with the simplified reference tissue model (SRTM) performing 
best. Average (± SD) SRTM derived mean binding potential BPND of all (first) baseline scans was 
0.64 ± 0.31, which reduced to –0.01 ± 0.03 following aprepitant administration. Test-retest 
results showed good variability (14.0 ± 10.7%) and excellent reliability (intraclass correlation 
coefficient ICC = 0.93) for SRTM derived BPND. Striatum to cerebellum SUV ratios minus 1, 
an approximation of BPND, showed excellent variability (6.2 ± 3.1%) with excellent reliability 
(0.98) and correlated well with SRTM (r2 = 0.96) with acceptable (15%) bias. In conclusion, 
SRTM was found to be the optimal model for quantification of [11C]R116301 binding, but semi-
quantitative SUV methods hold promise for routine clinical applications.
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Discussion section C
Subsance P (SP) was first discovered by Ulf von Euler and John Gaddum in 1931100. Gaddum 
and Schild101 named this new agent SP, P referring to the powder which was obtained after 
the extraction procedure from equine brain and gut, and which was found to have potent 
hypotensive and smooth muscle contractile properties.
To date, almost 8 decades later, the neuropeptide SP and its preferred receptor, the tachykinin 
neurokinin type 1 (NK1) receptor, have been of particular interest because of their potential 
implication in various neuropsychiatric and other disorders. Depression and anxiety, 
for example, are related to changes in the release of SP binding to NK1 receptors in the 
human brain102-106. However, despite extensive preclinical and clinical studies on the widely 
distributed central pathways and NK1 receptors in pain, anxiety, depression, schizophrenia, 
Parkinson’s disease, and Alzheimer’s disease and other neuro-psychiatric disorders, to date, 
NK1 receptor antagonists have only found proven efficacy in the prevention of acute and 
delayed chemotherapy induced nausea and vomiting.
The NK1 antagonist, aprepitant (EMEND®) is on the market for treatment of radio- and 
chemotherapy induced emesis.  Recently, compounds like casopitant and AV608 have 
entered phase II clinical trials for various indications such as myalgia, insomnia, irritable 
bowel syndrome and urinary incontinence. As there is very little known about the functions 
mediated by SP in humans, PET imaging of NK1 receptors is a useful tool to study this 
system in health and psychiatric and neurological diseases. Moreover, it could be a useful 
tool to visualise and quantify specific receptor binding in order to gain more insight in 
neurotransmitter-receptor function and it could aid in assessing the optimal dose range of 
new drugs that act by occupancy of central NK1 receptors. For this purpose, quantification of 
[11C]R116301 binding to the NK1 receptor was evaluated in section C. 
Conclusions section C
It can be concluded from these PET studies, that SRTM107 is the optimal model for 
quantification of [11C]R116301 binding. This method shows good test-retest variability and 
good reliability, and it seems feasible to shorten scan durations. Tissue ratio methods hold 
promise for clinical applications as even shorter scan durations can be used.  In future studies, 
tissue ratio methods need to be further validated over a larger range of BPND. Furthermore, it 
will be necessary to demonstrate a difference in BPND between healthy controls and patients. 
In addition, it should be evaluated whether the good correlation with SRTM observed in 
normal controls also applies to various patient populations, for example those who are at 
risk for anxiety and depression, and those who are diagnosed with major depression. In other 
words, this should be performed by comparing groups with abnormal NK1 receptor status 
with healthy controls. 
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At present, there is no ideal PET tracer for NK1 receptors. Of the available tracers 
[18F]SPARQ shows a much higher specific signal than [11C]R116301. Therefore, at least in 
theory, it should provide a more accurate assessment of NK1 receptor status or occupancy, 
which could be important dealing with small differences between groups. For example, 
the expected reduction in binding of NK1 receptors in anxiety and depression (12-21% panic 
disorder) can better be studies using [18F]SPARQ, as far fewer patients would be required. 
Nevertheless, for clinical applications and also for research purposes,[18F]SPARQ is hampered 
by its slow kinetics, requiring very long study durations, thereby increasing the risk of 
movement artefacts. At the cost of a reduced signal,[11C]R116301 has the advantage that 
studies can be performed within a reasonable time (90 minutes).[11C]R116301 could have a 
future role in assessing whether a (new) drug results in significant NK1 receptor occupancy.
When ranking the affinity of NK1 ligands, it is clear that the affinity of R116301 is lower 
than that of SPARQ, which is in agreement with the higher specific signal observed with 
[18F]SPARQ On the other hand, the lower affinity of R116301 implies that [11C]R116301 could 
be more sensitive to differences in endogenous substance P concentrations. This would 
be very interesting in intervention studies, where release of the endogenous ligand could 
be manipulated by a pharmacological challenge or, for example, a fear stimulus. In fact, 
[11C]R116301 should be ideally suited for this, as it has a lower affinity than any other (known) 
available alternative tracer for the NK1 receptor. Clearly, further studies are needed to 
establish whether this is feasible. 
Future perspectives
This thesis has shown the power of a discordant/concordant MZ twin design to detect, 
using MRI, structural and functional brain differences in subjects at genetically and/or 
environmentally determined low and high risk for anxiety and depression. Future studies 
may apply this fMRI and molecular imaging design to other neuropsychiatric illnesses based 
on a combined genetic and environmental aetiology. First, the issue of differences in baseline 
activation between groups and within an MZ twin pair could be addressed by making use of 
either [15O]H2O PET for absolute measurements or arterial spin labelling (MRI) as an imaging 
tool for cerebral perfusion. This will allow comparison of baseline activation states within 
twin pairs to possibly explain differences in neuronal activation measured, using fMRI. One 
of the drawbacks of arterial spin labelling is its inability to explore the whole brain. It may, 
nevertheless, be suitable to study one specific region of interest. 
Secondly, further use of PET could clarify differences in genetic and environmental risk 
factors on a molecular (e.g. receptor) level and, therefore, help with interpreting results of 
functional and structural neuroimaging studies in the same subjects. Various ligands for 
neuroreceptor mapping can be used. For example, serotonin transporter (SERT) status can be 
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investigated using [11C] DASB, a ligand to the serotonin transporter receptor. This can be used 
to explore possible differences in receptor status between genetically and environmentally 
determined risk factors. Therefore, receptor density and affinity of the ligand to the receptor 
in specific brain regions could shed some light on the functional and structural imaging 
data, i.e. increased activation or volume reduction in a region of interest could be associated 
with a change in receptor status in this region. 
As mentioned in the discussion of sections A and B, genetic and environmental risk factors 
could lead to differential underlying neurobiological mechanisms, such as differences in 
receptor status. These differences (different types of vulnerability profiles for the specific 
disorder) at a receptor level may have differential responses to pharmacologic intervention 
(treatment). Unravelling these underlying mechanisms in future research could, therefore, 
lead to novel or more individualised therapeutic or even preventive strategies. 
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Dit proefschrift beschrijft de resultaten van onderzoek naar hersengebieden die betrokken zijn 
bij angst en depressie met behulp van verschillende beeldvormende (neuroimaging) technieken. 
De gebruikte technieken worden hier kort toegelicht. Om functionele en structurele verschillen 
in de hersenen zichtbaar te maken werd gebruikt gemaakt van zowel functionele- als structurele 
magnetic resonance imaging (MRI), dat wil zeggen beeldvorming van de hersenen, waarbij gebruik 
wordt gemaakt van magnetische resonantie. Functionele MRI (fMRI) is een speciale MRI techniek, 
die gebruik maakt van zeer kleine regionale veranderingen in de  bloeddoorstroming, welke wordt 
veroorzaakt door neuronale activiteit in het betreffende hersengebied tijdens het maken van een 
neuropsychologische taak. 
Om de binding van bepaalde stoffen (liganden) aan specifieke receptoren in de hersenen te 
kwantificeren werd gebruik gemaakt van positron emissie tomografie (PET). Bij deze techniek 
wordt een zeer kleine hoeveelheid van de stof radioactief gelabeld met een positron emitter en, na 
intaveneuze injectie, worden opname en klaring in de hersenen afgebeeld en gemeten met een PET 
scanner. Door toepassing van geschikte tracer modellen kan vervolgens de binding van deze ligand 
(tracer) aan de receptor gekwantificeerd worden.  
In sectie A en B van dit proefschrift worden de functionele en structurele neuroimaging studies 
bij eeneiïge of wel monozygote (MZ) tweelingen met hoog en laag risico voor angst en depressie 
besproken. In sectie C, wordt een nieuwe PET ligand voor neurokinine1(NK1)-receptoren in vivo 
onderzocht. De NK1 receptor is betrokken bij angst en depressie. 
Deze benadering kan de basis vormen voor toekomstig beeldvormend genetisch (imaging genetics) 
onderzoek gericht op functionele, structurele en moleculaire (receptor ligand) veranderingen, om 
op die manier de bijdrage van genetische- en omgevingsrisicofactoren voor angst en depressie te 
ontwarren.
 
Samenvatting secties A en B
De MZ discordant/concordant tweelingstudie
In sectie A en B, werd de hypothese getest of genetische- en omgevingsrisicofactoren voor angst en 
depressie a) van invloed zijn op gedeeltelijk verschillende hersenstructuren en/of b) in het geval dat 
deze risicofactoren van invloed zijn op dezelfde hersenstructuren, dit wordt bereikt  op een geheel 
andere, wellicht tegengestelde, manier.
Daartoe werden twee imaging technieken gebruikt in MZ tweelingparen sterk concordant of 
discordant voor het risico op angst en depressie om verschillen in structuur en functie aan te tonen 
tussen de tweelingparen. Dit risico op angst en depressie werd berekend op basis van longitudinale 
onderzoeksgegevens over angst, depressie, neuroticisme en somatische angst, verzameld in 1991, 
1993, 1997 en 2000. Eerder werd een sterk voorspellende waarde op klinische angst en depressie 
aangetoond op basis van deze onderzoeksgegevens, die voortkwamen uit het Composite 
International Diagnostic Interview. 
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Omdat MZ tweelingparen als genetisch identiek beschouwd kunnen worden, zou hun risico voor angst 
en depressie moeten worden veroorzaakt door differentiële blootstelling aan omgevingsinvloeden. 
Hieruit vloeit voort dat de intrapair vergelijking van de discordante tweelingen verschillen laat zien 
in neuronale activiteit en hersenstructuur, die gevoelig zijn voor omgevingsfactoren. Er werden in 
totaal 10 MZ tweelingparen geselecteerd, discordant voor het risico op angst en depressie.
Bij de MZ tweelingparen die geselecteerd werden als hoog of laag concordant, was het risico op 
angst en depressie ofwel zeer hoog in beide leden van het paar (zelfs al waren ze blootgesteld aan 
verschillende omgevingsfactoren) ofwel zeer laag in beide leden. Het vergelijken van deze twee 
groepen creëert een genetische contrast, hetgeen werd bevestigd door te controleren of de ouders 
van deze tweelingen inderdaad ook hoog versus laag risico scores hadden. Vandaar dat de laag-/
hoog-groepsvergelijking van concordante tweelingen de verschillen laat zien in neuronale activiteit 
en hersenstructuur, die gevoelig zijn voor genetische factoren. Er werden in totaal 10 concordant 
hoge en 15 concordant lage MZ tweelingparen geselecteerd.
 
Sectie A: Functionele Neuroimaging 
Eerdere functionele neuroimaging studies lieten een veranderde activatie van de amygdala op 
emotionele stimuli zien, waarbij zowel hyperactiviteit als hypo-activiteit werd gerapporteerd 
bij angst en depressie patiënten in vergelijking met gezonde controles. In hoofdstuk 2, werd de 
hypothese getest of deze tegenstrijdige bevindingen zijn gebaseerd op het verschil in effect van 
genetische- en omgevingsrisicofactoren op het functioneren van de amygdala. Om deze hypothese 
te testen, werd de amygdala reactie op een emotionele gezichtentaak bepaald tijdens fMRI in MZ 
tweelingparen die discordant, concordant hoog of concordant laag zijn, voor het risico op angst 
en depressie. Tijdens de taak werden er verschillende emotioneel beladen gezichten getoond, nl 
angstige, boze, blije en neutrale gezichten, afgewisseld met een baseline. Het hoofdeffect (alle 
gezichten  versus baseline) van de taak liet een robuuste bilaterale amygdala-activiteit zien over alle 
groepen. Er werd een toegenomen amygdala response gevonden op negatieve stimuli (boos/angstige 
gezichten) in de discordant tweelingen met hoog risico op angst en depressie in vergelijking met hun 
discordant co-tweelingen met een laag risico. In tegenstelling hiermee lieten concordant hoge paren 
een afgestompt of ‘blunted’ amygdala reactiviteit zien op zowel positieve als negatieve gezichten 
in vergelijking met concordant lage paren. Post-hoc analyses toonden aan dat deze bevindingen 
onafhankelijk waren van het serotonine transporter (5-HTTLPR) genotype. 
Deze bevindingen wijzen erop dat de amygdala hyperactiviteit werd gevonden bij deelnemers 
met een hoog risico op angst en depressie gebaseerd op omgevingsfactoren, terwijl amygdala 
hypoactiviteit juist werd gevonden bij deelnemers die een hoog risico op angst en depressie hadden 
voornamelijk op basis van genetische factoren. De hyperactiviteit van de tweelingen met verhoogd 
risico op basis van omgeving verdween na correctie voor het angstniveau (‘state anxiety’), wat 
aangeeft dat hyperreactiviteit door emotionele stimuli samengaat met een verhoogde staat van 
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angst. Het angstniveau was eveneens verhoogd in de tweelingen met een hoog risico op angst 
en depressie op basis van een genetisch risico. Echter, de reponse van de amygdala op emotionele 
stimuli ten op zichte van neutrale stimuli was bij deze groep lager en deze hypoactiviteit verdween 
ook niet nadat met state anxiety rekening was gehouden. Deze resultaten zouden kunnen duiden 
op een verhoogde baseline activiteit van de amygdala bij deelnemers met een hoog genetisch risico 
op angst en depressie, welke zou kunnen dienen om verdere activatie ten gevolge van een algemene 
verhoging van het angstniveau of op basis van een specifieke emotionele stimulus (boos gezicht) te 
verminderen. 
 
In hoofdstuk 3, werd emotionele verwerking en hersenactiviteit onderzocht tijdens een coderings- en 
herkenningstaak met behulp van emotioneel geladen woorden (negatief, neutraal, positief en een 
baseline) in dezelfde onderzoeksgroep als in hoofdstuk 2. Psychologische theorieën over ernstige 
depressie hebben de rol benadrukt van een negatieve bias in de informatie-verwerking in de etiologie 
en het beloop van de aandoening. Een dergelijke emotioneel negatieve bias wordt zowel gezien bij de 
interpretatie als bij de opslag van emotionele informatie. Deze bevinding zou mogelijk kunnen wijzen 
op het bestaan van een emotionele bias voorafgaand aan de ontwikkeling van een klinische depressie 
en op die manier gezien kunnen worden als een risicofactor voor de verdere ontwikkeling van deze 
ziekte. Om te onderzoeken of de emotionele bias vooraf gaat aan de ontwikkeling van een depressie 
is het noodzakelijk om mensen te onderzoeken met een verhoogd risico op angst en depressie, maar 
die geen depressie of angst diagnose hebben. Tot op heden zijn functionele MRI studies, waarbij de 
deelnemer een bepaalde neuropsychologische test uitvoert tijdens het scannen, schaars, in groepen 
met een hoog risico op depressie en angst. De studies die beschikbaar zijn hebben zich voornamelijk 
gericht op het uitvoerende ofwel executieve functioneren.
In de studie beschreven in dit hoofdstuk, boden de performance data geen ondersteuning voor het 
bestaan van een negatieve emotionele respons bias in deelnemers met een hoog risico op angst en 
depressie. Op neuronaal niveau, echter, werd verhoogde activiteit gevonden in de linker frontale gyrus 
inferior op negatieve woorden bij deelnemers met een hoog risico, hetzij door middel van genetische-, 
hetzij door middel van omgevingsfactoren. Dit was het meest opvallend tijdens de herkenningstaak. 
Met andere woorden, genetische en omgevingsfactoren leken te convergeren. Dit kan betekenen 
dat verhoogde activering van de linker frontale gyrus inferior in een herkenningstaak met behulp 
van emotioneel geladen woorden, gebruikt zou kunnen worden als een kwetsbaarheidsmarker voor 
angst en depressie, ongeacht de onstaanswijze.
 
Deel B: Structurele Neuroimaging
In hoofdstuk 4 werd bij tweelingen met een hoog risico op angst en depressie een volume vermindering 
waargenomen in de temporaalkwab, met name in de linker posterior hippocampale regio. Echter, 
dit werd uitsluitend gevonden bij tweelingen met een hoog risico door omgevingsfactoren. Een 
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groepsvergelijking tussen hoog en laag concordante paren, welke meer verschillen in genetische 
kwetsbaarheid weergeeft, liet geen volume vermindering zien in de temporaalkwab en de 
hippocampus posterior in de paren met een hoog risico op angst en depressie. Deze resultaten 
geven aan dat schade aan de structuren van de temporaalkwab specifiek zouden kunnen zijn voor 
een omgevingsgedreven pathogenese van angst en depressie. De volgende mogelijk verklaringen 
voor deze resultaten werden overwogen. De discordante tweelingen met hoog risico voor angst 
en depressie rapporteerden vaker, en ernstiger blootstelling aan life stressors vroeg in het leven. 
In lijn met de glucocorticoid(stresshormoon)-cascade-hypothese, zouden deze life stressors zeer 
wel verantwoordelijk kunnen zijn voor een deel van de omgevingseffecten op de grijze stof van de 
temporaal kwab, met name de hippocampus regio, welke een hoge dichtheid aan glucocorticoid 
receptoren heeft. Een alternatieve verklaring is epigenetische herprogrammering. Epigenetische 
herprogrammering kan in genetisch identieke tweelingen leiden tot grote fenotypische divergentie 
door het selectief onderdrukken of stimuleren van  expressie van bepaalde genen. Er zijn opmerkelijke 
verschillen in gen-expressie profiel gevonden in met name oudere tweelingen. 
Epigenetische drift is dus een potentiële bron voor het ontstaan van discordantie in de amygdala 
activiteit, de volumina van de linker temporaal kwab en het risico op angst en depressie. Ten slotte 
is het mogelijk dat beide verklaringen convergeren en dat life stress en de hypothalamus-hypofyse-
bijnierschors (HPA)-as activatie op een of andere manier een directe impact hebben op epigenetische 
herprogrammering. Toekomstige (longitudinale) studies zouden gericht kunnen zijn op deze 
belangrijke vragen. 
Samenvatting sectie C
Moleculaire Neuroimaging 
NK1-receptoren zijn betrokken bij diverse neuropsychiatrische en andere aandoeningen, en zijn 
potentieel belangrijke targets voor de ontwikkeling van geneesmiddelen, omdat ze een rol spelen in 
o.a. angst, depressie en pijn perceptie.
R116301 is een selectieve antagonist met hoge affiniteit voor de NK1 receptor. In hoofdstuk 5 is een 
verkennende studie (pilot) uitgevoerd bij drie gezonde vrijwilligers, ter evaluatie van [11C]R116301 als 
een potentiële PET ligand voor de NK1 receptor, waarbij met name de aanwezigheid van een specifiek 
signaal werd onderzocht. Dit werd gedaan met behulp van twee dynamische [11C]R116301 scans met 
een duur van 90 minuten. De tweede scan bij dezelfde vrijwilliger vond 5 uur na de start van de 
eerste scan plaats, vóór en na een orale dosis van 125 mg aprepitant, waarmee het specifieke signaal 
geblokkeerd zou moeten worden. De data uit deze scansessies werden geanalyseerd door de ratio 
te nemen van de opname in het striatum en het cerebellum (de kleine hersenen), met behulp van 
gestandaardiseerde waardes voor opname (SUV). Het striatum is de regio met de hoogste dichtheid 
aan NK1 receptoren. Het cerebellum is juist een regio zonder NK1 receptoren, en kan om die reden 
als referentie regio fungeren. Baseline (scan zonder interventie) SUV ratios op 60-90 minuten na 
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injectie varieerden van 1,22 tot 1,70. Na toediening van aprepitant werd volledige blokkade van dit 
specifieke signaal bereikt. De toediening van aprepitant had geen significante invloed op de opname 
in het cerebellum, hetgeen de afwezigheid van NK1-receptoren in het cerebellum bevestigd. Deze 
voorlopige resultaten geven aan dat [11C]R116301 mogelijkheden biedt als een radioligand voor de in 
vivo evaluatie van NK1-receptoren in de humane hersenen. 
Omdat een specifiek signaal werd gevonden in hoofdstuk 5, beschrijft hoofdstuk 6 de evaluatie van 
verschillende kwantitatieve uitkomstmaten van [11C]R116301 binding in gezonde vrijwilligers met 
behulp van zowel de data van de blokkade studie als de data van een test-retest studie met als doel 
het meest geschikte model voor kwantificatie te vinden. Zoals eerder beschreven werden er twee 
dynamische [11C]R116301 scans uitgevoerd met een duur van 90 minuten, waarbij de tweede scan 5 
uur na de start van de eerste scan plaatsvond in 11 gezonde vrijwilligers. De data uit hoofdstuk 5, de 
eerste 3  gepaarde PET scans uit de blokkade studie (vóór en na een orale dosis van 125 mg aprepitant) 
werden gebruikt voor verdere analyse, terwijl bij de andere 8 gepaarde PET scans geen interventie werd 
uitgevoerd (test-retest). De conclusie was dat de meest stabiele resultaten werden verkregen met 
een methode die ‘simplified reference tissue model’ wordt genoemd, afgekort SRTM. Deze methode 
heeft in principe het voordeel dat het afnemen van bloed uit de polsslagader niet noodzakelijk is. 
Hierdoor is het scannen minder belastend voor vrijwilligers. Gebruik makend van deze methode, 
lieten de test-retest resultaten goede variabiliteit zien (14,0 ± 10,7%) en uitstekende betrouwbaarheid 
(ICC intraclass correlatiecoëfficiënt = 0,93) voor SRTM afgeleide BPND, een maat voor binding van de 
ligand aan de receptor. De ratio van striatum en cerebellum SUV minus 1, een benadering van BPND, 
bleek een uitstekende variabiliteit (6,2 ± 3,1%) met een uitstekende betrouwbaarheid (0,98) te laten 
zien en correleerde goed met SRTM (r2 = 0,96), met een acceptabele (15%) bias. Tot slot, SRTM bleek het 
optimale model om [11C]R116301 binding te kwantificeren, terwijl semi-kwantitatieve methoden zoals 
SUV ratios gebruikt zouden kunnen worden voor standaard klinische toepassingen in de toekomst.
Conclusie
De belangrijkste resultaten van dit proefschrift waren dat genetische- en omgevingsrisicofactoren 
voor angst en depressie van invloed kunnen zijn op gedeeltelijk verschillende hersenstructuren 
(amygdala en hippocampus), maar dat deze risicofactoren ook kunnen convergeren op dezelfde 
hersenstructuur (frontaal kwab).  Daarom zou toekomstig beeldvormend onderzoek  in de 
hersenen bij angst en depressie moeten worden uitgevoerd bij vrijwilligers die geselecteerd zijn op 
een ofwel genetisch ofwel omgevings bepaalde risicofactor. 
Toekomstige studies met een zelfde design zouden functionele, structurele MRI en moleculaire 
neuro-imaging kunnen toepassen op andere neuropsychiatrische stoornissen die ook gebaseerd zijn 
op een gecombineerde genetische en omgevings gedreven etiologie. 
Nederlandse samenvatting
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Allereerst wil ik graag alle gezonde proefpersonen en patiënten bedanken voor hun deelname 
aan het onderzoek, en voor hun geduld en vertrouwen in deze projecten. De tweelingen wil 
ik graag speciaal bedanken voor de lange scandagen die plaatsvonden in het weekend. Ik heb 
met veel plezier met jullie gewerkt.
Naast mijn mede-auteurs bedank ik graag iedereen die mij de afgelopen jaren heeft geholpen 
met het onderzoek. Een paar personen zou ik graag in het bijzonder noemen:
De promotiecommissie werd pas aan het einde van mijn promotie-periode definitief 
vastgesteld, waarin ieders kwaliteiten elkaar goed aanvulden.
Beste Witte, jij hebt me de mogelijkheid gegeven om te promoveren. Tot het einde van mijn 
promotietijd had jij de hoop dat de productie van [18F]MPPF (humaan) alsnog op tijd werd 
goedgekeurd. Het humane MPPF protocol  werd herschreven en goedgekeurd (warm en 
koud MPPF) in verband met veroudering van het eerste  protocol. De rattenstudie met de 
5HT1A receptor ligand [18F]MPPF werd wel uitgevoerd, maar kon in verband met praktische 
problemen moeilijk worden opgeschreven. In de tussen tijd zijn we, op initiatief van Adriaan, 
overgestapt op een studie met de [11C]R116301 tracer welke eerder door onze groep werd 
toegepast op apen. En verder ben ik, door jou toedoen, de functionele en structurele MRI 
studie met de discordante twins met hoog en laag risico voor angst en depressie gaan doen. 
Een beter zij-traject had ik me niet kunnen voorstellen. Dank voor de geboden mogelijkheid. 
Beste Adriaan, bij aanvang van dit project was jij de enige die als hoogleraar direct betrokken 
was bij dit project. Witte, Eco en Dick volgden je. Jij had de rust en de klasse om te bemoedigen 
waar dat nodig was, ongeacht de omstandigheden, en je verstaat je vak als de beste. Misschien 
was je net zo bevlogen geweest als je andere keuzes had gemaakt en voor de psychiatrie had 
gekozen ;-). Met name door jouw steun kreeg ik ook de mogelijkheid om kennis en ervaring 
op te doen buiten de Nederlandse landsgrenzen. Hopelijk volgen er in de toekomst meer 
psychiatrie/genetica studies op de afdeling nucleaire geneeskunde en PET research.
Beste Eco, als geen ander had jij oog voor het belang van het afronden van projecten. Met 
jouw ongeëvenaarde tempo en gedrevenheid is het nu af. Jij hebt je niet alleen gebogen over 
het twin design, maar vervolgens je vleugels over het gehele project uitgeslagen. Hoewel 
enigszins op afstand, heb ik juist heel erg veel aan je steun gehad. Je bijdrage was zeer 
verfrissend.
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Beste Dick, jij hebt me intensief begeleid met de analyses van de MRI studies. Het verkopen 
van de oogst was een ingewikkelde klus, waarbij de prille eerste samenwerking vanuit de 
afdeling Psychiatrie met de afdeling Biologische Psychologie verder vorm kreeg.
De medewerkers van de afdeling Nucleaire Geneeskunde en PET Research en van de afdeling 
Radiologie wil ik graag bedanken voor de prettige en leerzame samenwerking. Jullie maakten 
me wegwijs in de wereld van de PET en de MRI. Ook de andere Neuro-imaging promovendi en 
post-docs: bedankt voor alle hulp en gezelligheid. In het bijzonder wil ik noemen de Michiel 
de Ruiter, Joost Kuijer en Marjan Nielen voor de hulp met de Sonata scanner en het in elkaar 
zetten van de taakjes en Bert Windhorst voor de adviezen van allerlei aard.  Daarnaast speciale 
dank aan Amanda, Bart, Ronald, Mark, Maqsood, Robert, Gert, Henri, Patricia, Femke, Harry, 
Ab, Emile, Remi, Kevin, Carla en Virginie. De collega’s op de J-vleugel, o.a Reina, Nikie, Jurgen, 
Floris, en Anke. En dan de dames van de neuroPET, Nelleke, Hedy, Ursula, en Alie: heel veel 
dank voor alle steun en gezelligheid. I would like to thank Kaoru Maruyama from Japan for the 
contribution to our work. It was an intensive and fruitful collaboration.
Verder wil ik de medewerkers van de afdeling Biologische Psychologie bedanken, in het 
bijzonder Dorret Boomsma, voor de steun en het vertrouwen en de geboden kans en Kim en 
Marcel voor hun betrokkenheid bij de twin studie. Zonder jullie was het niet gelukt.
Natuurlijk ook veel dank voor de hulp van de medewerkers van de afeling Psychiatrie, 
en met name de promovendi van de Psychiatrie/Neuro-imaging: Ursula, Peter en Odile: 
gedeelde smart is halve smart.
Verder ook dank aan alle medewerkers van de afdeling Klinische Genetica van het LUMC. 
Mijn naaste collega’s, veel dank voor de gezelligheid aan Emmelien, Marije, Maartje, Dietje, 
en Gijs. In het bijzonder dank aan mijn opleider, professor Martijn Breuning, die mij uit 
het promotiemoeras –zo voelde het soms- heeft getrokken door mij de mogelijkheid te 
bieden de opleiding tot klinisch geneticus te volgen en mij te stimuleren dit boekje echt af 
te ronden. Een betere werkplek en een beter opleidingsklimaat kan ik me niet voorstellen. 
Heel hartelijk dank. 
De leden van de leescommissie: prof.dr. K.L. Leenders, prof.dr. H.E. Hulshoff, prof.dr. F. Barkhof, 
prof.dr. R. Van Dyck. Allen bedankt voor het bestuderen van mijn proefschrift. Furthermore, 
I would like to thank professor Vincent Cunningham for his interest in my thesis. It is a great 
honour that you are a member of my reading committee.
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De laatste loodjes… Esther Beekman, met het fabriceren van dit mooie boekje in mijn 
kraamperiode heb jij je enorm bewezen, niet alleen qua lay out, maar ook qua communicatie 
en improvisatie. Dank daarvoor.
En dan mijn fantastische paranimfen. Lieve Alie, vanaf dag 1 hebben wij lief en leed gedeeld 
in J-089. Het was heerlijk om jou als kamergenoot te hebben. Jij was de bindende factor van 
ontzettend veel gezelligheid. Bedankt voor de mooie tijd en hopelijk hebben we met het 
afronden van onze proefschriften wat meer tijd voor koffie.
Lieve Afke, jij hebt samen met mij de switch gemaakt van Medische Biologie naar Geneeskunde. 
Hoewel jij ook lange tijd in de VS hebt gewoond in de afgelopen jaren, hebben wij toch altijd 
met name onze prive avonturen kunnen delen. Dank je wel daarvoor
Daarnaast heb ik de afgelopen tijd veel steun en plezier gehad van en met mijn familie en de 
familie van Ian uit Suriname, van studiegenoten uit Antwerpen, van de medische biologie 
en geneeskunde. Mijn oude trouwe vrienden van het HML, Julia, Eveline, Rachel en Esther: 
bedankt voor alle warmte. De vrienden uit mijn Engeland periode, en andere vrienden: 
dank je wel voor heerlijke avondjes en telefoontjes. De buren, de ouders en juffen van de St. 
Jozefschool, in het bijzonder Ariaen, Roeselien, Katinka, en juf Reina, inmiddels directeur van 
de school, en de andere juffen: bedankt voor jullie gezelligheid en steun! Ingrid, bedankt voor 
met name alle telefoontjes: alles komt op z’n pootjes terecht. Ook speciale dank aan Lucia, 
voor de ondersteuning van binnen uit: je hebt er inmiddels je beroep van gemaakt.
Lieve papa en mama, dank voor alle stimulans en de enorme steun, niet alleen aan mij, maar 
aan alle gezinsleden. Ontzettend bedankt daarvoor. Mijn kinderen zullen jullie liefde dragen 
en doorgeven.
Lieve Lucas, Juliette en Samuel, bedankt voor jullie komst in ons leven, jullie vrolijkheid, 
onbezorgdheid, wijsheid en liefde. Jullie hebben mij de energie gegeven voor het bereiken 
van deze mijlpaal, en gezorgd dat ik te allen tijde alles kan relativeren.
Lieve lieve Ian, jij bent naar Nederland gekomen, patholoog geworden, wij zijn getrouwd en 
hebben drie kinderen gekregen en nog veel meer… allemaal tijdens mijn promotieperiode. 
Ik had je al met al toch een relaxtere start toegewenst in dit koude landje. Dank je wel voor 
je onvoorwaardelijke steun, je vertrouwen en je liefde voor de kinderen en mij. Jij bent mijn 
eeuwige stimulans om het allerbeste uit mezelf te halen en door te zetten. Dank je wel 
daarvoor en dank je voor nog ontzettend veel meer. Laten we ons 5 jaar huwelijk maar voor 
dit jaar op de agenda zetten (6 jaar dus ;-), een paar dagen na 11 mei…
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